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Executive summary 
Introduction 
This report presents the evaluation of Enterprise Ireland’s (EI) RD&I Programme, commissioned 
by the Department of Business, Enterprise & Innovation (DBEI) in July 2019 to Technopolis. The 
report is organised into chapters that correspond to the evaluation objectives.  
This evaluation 
This independent evaluation focused on the suite of direct financial supports to firms through 
the EI RD&I Programme. It does not cover RD&I supports provided to High Potential Start-Up 
firms through the RD&I Programme, since these are out of scope of the evaluation. The 
evaluation has three main objectives: 
Objective 1: a) Determine the appropriateness of the Programme, b) Determine the 
effectiveness of the Programme in achieving the desired or any impact, c) 
Determine the effectiveness of the Programme at increasing the number of 
companies investing in RD&I, d) Determine whether the Programme can be 
delivered more efficiently, and e) Assess the performance of the Programme 
relative to similar programmes available in other comparator countries 
Objective 2: a) Compare the role and performance of the direct-to-firm financial supports of 
the EI RD&I Programme in terms of achieving increased BERD to indirect 
supports, b) Explore the synergies of the EI RD&I Programme with indirect 
supports 
Objective 3:  Develop findings, conclusions and recommendations from the evaluation of the 
RD&I Programme and the comparison of the role and performance of 
enterprise RD&I supports 
This study used a mixed-methods approach, comprising desk research, secondary data 
analysis, econometric analysis, a series of high-level interviews, online surveys of Enterprise 
Ireland client firms, and a programme of semi-structured interviews with Enterprise Ireland client 
firms. 
The assessment of impact of the RD&I Fund, and the counterfactual analysis has been done 
via econometric analysis rather than cost-benefit analysis, which some previous evaluations 
have used. 
Support for RD&I 
The RD&I agenda has been championed by successive ministers and policy teams within the 
Department of Business, Enterprise & Innovation (DBEI), through a series of national strategies 
that sought to underpin sustainable growth and stimulation of innovation and 
entrepreneurship. 
Ireland has a comprehensive suite of direct financial enterprise supports to deliver on policy 
goals, delivered primarily through Enterprise Ireland. The RD&I Programme is one of the most 
long-running supports in this space, with the current iteration now in its twelfth year of operation. 
The Programme is comprehensive, and includes the following schemes: The Exploring 
Innovation Grant, the Research and Development (R&D) Fund, The Intellectual Property 
Strategy Offer, The Agile Innovation Fund, and The Business Innovation Offer. These may be 
delivered as standalone grants or as part of a tailored package of supports. Over the period 
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2007-2018, a sum of €464.7m was awarded via 2,005 grants to a total of 1,562 individual firms 
through the RD&I Programme. On average, 5% of EI clients have been awarded a grant in a 
given year over the period. 
Sitting around these direct financial supports are a range of indirect supports. These include 
two procurement-based schemes administered by Enterprise Ireland: European Space Agency 
(ESA) funding1 and Small Business Innovation Research funding,2 as well as two tax-based R&D 
supports, in the form of the R&D Tax Credit and the Knowledge Development Box. 
Appropriateness (Objective 1a) 
The assessment of the RD&I Programme’s appropriateness is addressed through two main 
avenues: i) An examination of alignment with national policies and strategies, and ii) 
Consultation on current and anticipated firm needs.  
The RD&I Programme demonstrates good levels of appropriateness toward both national 
policy and firm needs. The Programme has been consciously developed over its lifetime, in 
response to both client feedback, including the introduction of the Agile Innovation Fund and 
Business Innovation Offer in 2016/17. These two new strands of the Programme address support 
requirements for shorter lifecycle projects and non-technical, business innovations. This – and 
the support available from Development Advisors – makes the RD&I Programme among the 
most comprehensive support schemes available when compared to similar schemes in other 
countries.  
Effectiveness (Objectives 1b, 1c, 2a and 2b) 
Evidence from our econometric analysis and consultation with firms reveal that the Programme 
evidently has a positive impact on a number of innovation and economic performance 
indicators.  
When compared to similar, matched firms that had not received support through the 
Programme, awardees of grants show a significant boost to their R&D performance in the five 
years after receiving their grant(s).  We find that the programme has had substantial positive 
effect on R&D expenditure after five years (between 138% - 157.6% across different measures). 
The increment is quite substantive and partly reflects the fact that the programme has 
attracted a good number of non-RD&I performers (between 8%-14% according to our 
calculations). We also find that the programme has led to positive effects on R&D employment 
albeit a milder one (36%). This milder impact on R&D employment could reflect more extra-
mural R&D and collaboration with external partners among awardees.  
Furthermore, our analysis shows that over the five years since awarding of their grant(s), the 
economic performance of awardees is significantly better than that of matched non-
awardees in terms of  turnover (19.5%), Total value added (35.2%), Employment (18.9%), Export 
sales (69.3%) and Export intensity (49.6%).  
Indicators Average effect after 5 years (increment, in 
comparison with control group) 
R&D performance  
 
 
1 The included assessment of the ESA Programme does not include MNCs and non-EI Client firms, and as such the 
analysis should not be construed as an assessment of Ireland’s return on investment in ESA as a whole 
2 Over the period examined, a total of €46.5m was awarded via 98 grants were awarded to 25 firms through the ESA 
programme, and €0.075m was awarded to four EI client firms 
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Net R&D expenditures 156.9% 
Net R&D expenditures/ turnover 137.8% 
Net R&D expenditures/ employees 138.0% 
R&D employees   36.0% 
R&D employees / total employees 17.0% 
Economic performance  
Turnover 19.5% 
Employment 18.9% 
Total value added 35.2% 
Export sales 69.3% 
Export / turnover 49.6% 
*Only statistically-significant results are shown 
However, the impact of R&D support on overall productivity is less clear. Although productivity 
(as measured by Value Added per Employee) was 16.5% higher among awardees compared 
to the control group, the difference was not statistically significant3. There are two potential 
explanations for this. First, literature suggests that this may be related to the timeframe under 
examination. Secondly, productivity effects may also vary across sectors. For example, sectors 
such as ICT and services tend to be in constant cycles of innovation, meaning almost-perpetual 
reinvestment, which may mask measures of productivity. 
In alignment with results found via econometric analysis, interviews with companies reveal that 
clients do associate positive effects to participation in the programme. The majority of firms 
also suggested that the Programme had allowed them to undertake their RD&I projects at a 
larger scale and sooner than if the support had not been available. The RD&I Fund in particular 
was regarded positively for its contribution to experienced benefits. 
As mentioned above, the Programme is also attracting non-RD&I performers, and appears to 
help a proportion of them to become RD&I-active post-award. 
There is evidence of synergy and positive interaction between the direct financial support 
available through the RD&I Programme and the indirect support for RD&I available particularly 
through the R&D Tax Credit. Firms and stakeholders believe that a holistic approach – i.e. the 
presence of both types of support – is the optimal way to achieve an uplift in RD&I expenditure. 
Efficiency (Objective 1d) 
The examination of the programme’s efficiency through this evaluation was underpinned by 
three dimensions of investigation: i) The processes and procedures related to the 
implementation of the programme, through the lens of awardee satisfaction, ii) the extent to 
which awardees experienced barriers to accessing support and maximising the benefits or 
impact of that support, and iii) the main routes through which firms learn about and access the 
support available through the programme. This approach was taken, as an examination of 




3 The p-value (probability value) is used in hypothesis testing. Since the p-value is above 0.05, this means that we 
have less than 95% confidence that the results are different from zero 
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Awardees are predominantly satisfied with the processes and procedures associated with 
accessing support. Where concerns were raised in consultation, these were largely seen as 
being a reasonable cost for accessing the support, though some consultees noted that the 
turnaround times of agile-track applications where committees are not used to their maximum 
strengths. The main concern raised in terms of procedures related to the recently-introduced 
Business Innovation Offer, whose criteria some firms felt were difficult to grasp. Firms’ 
Development Advisors were the most common routes to access support from the RD&I 
Programme. Among client firms that had not accessed the Programme, the main barrier to 
doing so was a lack of relevance or low awareness. 
Comparative view of RD&I supports (Objective 1e) 
The study selected a range of international programmes with which to compare the RD&I 
Programme. Comparators operate in countries that are either members of the Small Advanced 
Economies Initiative of which Ireland is also a member, or rank well in the latest Global 
Innovation Index (2019) published by Cornell University, INSEAD, and the World Intellectual 
Property Organization (WIPO). The programmes selected as comparators are: Frontrunner 
(Austria), InnoBooster (Denmark), Research, development and piloting for SMEs & midcaps 
(Finland), R&D Fund (Israel), the SME+ Innovation Fund (Netherlands), R&D Project Grant (New 
Zealand), Innovation projects in small and medium-sized companies (Sweden), Innovation 
projects (without innovation partner) (Switzerland), and Smart Grants (UK). 
The Enterprise Ireland RD&I Programme is among the most comprehensive support available 
to firms for RD&I within this set of comparators. This is largely due to the features of the 
international comparator programmes, which in general focus more narrowly on technological 
innovations. The RD&I Programme is made up of more components and supports a broader 
range of activities, from specific IP support to support for business innovations. The addition of 
the Agile Innovation Fund for firms in sectors with short product cycles also stands out among 
the comparators, as does the explicit eligibility of commercialisation costs. The support 
available through Enterprise Ireland appears to be more holistic in nature, due to the presence 
of dedicated Development Advisors that work with firms to identify and signpost additional 
support attached to their funding. 
Recommendations (Objective 3) 
Drawing on the analysis above, we have formulated nine recommendations, broken down 
across appropriateness, effectiveness, efficiency and further monitoring and evaluation. These 
are set out in turn below. 
Appropriateness 
 Our examination of the support available for RD&I, in light of both policy objectives and firm 
needs, suggests that the holistic approach to RD&I support (a mix of both direct and indirect 
supports) is optimal and appropriate. It is clear that the individual supports address different 
objectives and are used differently by firms. Similarly, Ireland appears to be a frontrunner 
among comparators in the ways in which a broad range of firms are addressed via its RD&I 
support. Ireland should continue to invest in both direct and indirect support for RD&I, rather 
than focusing solely on directional grants or indirect supports 
Effectiveness 
 Our econometric analysis and consultation with firms has revealed the RD&I Programme to 
be effective when considering the economic and innovation performance of beneficiaries 
as compared to firms that have not accessed the programme. While the effect of the 
programme on firms’ productivity is less visible, this is likely related to the time period of data 
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examined in this study. Therefore, the current constitution of the Programme should be 
maintained, with sensitivity to the productivity issue – some consideration may need to be 
given to how productivity is addressed in some sectors 
 While our analysis shows that the RD&I Programme performs well in attracting and 
supporting new performers, a recent OECD review suggested that there is untapped 
entrepreneurial potential within the firm base. The review suggests a further role for the Local 
Enterprise Offices across Ireland in order to better tap into this potential for innovation 
among firms. We would mirror this and suggest a review of the role or the Local Enterprise 
Offices to attract firms in the regions, or firms that have not yet applied for RD&I support 
Efficiency 
 It is clear that continual efforts are being made to improve turnaround times for the 
approval of grant applications, however some issues were revealed in consultation 
regarding the use of the R&D Committee for agile-track applications. We recommend that 
these efforts are maintained, and that some  consideration should be given to procedures 
to ensure no barriers exist to accessing appropriate funding along optimal timescales (e.g. 
in scenarios where serial innovators apply for Agile Innovation Fund grants) 
 Furthermore, we would suggest that efforts are continued to simplify the application 
process to encourage greater up-take among less-experienced firms. It is clear that firms 
expect a learning curve in applying for (and managing) public grants, but consultation 
revealed that some Development Advisors believe that application systems could be 
improved, including the online system 
 Consultation with firms revealed a high degree of connectedness and trust in Development 
Advisors, who were the most-commonly reported route to finding out about, and applying 
for support through the RD&I Programme. In order to further broaden the base of firms 
accessing the Programme, more active communication about the Programme and its 
benefits could be instrumented via Development Advisors 
Future monitoring and evaluation 
 Like the expected learning curve in applying to public grants (see above), consulted firms 
also largely reported an expectation to participate in monitoring activities as part of 
accessing public money. Many found this to be manageable once learned, though some 
found difficulties in fulfilling the requirements to complete project timesheets in addition to 
their own systems (leading to duplication), while others found the requirement for an 
external audit of claims to be financially challenging. Some consideration could be given 
to simplifying these requirements in some cases  
 Linked to the second recommendation, above, we believe that there is merit in seeking to 
further understand the link between RD&I and productivity across sectors within the 
economy. This research project would ideally feed into the ways in which data are 
collected through applications and monitoring, as well as broader on-going data 
collection exercises. We would also recommend further monitoring with sensitivity at the 
sectoral level, in order to better assess impact across the programme in the future  
 Finally, in order to gain a better view of the effects of the RD&I Programme on firm 
productivity, we recommend that this evaluation (and specifically the econometric 
exercise) is repeated in two or three years. This would enable the evaluation to examine 
data across a larger time period, ideally seven or nine years after grant award, which 
literature suggests is a more appropriate window to observe productivity effects for such 
activities. The repeated evaluation would also be in a position to take in additional 
monitoring at the sectoral level, as set out in the preceding bullet point   
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1 Introduction 
1.1 This evaluation 
This evaluation was commissioned by the Department of Business, Enterprise & Innovation (DBEI) 
in July 2019. This is an independent evaluation focused on the Enterprise Ireland Research, 
Development and Innovation (EI RD&I) Programme, and runs from July 2019 to March 2020.  
The evaluation focuses specifically on direct financial supports to firms through the EI RD&I 
Programme but does not cover RD&I supports provided to High Potential Start-Up firms through 
the RD&I Programme. The evaluation has three main objectives, presented in the table below. 
Each report section includes a cross-reference to the specific evaluation objective that is to be 
addressed. It should be noted that addressing Objective 2 was hampered by data issues.4 
Objective Evaluation scope 
Objective 1 a) Determine the appropriateness of the Programme, including: an assessment of the Programme in 
relation to Ireland’s enterprise and Innovation policies (past, current and future policy challenges), 
and the economic context that applied during the time period under review; assessment of the 
Programme’s fit with the emerging needs of enterprises 
b) Determine the effectiveness of the Programme in achieving the desired or any impact, including: 
measuring as accurately as possible the direct relationship between the EI RD&I Programme 
supports and increased business expenditure on R&D (BERD); quantifying as accurately as possible 
the full benefits relative to the cost of the programme 
c) Determine how effective the EI RD&I Programme has been at increasing the number of companies 
investing in RD&I and the intensity of these RD&I investments: determine the factors that limit the 
take-up of direct financial supports that can be accessed through the EI RD&I Programme 
d) Determine whether the Programme can be delivered more efficiently 
e) Assess the performance of the Programme relative to similar programmes available in other 
comparator countries. 
Objective 2 a) Compare the role and performance of the direct-to-firm financial supports of the EI RD&I 
Programme in terms of achieving increased BERD, to the roles and performances of: The 
Knowledge Development Box; The R&D Tax Credit; European Space Agency Funding; and Small 
Business Innovation Research. 
b) Explore the synergies with the above RD&I supports to the EI RD&I Programme 
Objective 3 Develop findings, conclusions and recommendations from the evaluation of the RD&I Programme 
and the comparison of the role and performance of enterprise RD&I supports 
1.1 Methodology 
This study used a mixed-methods approach, comprising desk research, secondary data 
analysis, econometric analysis, a series of high-level interviews, online surveys of Enterprise 
Ireland client firms, and a programme of semi-structured interviews with Enterprise Ireland client 
firms. The evaluation was commissioned to focus on econometric analysis rather than cost-
benefit analysis, which some previous evaluations have used. Details of each strand are 
presented below.  
•  Desk research: A rapid review of key national strategies and policy documents was 
undertaken to formalise our understanding of Ireland’s current ambitions regarding the 
 
 
4 Data issues included a lack of access to data for the indirect supports, and a low number of observations in ESA 
and SBRI data that precluded econometric analysis 
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development of knowledge-based competitiveness. This has informed several aspects of 
the evaluation, including: the understanding of the rationale and appropriateness of the 
intervention, informing the design of data collection tools (e.g. developing the programme 
logic model), and feeding into the international comparators for the programme 
•  Secondary data analysis: Programme data have been analysed to establish uptake of 
support for RD&I by firms 
•  Econometric analysis: The econometric analysis identifies and quantifies the direct impact 
of the RD&I Programme on a range of performance outcomes of Enterprise Ireland client 
firms. The impacts have been estimated year by year up to five years after the award of 
the RD&I financial supports  
•  Two surveys of Enterprise Ireland client firms: The survey of awardees was launched to 1,058 
firms on Wednesday 27th November 2019, and remained open for three weeks. The survey 
received 220 responses, representing a final response rate of 21%. The survey of client firms 
that had not accessed the RD&I Programme was launched on Wednesday 4th December 
to a random sample of 300 EI client firms drawn from the control group identified through 
the descriptive analysis. This survey ran for two weeks and received 53 responses, 
representing a final response rate of 18%.  
The survey questionnaires covered motivations to access the RD&I Programme, access to 
other instruments and their complementarity, the main benefits emerging from access, 
experienced barriers, and levels of satisfaction with the offer and its process.  
A breakdown of the survey population is available in Appendix A. 
•  Interviews: The study team conducted 40 interviews with Enterprise Ireland client firms, 
identified via the online surveys. The 40 interviews were divided between firms that had 
benefitted from the Programme (34) and firms that had not accessed the Programme (6). 
A total of 88 invitations were sent to recruit firms for interview. The interview programme was 
used to collect more detailed responses and concrete examples of benefits, impacts and 
barriers, as well to explore issues such as the impact of the support on firm productivity. 
Interviews with stakeholders and comparators: The study team conducted eight interviews 
with Enterprise Ireland Development Advisors (identified and recruited with the support of 
Enterprise Ireland), and four interviews with representatives of international comparator 
programmes in Austria, Denmark, the Netherlands and Sweden.  
A breakdown of the interview group populations is available in Appendix B. 
1.2 This report 
The report presents the evaluation of Enterprise Ireland’s RD&I Programme. The report is 
organised into chapters that correspond to the evaluation objectives. The remainder of this 
report is set out as follows: 
Chapter 2 includes a discussion of the policy context in Ireland and a mapping the support that 
is available through the RD&I Programme, as well as the uptake of support by client firms 
Chapter 3 sets out an assessment of the appropriateness of the RD&I Programme, including 
alignment with national policy objectives and firms’ needs 
Chapter 4 sets out an assessment of the effectiveness of the RD&I Programme, including the 
results of an econometric analysis and firms’ views drawn from consultation. The chapter also 
explores synergies between the RD&I Programme and other available RD&I supports 
Chapter 5 sets out an assessment of the efficiency of the RD&I Programme, covering firm 
satisfaction, barriers experienced and access routes for support 
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Chapter 6 sets out a brief overview of international comparators  
Chapter 7 sets out conclusions and recommendations  
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2 Support for RD&I in Ireland 
2.1 Policy context 
2.1.1 Overview of key policies 
The RD&I agenda has been championed by successive ministers and policy teams within the 
Department of Business, Enterprise & Innovation (DBEI), through a series of national strategies 
that sought to underpin sustainable growth and stimulation of innovation and entrepreneurship 
(e.g. Government’s Strategy for Science, Technology and Innovation 2007-2013). Since 2012, a 
more focused approach has been adopted in the public funding of research and innovation 
activity. The national Research Prioritisation exercise identified 14 major areas in which to focus 
competitive funding,  as they were deemed likely to yield the greatest economic and societal 
impact5. Figure 1, below, sets out a timeline of recent relevant policies and strategies at the 
national level. 




The current suite of policies and strategies that pertain to the RD&I Programme include the 
Action Plan for Jobs, Innovation 2020 (including its Mid-term Review), Enterprise 2025 and Future 
Jobs Ireland. The main policy objectives of these strategies are to increase the number of 
people in employment in all regions, while developing entrepreneurship, increasing 
productivity and positioning Ireland as a global innovation leader. Innovation 2020 and 
Enterprise 2025 also contain two specific statements related to firms’ investment in RD&I:  
•  Irish firms’ investments in RD&I remain below competitor countries, and the proportion of 
enterprises engaging in R&D is too low (Enterprise 2025) 
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•  Firms under-invest in research and focus more on ‘new to company’ innovations rather than 
‘new to market’ innovations (Innovation 2020) 
The Innovation 2020 Strategy, adopted in 2015 as Ireland’s overarching policy framework for 
research and innovation covers the implementation of 140 actions by Enterprise Ireland (EI), 
Science Foundation Ireland (SFI), the Local Enterprise Offices (LEOs) and other government 
departments and agencies. The Strategy sets out the government’s vision of Ireland becoming 
a Global Innovation Leader, driving a strong, sustainable, high employment economy and a 
better society enjoying a good quality of life.  
As part of the Strategy, DBEI aimed to increase gross expenditure on R&D to 2.5% of GNP, of 
which a significant portion was envisaged to come from the business sector investing more in 
R&D.  
The five high-level goals it set out to achieve are:  
•  Excellent research in strategically important areas that has relevance and impact for the 
economy and society  
•  Achieving a strong innovative and internationally competitive enterprise base, growing 
employment, sales and exports  
•  A renowned pool of talent both in Ireland’s public research system and in industry that 
maximises exchange of talent and knowledge  
•  A coherent joined-up innovation ecosystem, responsive to emerging opportunities, 
delivering enhanced impact through the creation and application of knowledge  
•  An internationally competitive research system that acts as a magnet and catalyst for 
talent and industry  
A Mid-term Review of Innovation 2020 was carried by DBEI out in 2019,6 to ensure that the 
Strategy could continue to deliver the vision and objectives for Ireland’s RD&I system whilst 
acknowledging important changes in the policy environment, such as the impact of the UK 
leaving the EU, changes in US trade and investment policy, the commitment of transitioning to 
a low-carbon and climate-resilient society and the increased role of technologies such as 
robotics, virtual reality and artificial intelligence. 
The review found that until June 2019, 22% of the actions in the Strategy had been completed 
or nearly completed, 65% of actions were progressing or ongoing, 6% of actions (8 actions) 
were delayed and 2% of actions (three actions) remained to be initiated. The review 
concluded that the goals of Innovation 2020 remain appropriate, and stressed the continued 
importance of ensuring that public investment in R&D translates into economic and social 
returns, including the development of the skills base in enterprise. The review also notes the on-
going importance of increasing R&D intensity and the number of R&D performers.  
In addition, the Action Plan for Jobs has been published and refreshed every year since 2012, 
with the most recent one dated 2018. These documents outline the government’s approach 
to maximising employment across Ireland, by reducing regional disparities, improving the 
innovative capacity of its firms, improving productivity and increasing trade.7 
Despite a significant decrease in the unemployment rate from 16% in 2012 to 5.7% at the end 
of 2018, the domestic economy retains a number of vulnerabilities such as low productivity 
 
 
6 See: https://dbei.gov.ie/en/Publications/Mid-term-Review-of-Innovation-2020.html  
7 See: https://dbei.gov.ie/en/Publications/Publication-files/Action-Plan-for-Jobs-2018.pdf 
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levels, especially in indigenous firms. As a result, in 2019 the government published the first of a 
series of annual reports - Future Jobs Ireland 2019 - which is part of a multi-annual framework to 
support enterprises and workers in adapting to a changing economy. This includes preparing 
for the challenges of adapting to a low-carbon future and the increasing adoption of 
digitalisation and automation.  
Five pillars are identified as central in adapting to the future economy: 
•  Embracing Innovation and Technological Change 
•  Improving SME Productivity 
•  Enhancing Skills and Developing and Attracting Talent 
•  Increasing Participation in the Labour Force 
•  Transitioning to a Low Carbon Economy 
The increasing focus on RD&I over successive periods has enabled Ireland to begin to compete 
on an equal footing with major European and global economies. 
2.2 Overview of support available for RD&I 
Ireland has a comprehensive suite of enterprise supports to deliver on these policy goals, 
delivered primarily through Enterprise Ireland. The RD&I Programme is one of the most long-
running supports in this space, with the latest iteration of the programme now in its twelfth year 
of operation. Using a rough typology, the RD&I Programme supports three categories of 
projects: R&D projects; Business Innovation projects; and ‘Agile Innovation’ projects. This 
typology demonstrates the development of the programme over its years of implementation, 
with the latter two supports added in recent years. This has an important impact on the 
programme objectives, and reflects required changes to eligibility, the application and 
approvals processes, and the ways in which the State is able to support firms. 
2.2.1 Overview of direct financial support 
The EI RD&I Programme provides direct financial supports to firms for in-company RD&I 
activities. Since it was established in 1998, EI has provided RD&I support to firms in various 
configurations and under several names.  
The RD&I Programmes aims to achieve a significant uplift in investment in RD&I, and to enable 
firms to innovate. The table below summarises the direct financial supports available to firms 
through the RD&I Programme, provided through equity or grants, and via standalone support 
or as part of a package of supports. Via its constituent parts the programme supports firms to 
address a number of aspects of RD&I activity, ranging from understanding and planning RD&I 
within a firm, to conducting projects, and onto protection of intellectual property. The 
objectives of the individual aspects of the programme are broken down below. 
Table 1 Overview of the objectives of constituent parts of the EI RD&I Programme  
Support name Specific objective 
Exploring Innovation Grant8 • Help firms to understand the role of RD&I in their firm 
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The Research and Development (R&D) 
Fund9 
• Help firms to develop new or improved products, processes or 
services 
Intellectual Property Strategy Offer10 • Encourage firms to develop an IP strategy to help maximise the 
value of RD&I activities 
Agile Innovation Fund11 • Encourage firms to engage in RD&I in certain sectors or those with 
short product lifecycles to develop new or improved products, 
processes or services 
Business Innovation Offer12 • Help firms to develop new or improved business innovations, 
including production methods, service delivery or organisational 
methods 
Source: Technopolis, based on Enterprise Ireland webpages and validated in interview 
The constituent parts of the RD&I programme are set out below, as agreed with Enterprise 
Ireland. The table sets out funding amounts and funding rates, as well as eligibility information. 
Table 2 Overview of details of constituent parts of the EI RD&I Programme  
Support name Funding available Funding rate Eligibility 
Exploring 
Innovation Grant 
Up to €35,000 Up to 50% Clients or potential clients 





Up to €650,000 fir 
RD&I projects  
Up to €150,000 for 
Business Innovation 
projects 
25% / 35% / 45% for R&D 
projects 
50% for Business 
innovation projects 
Irish-based manufacturing or internationally 
traded services company 




IP Start: €2,160 
IP Plus: €35,000 
IP Start: 80% of the cost 
of employing an IP 
advisor  
IP Plus: up to 50% of the 
cost of up to 18 months 
of consultancy and 
training 
EI clients, SMEs only  
Applicants must provide details of a ‘linked’ 
RD&I project which received support from EI 
within the preceding 7 years 
HPSUs eligible in limited circumstances 
Agile Innovation 
Fund 
Up to €150,000  Up to 50% of total 
project cost of €300,000 
Irish-based manufacturing or internationally 
traded services company 
R&D projects and Business Innovation 
projects are eligible 
Accessible to non-EI clients, via an outline 
proposal 
Possible collaboration bonus (15%) 
HPSUs are eligible 
Business 
Innovation Offer 
Up to €150,000 Up to 50% of the eligible 
costs 
Irish-based manufacturing or internationally 
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Available through the routes of Agile 
Innovation, RD&I Fund, or Operational 
Excellence Offer13) 
HPSUs not eligible to apply 
Source: Technopolis, based on Enterprise Ireland webpages and validated with Enterprise Ireland in 
interview 
1.2.1 R&D Funding as part of Package Supports Client offers 
Support for R&D is also included in tailored packages to client firms. Client offers are often 
shaped via bi-lateral conversations with Development Advisors (DAs), though clients can also 
apply without speaking to a DA.14 Once an application is received, it is assigned to a DA to 
process. The DA would visit the company, conduct an analysis, model the company, and see 
where support could or should be applied. If the company requires more than one type of 
support, then a package would be put together.  
One example of a client offer is the Company Expansion offer, which is intended for firms 
undertaking or planning to undertake an ambitious expansion that will create employment 
and grow sales in international markets. Several things are supported through these packages, 
including: i) RD&I, ii)  Capital assets and job creation, iii) Training, iv) Management 
Development, and v) Consultancy.  
2.2.2 Overview of indirect financial supports 
Alongside the RD&I Programme are a number of other, indirect supports for RD&I. These include 
the R&D Tax Credit, the Knowledge Development Box and two procurement-based schemes 
administered by Enterprise Ireland: European Space Agency (ESA) funding and Small Business 
Innovation Research funding. Each of these are set out below, followed by an overview table 
of objectives for each support. 
The R&D Tax Credit is part of the national tax offering, aimed at developing a strong, 
innovation-driven business sector and attracting investment into Ireland via foreign direct 
investment (FDI). The R&D Tax Credit operates against a primary policy objective of increasing 
business R&D (BERD) in Ireland, with a particular view to generate increased innovation and 
productivity (Department of Finance, 2016).15 The R&D Tax Credit is available to companies 
that have spent money on R&D activities. The credit is used to reduce firms’ corporation tax, 
and is calculated at 25% of qualifying expenditure. Irish Tax and Customs sets criteria for  eligible 
expenditure.16 Firms claim an R&D Tax Credit via an online service, but must check eligibility 
before completing the application. These criteria state that claiming firms’ R&D activities must 
be in the field of science or technology, and: 
•  Involve systemic, investigative, or experimental activities  
•  Involve basic research, applied research or experimental development 





14 The amount of funding is determined by the need for financial support for the stated project, the client’s 
anticipated growth targets, potential employment, and the regional location of the company in Ireland 
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•  Involve the resolution of scientific or technological uncertainty 
Similar to the R&D Tax Credit, the Knowledge Development Box is corporation tax relief for firms. 
In the 2015 announcement of the Knowledge Development Box by the Department of Finance, 
the main objective of the scheme was described as contributing to the attraction and 
retention of firms with real economic substance, with a particular view to encourage the 
generation of knowledge-based capital in Ireland (Siedschlag, 2015; EY, 2015).17 As with the 
R&D Tax Credit, this presents a dual policy objective of further developing the Irish economy 
through endogenous growth and FDI by achieving a ‘best-in-class’ and sustainable tax 
instrument. The Knowledge Development Box allows firms to apply for a deduction against 
corporation tax of 5% of qualifying profits.18 Eligible profits include qualifying patents, computer 
software and some other certified intellectual property. This means that to apply for tax relief, 
firms must have created a useable qualifying asset.  
The two other indirect supports available for RD&I in Ireland are procurement-based schemes 
that seek to encourage firms to conduct RD&I activities in specific priority areas or in response 
to specific challenges. Enterprise Ireland assists Irish companies to successfully bid for ESA 
contracts.19 In 2018, ESA had awarded a total of €19.3m to 27 Irish companies. Most of the 
activity of Irish companies in the space sector focuses on downstream applications, both in 
terms of equipment and services/products for consumers. DBEI also published its National 
Space Strategy for Enterprise 2019-2025 to support the growing capabilities of Irish firms in the 
space sector. Enterprise Ireland also administers the recently-launched Small Business 
Innovation Research (SBIR) funding.20 This is a pre-commercial procurement which focuses on 
addressing specific ‘Challenges’. Under the first two calls, the maximum funding available via 
SBIR was €200,000. The third call, launched in 2019, offers a minimum of €200,000 in funding. 
Funding is administered in two phases: in phase 1 a number of companies undertake a 
technical feasibility study to understand the challenge and identify a potential solution; in 
phase 2, a smaller number of companies prototype a specific project, through extensive R&D. 
Table 3 Overview of objectives of indirect RD&I supports 
Support name Specific objective 
R&D Tax Credit • Encourage firms to invest in RD&I activities  
Knowledge 
Development Box 
• Encourage firms to manage and protect intellectual assets from RD&I 
ESA funding • Encourage firms to conduct R&D to develop products in priority areas 
SBIR funding • Encourage firms to conduct R&D to develop solutions to societal challenges 












20 See: https://www.enterprise-ireland.com/en/Research-Innovation/SBIR-Ireland/  
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2.2.3 Implementation of the EI RD&I Programme 
Figure 2, below, sets out the Programme Logic Model (PLM) developed for the EI RD&I programme. The PLM draws on desk research and 
scoping interviews, and sets out the objectives, inputs, activities, outputs, outcomes and impacts of the programme. Each category is 
discussed in the following dedicated sub-sections. 
Figure 2 Programme Logic Model of the RD&I Programme 
 
Source: Technopolis, based on desk research and interview 
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Programme inputs and processes  
In common with other programmes, the EI RD&I programme is resourced by agency funding 
and staff time (via Programme Managers, Development Advisors and Technology Advisors), as 
well as match funding secured by applicants and awardees, plus the in-kind contributions from 
firms in the form of time spent on the application for (and eventual implementation of) grants. 
The Enterprise Ireland budget for the programme is set as an overall envelope, with the lines 
within the budget kept flexible in order to maintain responsiveness. 
Staff time toward the programme is in the form of both management staff and technical staff. 
Development Advisors (DAs) signpost companies to supports and also handle the commercial 
analysis of applications for support.21 Technologists and Technology Advisors are also key to 
helping formulate supported projects, being responsible for preparing the technical analysis of 
proposals for EI’s approval committees. The decision-making processes and relevant 
committees are detailed below: 
•  Decisions on funding amounts under €120,000 are approved through an internal line 
management sign-off process. A client would make an application online and approved 
by the grants administration team 
•  Grants under €150,000 can be approved through the Agile Innovation Fund 
•  The R&D Committee approves amounts up to €650,000, meeting once per month.  
•  The Investment Committee approves amounts over €650,000, meeting every 2 weeks 
•  The Management Approval Committee meets weekly and approves Agile Innovation Fund 
grants that are too large to be approved online. (i.e. over €150,000) or those where the 
client has received cumulative funding greater than €150,000 in the preceding 12 months 
•  The Financial Products Committee approves Programme changes and new instruments, 
focusing on the consistency and operation of the changes 
Programme activities 
The RD&I programme is a comprehensive suite of supports for firms looking to undertake in-
house R&D. As set out in the programme logic model in Figure 2, support is offered in two ways: 
project grants from the five constituent ‘standalone supports’, or tailored packages of support.  
While the grants offered do not make a distinction between experimental research and more 
traditional R&D activity, there is a distinction to how EI supports firms of different levels of 
maturity. EI funds firms on a grant basis that are generally three-plus years old and EBITDA22 
positive, while younger firms are funded on an investment basis. 
In consultation, the number of programme participants (awardees) was seen to have fallen, 
due to lower numbers of proposals. This is reinforced by the descriptive analysis of programme 
data (see section 2.3), which shows that the number of awardees decreased from 2012 to 
2017, before reverting to prior levels in 2018. This may be explained by the cyclical nature of 
RD&I activities, whereby applicants receive support for projects and then do not apply to the 
programme again until another project idea and the resources to support it are ready. The 
increase of awardees in 2018 may additionally be contributed to by the launch of the Agile 
Innovation Fund and Business Innovation Offer strands.  
 
 
21 Many companies have one-to-one relationship with a Development Advisor, though there are also companies (i.e. 
in the Core and Export Develop departments) that engage on a one-to-many basis as per Enterprise Ireland’s new 
Client Engagement Model, implemented in recent years. For these companies, the engagement with a 
Development Advisor usually involves the R&D Core Unit and/or the Innovation Department 
22 A company's earnings before interest, taxes, depreciation, and amortisation 
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Expected outputs, outcomes and impacts 
The series of outputs presented in the draft programme logic model represents the 
comprehensive nature of the RD&I fund. The draft programme logic model presents simple 
outputs that reflect the expected countable outputs of each individual support, from project 
plans produced (Exploring Innovation) to the number of R&D projects supported (R&D Fund, 
Agile Innovation Fund, Business Innovation projects. The specific focus on IP has been relatively 
recent, and is represented by a count of the number of firms engaging in IP management. 
The expected outcomes are similarly wide-ranging, from increased knowledge, awareness and 
appetite, to increased capabilities and higher levels of investment. These outcomes map 
relatively clearly to the individual supports. For example, the Exploring Innovation Grant is 
focused on raising awareness of RD&I, its benefits to a business, and capacity building. The 
Exploring Innovation Grant is not always a pre-cursor to further R&D funding, but is also awarded 
to SMEs where an R&D Fund grant is less appropriate. The Agile Innovation Fund supports RD&I 
projects in industries with shorter cycles, such as ICT, and is intended to speed up projects. As 
such, the Agile Innovation Fund is also intended to increase the number of SMEs undertaking 
RD&I activities.  
Finally, the intended impacts set out in the programme logic model represent the goals of the 
RD&I Programme, which form the areas of examination for this evaluation. 
Changes to the programme over time 
The EI RD&I has evolved continuously, in line with the direct experience of running the 
programme, but also to take advantage of developments seen elsewhere. For example, since 
the 2017 review conducted by Indecon, the programme has been modified to include the 
Agile Innovation Fund and Business Innovation projects strands.  
The introduction of the Agile Innovation Fund was a notable change, brought in response to 
both client sentiment and following an Enterprise Ireland examination of similar programmes, 
such as those offered via BPI France and FFG (Austria). Based on feedback from their own 
clients, Agile was introduced to help clients in industries with shorter lead-in times or product 
cycles, such as those in the ICT industry. We gathered similar feedback in our consultation, with 
stakeholders stating that funding had often arrived too late for these types of companies, at a 
time when RD&I projects were nearly complete. This emphasises the need for Ireland, like other 
countries, to have smaller, more flexible and responsive funding pots available.  
The second main change to the programme is the addition of the Business Innovation Offer 
strand. This was introduced in response to changes in State Aid rules, as well as due to a desire 
to focus on an a more ‘holistic’ approach to supporting RD&I (i.e. beyond products and 
services). Following a change to the rules, State Aid only applied when grants provided 50% of 
funding, an increase from the previous threshold of 15%. This change saw the introduction of 
20 new pilot projects under the Business Innovation Offer grant in the space of one year, though 
there has reportedly been little uptake since, due to a perceived lack of clarity as to what is 
eligible (from both companies and assessors). Nonetheless, there is still a strong desire within EI 
to support these projects as part of supporting uptake of RD&I across a broad range of firms 
(see objectives above). 
A more minor change was the launch of the IP strategy offer, which recently completed its 
pilot period. Firms have been able to claim IP-related costs from their EI R&D grants for some 
time, though there is a perceived lack of awareness of this, as only a small proportion of firms 
(estimated to be approximately one third) do so. The IP Strategy Offer was therefore introduced 
to provide more visibility to support for this aspect of RD&I activity (see objectives, above). 
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2.3 Uptake of direct supports for RD&I 
In the following sections, we examine the uptake of direct financial supports for RD&I.23 
Additional data tables from this analysis can be found in Appendix A.1. Data are limited for the 
uptake of indirect supports, so we include a cursory overview of this in Appendix A.3. 
2.3.1 Number and amount of grants 
Over the period 2007-2018 2,005 grants have been awarded through the RD&I Programme. 
There is a variation in number of awards per year, ranging from a high of 224 grants in 2008 to 
a low of grants 107 grants in 2016. The total number of awardees over the period amounts to 
1,562, ranging from a high of 176 awardees in 2009 to a low of 91 awardees in 2017. Both the 
number of grants and number of awardees increased again in the last year of data. This is 
summarised in Table 4, below. On average, 5% of EI clients have been awarded a grant in a 
given year.  
Table 4 Number of grants and number of awardees of EI RD&I direct financial supports by year  
Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Total 
# grants 223 224 215 165 148 167 179 168 129 107 111 169 2,005 
# awardees 134 143 176 124 128 148 142 132 105 92 91 147 1,562 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. Notes: Different projects of 
the same grant type and approved on the same date are aggregated to one grant.  
Figure 3 and Figure 4 below show the annual numbers of grants and awardees, respectively, 
broken down by the constituent parts of the programme. Over the period 2008-2018 the largest 
numbers of grants and awardees were funded from the R&D Fund.   
Figure 3 Number of grants of EI RD&I direct financial supports by offer bundle and by year  
 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. Note: Different projects of the 




23 Our analysis covers the key characteristics of awardees based on the RD&I data set provided by Enterprise Ireland, 
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Figure 4 Number of awardees of EI RD&I direct financial supports by offer bundle and by year  
 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. Note: Different projects of the 
same grant type and approved on the same date are aggregated to one grant.  
The total amount of the EI RD&I direct financial supports over the period 2007-2018 amounts to 
€464.7m, of which 66% has been drawn down on average. The proportion of the drawn down 
amounts has declined over time with the highest shares of drawn down funding at the 
beginning of the period and the lowest at the end of the period. It should be noted that it is 
possible that full amounts have not yet been drawn down by awardees for years 2016-2018.24 
Figure 5 shows the evolution over time of the value of approved, paid and cancelled EI RD&I 
direct financial supports. As shown below, the uptake of these financial supports has declined 
over time.  
Figure 5 Total EI RD&I direct financial supports, 2007-2018 
 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. Note: Figures are in constant 2015 prices in 
million euros. 
While a significant number of awardees have received funding for one RD&I project over 2007-
2018, a slightly larger proportion still received direct RD&I funding for two projects. A smaller 
number of awardees received funding for more than three projects. 
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Figure 6 The distribution of the number of grants funded by EI RD&I direct financial supports per 
awardee over 2007-2018 
 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. Notes: Different projects of the same grant 
type and approved on the same date are aggregated to one grant. 
2.3.2 Types of support  
Examining the distribution of support by non-equity grants and equity-type supports shows that 
the majority of EI RD&I direct financial supports have been non-equity grants, as opposed to 
equity-type supports. High Potential Start-Up supports are not within the scope of this 
evaluation. A few notes on the distribution of each type of support over the period are set out 
below: 
•  The largest number of awardees of non-equity grants was in 2009 (163) and the smallest in 
2017 (78). The largest approved amount of non-equity support was in 2008 (€48.9m) and 
the lowest in 2011 (€24.2m)  
•  The number of awardees of equity-type financial supports was largest in 2018 (15) and the 
lowest in 2014 (1). There were no awards of equity type financial supports in 2015. The largest 
amount of financial support delivered as equity was approved in 2009 (€6.5m) and the 
smallest was in 2014 (€0.2m)      
The drawing down of payments appears to be greater in the case of the equity type RD&I 
financial supports.   
2.3.3 Support by firm characteristics 
In terms of sectoral split, awards have been allocated across 10 sectors, with 76% of the grants 
having been allocated across three of them: “Traditional Manufacturing” (30%), “Information 
and Communication and other Internationally Traded Services” (28%) and “Food, Drink and 
Primary Production” (16%) sectors (see Table 21 in Appendix A.1).  
As shown in Figure 5 below, the distribution of the total number of awardees across the 10 
sectors over the analysed period closely matches the corresponding distribution of EI clients. 
There are only a few sectors where there a sizeable differences between the two distributions: 
compared to the profile of EI clients, the ‘Business, Financial and Other Services’ sector appears 
to be under-represented, while the ‘Information and Communication and other Internationally 
Traded Services’ and (albeit to a lesser extent) the ‘Food, Drink and Primary Production’ sectors 
are slightly over-represented. Table 23Table 22 in the Appendix shows the comparison of the two 
distributions year by year.     
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Figure 7 The distributions of awardees of EI RD&I direct financial supports and of EI clients by sector, 
2007-2018   
   
Source: ESRI elaboration based on the data provided by Enterprise Ireland. 
In terms of regional split, grants have been allocated across six regions in Ireland, with 34% 
allocated in Dublin, 21% in South/South East, 15% in the Midlands, 11% in the Mid-West, 10% in 
the North East/North West and 7% in the West (see Appendix A.1). Figure 8 shows the evolution 
over time of the number of awardees of EI direct financial supports by region. The Dublin region 
has the largest and most-increased number over the period while the West had the lowest 
number.    
Figure 8 The number of awardees of EI RD&I direct financial supports by region (EI classification), 2007-
2018 
 
Source: ESRI elaboration based on the data provided by Enterprise Ireland.  
Figure 9 below compares the distribution of awardees by region with the corresponding 
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closely the profile of EI clients by region. Dublin appears to be under-represented while the 
Border region has a higher share in the total awardees compared with its share in the total 
number of EI clients. Table 18 in the Appendix shows the comparison of the two distributions 
year by year.   
Figure 9 The distributions of awardees of EI RD&I direct financial supports and of EI clients  by region, 
2007-2018  
 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. 
The analysis of data by enterprise group characteristics shows that the largest numbers of 
awardees are Irish-owned (98%), small-sized (60%), and engaged in product innovation (76%) 
and exporting activity (97%). This is summarised below in Figure 10. Year-to-year statistics are 
shown in in Appendix A.1. 
Figure 10 Percentage of awardees of EI RD&I direct financial supports based in enterprise group 
characteristics 
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Source: ESRI elaboration based on the data provided by Enterprise Ireland.  
2.3.4 Intensity of supports 
Analysis shows that overall, the intensity of EI RD&I direct financial supports has declined over 
time. This is in contrast to the intensity of the net R&D expenditures which has remained fairly 
constant over the period (see Figure 12 below).  
Relative to sales, on average, the intensity of EI RD&I direct financial supports ranges from 5.6% 
(2018) to 12.4% (2007). The intensity of EI RD&I direct financial supports appears less skewed 
over time when we consider the median statistics. These range from 2.7% (2018) to 4.5% (2010).  
Relative to employment, the average intensity of EI RD&I direct financial supports range from 
€6,400 per employee in (2018) to €12,700 per employee (2008). The corresponding median 
statistics are again less skewed, ranging from €3,500 per employee (2018) to €7,200 per 
employee (2008).  
Table 5, below, summarises the intensity of EI RD&I direct financial supports by year. The 
difference in the average and median statistics reflects the heterogeneity of awards and 
awardees.  
Table 5 Intensity of approved EI RD&I direct financial supports by year 
 Approved EI RD&I funding / sales  Approved EI RD&I funding / employment (thousand euros/employee, 2015 prices) 
Year Mean Median  Mean Median  
2007 12.4% 4.3%  9.7 6.7  
2008 11.1% 4.4%  12.7 7.2  
2009 8.5% 4.6%  10.3 6.4  
2010 7.2% 4.5%  8.3 6.0  
2011 8.8% 3.6%  9.4 5.1  
2012 6.9% 3.8%  8.8 5.6  
2013 6.8% 3.4%  8.8 6.2  
2014 7.0% 2.8%  8.4 5.1  
2015 6.2% 3.2%  7.0 5.3  
2016 6.2% 4.2%  7.5 5.1  
2017 10.0% 3.5%  9.2 5.7  
2018 5.6% 2.7%  6.4 3.5  
Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same enterprise group. Approved grants and sales are in constant 2015 prices. Very large outliers 
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Figure 11 The intensity of EI RD&I funding, 2007-2018  
Approved EI RD&I funding / sales (log) Approved EI RD&I funding / employment (thousand 
euros/employee in log, 2015 prices) 
  
Additional descriptive statistics on EI RD&I funding are presented in Appendix A.1. 
2.4 R&D and economic performance of awardees and of the other firms  
Figure 12 and Figure 13 compare graphically the evolution over the analysed period of the 
R&D and economic performance of awardees of EI RD&I direct financial supports and the 
corresponding performance of the other firms. The graphs, taken together, show that the 
awardees outperform substantially the other firms for all R&D, and economic and innovation 
performance indicators considered.  
The charts in Figure 12, below, show that over the analysed period, the awardees of EI RD&I 
direct financial supports substantially outperformed the control group firms (‘others’) with 
respect to R&D performance indicators such as: net R&D expenditures as well as the intensity 
of net R&D expenditures (measured as net R&D expenditures as a share of turnover and as net 
R&D expenditures per employee), R&D employment and the intensity of R&D employment 
(measured as the number of R&D employees in the total number of employees). While most 
indicators of R&D performance appear to demonstrate similar overall trends over time for both 
awardees and control group firms, the share of R&D employees within the total number of 
employees declined since 2010 in the case of awardees, while control group firms demonstrate 
a more volatile trend with a sharp decline after 2017. These trends are likely to reflect the 
pattern of economic recovery in Ireland with a fast increase in employment after 2014.  
Figure 12 R&D performance outcomes, 2007-2018   
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Net R&D expenditure / emp (log) R&D employment (log) 
  
R&D employment / Total employment (log)  
 
 
Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Notes: Individual awardees are integrated if they belong to the same enterprise group. An awardee-group is classified 
as recipient of RD&I financial support if it has been awarded at least once such financial supports between 2007 and 
2018. Other firms are those that have never been awarded any RD&I financial supports. The numbers shown in graphs 
are average values at enterprise group. The monetary values are in thousand euros in 2015 prices. Data of sales of new 
products is available since 2012. 
The charts in Figure 13, below, show that over the analysed period, the awardees of EI RD&I 
direct financial supports substantially outperformed control group firms (‘others’) with respect 
to a broad range of economic and innovation performance indicators such as: output 
(turnover and value added), employment, export activity (export sales and export intensity 
measured by the share of export sales in turnover), labour productivity (turnover per employee 
and value added per employee), and product innovation (new product sales and the share 
of new product sales in total sales). While in the case of awardees, the economic and 
innovation performance outcomes each trend upwards, the corresponding indicators for the 
control group firms are stable or trend downwards, with the exception of those for export 
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Export sales / turnover (log) New product sales (log) 
  
 




Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Notes: Individual awardees are integrated if they belong to the same enterprise group. An awardee-group is classified 
as recipient of RD&I financial support if it has been awarded at least once such financial supports between 2007 and 
2018. Other firms are those that have never been awarded any RD&I financial supports. The numbers shown in graphs 
are average values at enterprise group. The monetary values are in thousand euros in 2015 prices. Data of sales of new 
products is available since 2012.  
The better performance of awardees could be the result of the RD&I intervention as well as 
other firm-specific factors. To accurately identify the impact of the RD&I interventions on the 
R&D and economic performance of awardees, we use econometric analysis as discussed in 
the next chapter.  
2.5 Uptake of indirect supports for RD&I 
This section summarises available data on indirect RD&I financial support from the European 
Space Agency (ESA) and the Small Business Innovation Research (SBIR) Programmes. The ESA 
data refers to EI client firms only.25  
 
 
25 Analysis of ESA data is firms on companies that are currently in the Enterprise Ireland client base, but there may be 
firms that were EI clients at the time of receiving funding that have since moved out of the Enterprise Ireland client 
base, e.g. if acquired by a foreign-owned multinational 
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2.5.1 RD&I financial support from ESA programmes 
 
Table 6 shows that the number of grants awarded to recipients that also are receiving the EI 
RD&I supports over the period amounts to 98 grants across 25 firms, ranging from 5 (2008) to 18 
(2018) grants per year, which is lower in comparison with direct supports (1,562). This amount of 
grants represents the 32.8% of the overall number of recipients of the ESA support. 
The ICT and Computer sector accounts for the highest number of beneficiaries, 47, followed 
by Computer, Electronic and Optical with 20 awardees. Business and Financial services, 
Traditional Manufacturing and Chemicals and Pharmaceuticals are the other sectors in which 
the remaining ESA awardees operate. 
The total approved amounts equate to 46.5 million euros, i.e. around one tenth of the RD&I 
direct financial supports, which is relatively high given that the ESA programme supports only a 
subset of EI client companies and the number of beneficiaries is quite low compared to those 
that received the RD&I supports. ESA supports received by the EI RD&I recipients represents 
nearly half (52%) of the overall ESA programme supports26. 
All companies in Ireland are eligible to respond to ESA tender opportunities. The funding is 
procurement-based rather than grant-based. The funding available varies depending on the 
specific project, but funding is limited by Ireland’s financial contribution to the specific ESA 
programme. 
Table 6 RD&I funding from ESA Programmes, 2008-2018  
Year 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Total 
# awardees 5 6 8 6 6 8 10 9 13 9 18 98 
Total approved amounts 2.63 2.33 1.83 2.67 2.32 2.83 4.11 3.95 6.08 3.36 14.38 46.5 
Average approved   
amount per awardee  
0.53 0.39 0.23 0.45 0.39 0.35 0.41 0.44 0.47 0.37 0.8 4.83 
Source: DBEI elaboration based on ESA data provided by Enterprise Ireland. Notes: Projects by the same 
awardee in the same year are integrated. Monetary values are in constant 2015 prices in million euros. 
No information on payments is available. 
In terms of geographical distribution, the table below shows that most of the funds concentrate 
in Dublin, with 66 awardees and 30 in the rest of the country. 
Table 7 RD&I funding from ESA Programmes, by area 
 Participants Total funding (€ 000s) Average  funding  per awardee (€ 000s)    
Dublin 66 34.49 50.25 
Rest of Ireland 30 11.39 20.70 
Source: DBEI elaboration based on ESA data provided by Enterprise Ireland. Notes: Projects by the same 
awardee in the same year are integrated. Monetary values are in constant 2015 prices in million euros. 
No information on payments is available.  
 
 
26 Table 6 shows the number of firms that received both the EI RD&I and the ESA supports. The total number of ESA 
beneficiaries is higher, but those that are not also recipients of the EI RD&I funds, are not included in the table 
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In terms of firm size, the largest number of awardees of RD&I financial support from the ESA 
Programme is for small sized EI client firms (84%), while 3% are classified as large firms. See Figure 
14, below.  
Figure 14 Percentage of awardees of ESA programmes by size 
 
Source: DBEI elaboration based on ESA data provided by Enterprise Ireland. 
Table 8 summarises the intensity of ESA funding over the period for which data is available. On 
average, relative to sales, the intensity of ESA funding ranges from 581% (2018) to 78% (2010). 
Looking at the corresponding statistics for the median awardee, the intensity of the ESA funding 
ranges 6.28% (2018) to 19.30% (2010) of sales. Relative to employment, the average intensity of 
the ESA funding ranges from €3,040 per employee (2016) to €900 per employee (2010). The 
corresponding statistics for the median awardee range from €41 per employee (2016) to €88 
per employee (2017). The difference between the average and median statistics reflects the 
heterogeneity of awards and awardees.       
Table 8 Intensity of ESA funding by year 
 ESA funding / sales  ESA funding  / employment (thousands euros/ employee, 2015 prices) 
Year Mean Median  Mean Median 
2008 112% 14.11%  1.32 0.061 
2009 116% 12.45%  1.16 0.062 
2010 78% 19.30%  0.91 0.082 
2011 88% 18.24%  1.34 0.059 
2012 89% 12.94%  1.16 0.047 
2013 132% 15.11%  1.42 0.049 
2014 200% 7.68%  2.05 0.043 
2015 168% 12.15%  1.98 0.043 
2016 240% 11.37%  3.04 0.041 
2017 146% 17.47%  1.46 0.088 
2018 581% 6.28%  N/A N/A 
Source: DBEI elaboration based on linked ABSEI and ESA data sets provided by the DBEI and Enterprise Ireland. Notes: 
Individual awardees are integrated to awardee-group level. Monetary values are in constant 2015 prices in 1,000 euros.  
Additional descriptive statistics on RD&I funding from the ESA Programme are presented in 
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2.5.2 RD&I financial support from the SBIR programme 
Table 9 shows that among the firms awarded funding from the SBIR Programme (in 2017 and 
2018) four were EI clients, and eight were clients of Local Enterprise Offices (LEOs). 12 firms were 
high potential start-ups (HPSUs) and nine were other companies.  In the case of EI client 
companies, the total funding approved amounts to €74,500 with an average funding per 
participant of €18,600.  As shown in Table 10, of all awardees, 24 are located in Co. Dublin. The 
total funding for these awardees amounts to €568,000 with an average per awardee of 
€23,700.  
Table 9 Awardees of RD&I funding from the SBIR Programme by category 
Category # participants  Total funding (€ 000s)   Average  funding  per awardee (€ 000s)    
EI clients 4 74.5 18.6 
HPSUs 12 300.1 25.0 
LEO clients 8 225.6 28.2 
Others 9 292.5 32.5 
Source: ESRI elaboration based on the SBIR data provided by Enterprise Ireland. Notes: Total funding and average 
funding per participant are in thousand euros in current prices.   
Table 10 Awardees of RD&I funding from the SBIR Programme by region 
Region # participants  Total funding (€ 000s)   Average   funding  per awardee (€ 000s)    
Dublin 24 568.0 23.7 
Other regions 9 324.8 36.1 
Source: ESRI elaboration based on the SBIR data provided by Enterprise Ireland. Note: Total funding and average 
funding per participant are in thousand euros in current prices.  
Information for 16 awardees of funding from the SBIR Programme could be linked to the ABSEI 
data set. The majority of these (11) of these are in the sector Information and Communication 
and other Internationally Traded Services. Among these 16 awardees, 7 were also awarded EI 
direct RD&I funding and 3 of them were awarded funding from the ESA Programme.    
Given the limited data available for RD&I funding from the SBIR Programme, it is not possible to 




Evaluation of the Enterprise Ireland Research, Development and Innovation Programme 31 
3 Assessment of appropriateness  
Evaluation requirement: An assessment of the Programme in relation to Ireland’s enterprise 
and Innovation policies (past current and future policy challenges) and the economic 
context that applied during the time period under review; assessment of the Programme’s 
fit with the emerging needs of enterprises (Objective 1a) 
 
The assessment of the RD&I Programme’s appropriateness is addressed through two main 
avenues: i) an examination of alignment with national policies and strategies, and ii) 
consultation on current and anticipated firm needs.  
Across our analysis, the RD&I Programme demonstrates good levels of appropriateness with 
both national policy and firm needs. This is set out in turn in the following sub-sections 
3.1 Prevailing economic context and alignment with national policy  
Ireland has transformed its economy over the past 30 years with major success in attracting 
inward investment in the 1990s and the gradual movement of those multi-national corporations 
(MNCs) up the value chain, while also catalysing an ambition to innovate and export among 
Ireland’s indigenous firms. Enterprise Ireland has been at the centre of this deliberate evolution 
of enterprise policy in Ireland, and its increasing focus on Research, Development and 
Innovation (RD&I) has enabled Ireland to begin to compete on an equal footing with major 
European and global economies, whether that is within the context of European RD&I 
programmes like Horizon 2020 or European Space Agency (ESA) or international trade with its 
partners). Ireland’s enterprise base and economy have changed significantly over this period, 
with the emergence of a very much more dynamic indigenous industry characterised by high-
productivity and innovation-intensive activities.  
The RD&I Programme is a major support for firms, which has been consciously developed over 
time in order to address both feedback from client firms and changes to context conditions. 
Within this study, the development of the programme logic model for the RD&I Programme 
(see section 2.2.3) highlights the extent to which the objectives of the programme – as well as 
the anticipated outcomes and impacts – are aligned with the national policy context. 
However, when examining the relevance of supports for RD&I against national policy 
objectives, it is important to consider the full suite of supports (i.e. direct and indirect). It is our 
view this holistic approach, which works across several modes and models, is the optimal way 
to approach support to firms. Interviews with stakeholders and representatives of international 
comparator programmes substantiate this.  
Taken together, Ireland’s supports for in-house RD&I – the RD&I Programme and the in-direct 
supports that sit around it as set out in section 2.2.227 – are well-aligned with Ireland’s national 
strategies and policy documents. RD&I remains a central pillar of Ireland’s overall national 
strategies, an overview of which can be found in section 2.1. The individual components of the 
RD&I Programme, EI Client Offers and the indirect supports administered by EI each serve these 
objectives and demonstrate fit.  




27 The R&D Tax Credit, Knowledge Development Box, support to access ESA funding, and SBIR funding 
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Table 1 and Table 3) reinforces the view that each contribute to the national policy objectives 
set out in section 2.1.  This examination of individual support objectives demonstrates how each 
support addresses different aspects of the overarching policy objectives as well as difference 
subsets of the firm base. The examination also suggest that the direct supports are appropriate 
for both experienced and new or less-experienced RD&I performers. Indirect supports would 
appear to be more appropriate for experienced and repeat performers, or those in specific 
sectors or areas of application. 
The view that Ireland’s policy objectives are well-addressed through the programmes in place 
is further substantiated by the recent OECD report, “SME and Entrepreneurship Policy in 
Ireland”,28 which finds that Ireland has a strong set of policies and programmes in this area. Prior 
evaluative reports also highlight similar areas of success in the current (broad) set of available 
RD&I support, alongside a number of recommendations for future action.29 
The changes enacted to the RD&I Programme (as detailed in section 2.2.3) also reflect 
positively on the strategic fit of the programme. It is clear from consultation with senior Enterprise 
Ireland personnel that the programme is continuously and consciously developed in line with 
client feedback and international good practice. The introduction of the Agile Innovation 
Fund, for example, seeks to address the needs of firms that operate in areas of shorter project 
lifecycles, which holds direct relevance for the sectors of high strategic importance to Ireland, 
such as ICT, among others. Similarly, the introduction of the Business Innovation Offer shows an 
awareness of the need to address non-technological innovations, though consultation with 
senior Enterprise Ireland personnel revealed some challenges in defining eligibility and thus the 
selection of projects to support. 
The 2019 OECD report outlines that, while attitudes to entrepreneurship are positive and SME 
innovation rates are somewhat high in Ireland, clear challenges exist for addressing the 
‘untapped potential’ for entrepreneurship among some groups in society, as well as addressing 
variations of performance across the regions of Ireland. It has so far been difficult to identify 
areas where the programme concretely addresses these areas, though it is clear that the 
involvement of the Local Enterprise Offices across Ireland could contribute to the latter area.  
3.2 Programme fit with firm needs 
In order to address the extent to which the RD&I Programme (in its current configuration) aligns 
with firm needs, the study team directly consulted EI client firms via three specific survey 
questions. The first of these questions addressed the motivations for firms to apply to the 
programme (i.e. which goals and aspirations firms were hoping to address through the 
support). The second question asked firms which challenges they anticipated facing in the 
future, while the third question asked firms to what extent they believe the current configuration 
of the RD&I Programme could address those anticipated challenges.  
3.2.1 Motivations for accessing the RD&I Programme  
Awardees of the RD&I Programme were asked via survey about their motivations for accessing 
the support they had received. The responses show a strong correlation with the stated 
purposes of the programme (see the draft programme logic model, Figure 1 in section 2.2.3). 
 
 
28 OECD (2019), SME and Entrepreneurship Policy in Ireland, OECD Studies on SMEs and Entrepreneurship, OECD 
Publishing, Paris, https://doi.org/10.1787/e726f46d-en.  
29 Indecon (2017), Review of RD&I Supports available to Businesses in Ireland to Maximise Business Expenditure on 
Research and Development 
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In the survey responses, ‘Undertaking new RD&I projects in [their] core business area’ proved 
to be the most relevant motivation, closely followed by ‘Increase the company’s capacity and 
capability to undertake RD&I activities’, both of which were considered ‘Important’ or ‘Very 
important’ by almost 90% of respondents.  
Figure 15 Motive for grant application - awardees 
 
Source: Technopolis, based on Beneficiary survey. Base = 200 - 204, base for ‘Other’ = 22 
3.2.2 Appropriateness of direct financial support to address anticipated future challenges  
Awardees were also asked via survey what they expected to be the main challenges they 
would face in the next five to ten years. This question was intended to uncover the extent to 
which the programme – in its current configuration – might be well-positioned to address those 
issues.  
Issues relating to recruitment appeared as the most common foreseen challenge, reported by 
64% of all awardees. This was followed at some distance by ‘Maintaining profit margins’, 
‘Increased market uncertainty’ and ‘Technological advancement’ – see Figure 16. 
Respondents were given the opportunity to add their own self-identified challenges via an 
open text response. Responses submitted via this ‘Other’ option included Brexit (most 
common), as well as environmental issues and the pressure to compete financially with large 
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The study team also asked the same question of EI clients that had not accessed the RD&I 
Programme. Respondents to that survey reported anticipated future challenges in similar 
proportionality to their counterparts that had accessed the programme.30  
Figure 16 Expected challenges - awardees 
 
Source: Technopolis, based on Beneficiary survey. Base: 220 
When asked about how appropriate the current support provided via the RD&I Programme is 
to addressing those anticipated challenges, awardees were generally positive. Two out of 
three respondents (66%, 109 respondents) stated that the support was ‘Very appropriate’ or 
‘Appropriate’ compared to 14% (22 respondents) who felt the support was not appropriate to 
meet the challenges – see Figure 17. Perhaps unsurprisingly, non-beneficiaries were slightly less 
positive about the appropriateness of the programme to address anticipated future 
challenges.31 
Figure 17 Appropriateness of the (current configuration of the) RD&I Programme to address expected 
challenges – awardees  
 
Source: Technopolis, based on Beneficiary survey. Base: 169   
 
 
30 This is not shown in the figure 
31 Of surveyed non-recipients, just under one half (49%, 19 respondents) stated that the support was ‘Very 
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4 Assessment of effectiveness  
4.1 Role and performance in increasing R&D investment and intensity  
The examination of the effectiveness of the RD&I Programme draws on a number of areas of 
consultation and analysis. To address this question, the study team conducted econometric 
analysis to compare the performance of awardees of EI RD&I financial supports in contrast to 
a control group, as well. EI client firms that have accessed the Programme were also consulted 
on aspects of effectiveness via survey and interview, and EI Development Advisors were also 
consulted.  
In the following sub-sections, we address two evaluation requirements: i) the Programme’s 
effectiveness in reaching desired impacts, and ii) the Programme’s effectiveness in increasing 
the number of firms performing RD&I. 
4.1.1 Effectiveness of the RD&I Programme in reaching desired impacts  
Evaluation requirement: Determine the effectiveness of the Programme in achieving the 
desired or any impact including: measuring as accurately as possible the direct relationship 
between the EI RD&I Programme supports and increased business expenditure on R&D (BERD); 
quantifying as accurately as possible the full benefits relative to the cost of the programme 
(Objective 1b) 
 
Econometric analysis32 allows us to examine and measure the impact of EI RD&I financial 
supports on the performance of awardees (including R&D intensity), by drawing comparisons 
with an appropriate control group.33 A control group is a purpose-designed group of firms with 
similar characteristics that have not accessed the RD&I Programme. The control group has 
been identified by using a technique called Propensity Score Matching, to select a group of 
firms that were similar to the treatment firms before the intervention. This process comprised 
matching each awardee of EI RD&I financial support over the period of investigation with a 
firm that had the same probability (Propensity Score) of being awarded such financial supports 
over the same period (conditional on firm characteristics) but which were not awarded 
supports. A total number of 654 awardees of EI RD&I financial supports have been matched 
with the same number of non-awardees with similar characteristics.34 The econometric analysis 
shows that the awardees of EI RD&I Programme financial supports out-perform similar firms that 
have not received the support across all outcome performance indicators considered, 
including indicators of R&D inputs as well as economic and innovation outputs.35  
Overall, the results of the econometric analysis indicate that on average, five years after the 
first approved awards, the EI RD&I direct financial supports have boosted significantly the R&D 
 
 
32 The approach taken by the study team uses information available from the linked ABSEI and RD&I Programme 
data sets provided by DBEI and EI. The analysis has been carried out at enterprise-group level. 
33 Due to time lag in the data, only the R&D Fund was included in the econometric analysis. The new elements of the 
Agile Innovation Fund and Business Innovation Offer were introduced too recently to be included 
34 More details about the Propensity Score Matching are provided in Appendix B.1 
35 This better performance could be explained by the impact of the EI RD&I direct financial support as well as other 
factors including enterprise group - specific characteristics. To identify the direct impact of EI RD&I financial supports 
on the performance of awardees, we compare the performance of awardees after the approval of such supports 
with the performance of firms with similar characteristics which have not been awarded RD&I financial supports 
using a technique called propensity score matching. The impact of the RD&I intervention is then the performance 
differential between these two enterprise groups. More information on this approach can be found in Appendix B.1 
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performance of awardees as well as their performance with respect to sales, value added, 
employment, export sales and export intensity. More specifically, we find that: 
•  Relative to a situation of no RD&I financial supports, on average, after five years the R&D 
performance of awardees increased by more than 100% with respect to net R&D 
expenditures, R&D intensity (net R&D expenditure relative to firm size measured as sales and 
employment and R&D employees as a share of total employees) while the number of R&D 
employees was higher by 36.1% 
•  On average, after five years the output performance of awardees increased by 19% in the 
case of sales, by 35.2% in the case of value added, while export sales were higher by 69.3% 
and the export sales as share of total sales increased by 50% .36 In terms of employment, 
awardees grew by 19% 
•  Our results indicate an increase of the product innovation intensity three and four years 
after the first RD&I financial awards by more than 200% (more than two times higher). Given 
the more limited data availability for sales of new products (available since 2012) these 
results should be interpreted as indicative only 
•  There is no evidence of statistically significant productivity growth after five years as a result 
of the EI RD&I direct financial supports. This result might reflect the need for a longer time 
for the effects of RD&I interventions to translate into significant productivity growth (for 
example seven to nine years). Due to the limitations of the available data longer post-
intervention time period could not be considered. A more detailed examination of the 
relationship between R&D and productivity can be found in section 4.1.3 
These findings are substantiated by the results of direct consultation with firms via survey and 
interview, where consulted firms reported consistent benefits and impacts from their received 
support. Firms also noted high levels of attribution to the RD&I Programme support. The view on 
productivity effects was similarly muted, though we note that many firms consulted were still in 
the early stages of embarking on releasing new products or entering new markets, which could 
subsequently reveal productivity gains in the future. 
Examining these in more detail, we estimated year-on-year impacts of the EI RD&I Programme 
supports on i) the innovation performance and ii) the economic performance of firms that have 
received RD&I Programme support (awardees) compared to those that have not.  This is set 
out in the following sub-sections. 
4.1.2 Impacts on innovation performance 
The figure below shows that the R&D performance of awardees is significantly better than the 
corresponding R&D performance of non-awardees with similar characteristics indicating a 
significant positive impact of the EI RD&I direct financial supports.  
This conclusion holds for five measures of R&D and R&D intensity presented in the figure below: 
Net R&D expenditures; Net R&D expenditures as a proportion of turnover; Net R&D expenditures 
as a proportion of number of employees; R&D employment and R&D employment as a 
proportion of  number of employees. In all five cases, the difference (in the mean value of the 
indicators) between the treatment and control group increased over time.37 In the paragraphs 
below we explain the results for each measure. 
 
 
36 The impact of the EI R&D intervention is significant each year up to three years after the first approved awards.    
37 The charts on the left (‘panel a’) show the average change in the R&D performance of awardees and matched 
non-awardees five years after the approval of the EI RD&I direct financial supports. The charts on the right (panel 
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Figure 18 below presents the mean value of Net R&D expenditure for the treatment (awardees) 
and control group increases (Panel a) in the years after the treatment. It shows that that  the 
difference (in the mean value of) Net R&D expenditure between the treatment and control 
group increases over time (Panel b). The subsequent table shows that after five years net R&D 
expenditures of awardees increased by 157% (in comparison with the control group), i.e. that 
the programme has had a substantial positive effect on this measure of R&D performance. The 
increment is quite substantive and reflects in part the fact that the programme has attracted 
a good number of non-RD&I performers (between 8%-14% according to our calculations, see 
4.2). 
The results are statistically significant (since the p-value is lower than 0.05, which means that we 
have 95% confidence that the results are different from zero).38 The results are  shown using a 
logarithm scale (a treatment needed for the econometric analysis), as such their nominal 
values only provide a visual representation of the trends between the control and treatment 
group (but not the value of the impact). The value of the impact is show in the tables below 
the figures. The same applies for the subsequent indicators. 
Figure 18 Estimated impacts of the EI R&D direct financial supports on R&D performance on Net 





Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
Net R&D 
expenditures 
beta 0.997 1.425 1.517 1.757 1.975 2.295 1.569 
s.e. 0.172 0.194 0.214 0.250 0.268 0.288 0.168 




‘b’) show the impact of EI RD&I direct financial supports on the R&D and on the economic and innovation 
performance of awardees. The results are  shown using a logarithm scale (a treatment needed for the econometric 
analysis), as such their nominal values provide a visual representation of the trends between the control and 
treatment group (but not the value of the impact). The average value of the impact across the different 
performance outcomes is shown in Table 53 in Appendix B.1. The vertical red lines in the charts around the mean 
effects show the precision of the estimates, representing the 95% confidence interval. An effect is not statistically 
significantly different from zero at 95% confidence level if the vertical red line (indicating the error interval) crosses 
the zero line  
38 The p-value (probability value) is used in hypothesis testing. The gold standard in econometrics is to assume that 
any value above 0.05 means that the results are not statistically significant, as we would have lower than 95% 
confidence that the results are different from zero. 
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Figure 19 below presents the mean value the intensity of R&D expenditure (i.e. Net R&D 
expenditure over turnover) for the treatment and control group (Panel a). It shows that the 
difference in (the mean value of) Net R&D expenditure over turnover between those two 
groups increases over time (Panel b). The subsequent table shows that after five years R&D 
intensity of awardees increased by 138% (in comparison with the control group), i.e. that the 
programme has had a substantial positive effect on this measure of R&D performance. The 
results are statistically significant (since the p-value is lower than 0.05). 
Figure 19 Estimated impacts of the EI R&D direct financial supports on R&D performance on Net R&D 





Outcome variables Years after approval of EI RD&I direct funding  




beta 0.877 1.250 1.362 1.555 1.777 2.013 1.378 
s.e. 0.172 0.194 0.214 0.245 0.265 0.285 0.167 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
Figure 20 below presents the mean value of a different measure of intensity of R&D 
expenditure (i.e. Net R&D expenditure over employee), for the treatment and control group 
(Panel a). It also shows that the difference (in the mean value of) Net R&D expenditure over 
employee also increases over time (Panel b). The subsequent table shows that after five years 
R&D intensity also increased  by 138% (in comparison with the control group) i.e. that the 
programme has  also had a substantial positive effect on this measure of R&D performance. 
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Figure 20 Estimated impacts of the EI R&D direct financial supports on R&D performance on Net R&D 





Outcome variables Years after approval of EI RD&I direct funding  




beta 0.864 1.277 1.348 1.567 1.776 2.077 1.380 
s.e. 0.171 0.193 0.212 0.246 0.264 0.286 0.166 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
Figure 21 below presents the mean value of the R&D employment for the treatment and 
control group (Panel a). It also shows that the difference (in the mean value of) the R&D 
employment between those two groups increases over time (Panel b). The subsequent table 
shows that after five years R&D employment among awardees increased by 36% (in 
comparison with the control group), i.e. that the programme has had a substantial positive 
effect on  R&D employment albeit a milder one in comparison with other measures of R&D 
performance. Taking into account the results shown above (in terms of R&D expenditure), 
this could mean more extra-mural R&D and collaboration with external partners. The results 
are statistically significant (since the p-value is lower than 0.05). 
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Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
R&D employees   
beta 0.267 0.351 0.358 0.388 0.436 0.427 0.360 
s.e. 0.025 0.031 0.036 0.043 0.050 0.056 0.031 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
Figure 22 below presents the mean value of the R&D employment as a percentage of total 
employees for the treatment and control group (Panel a). It shows that  the difference (in 
the mean value of) the R&D employment as a percentage of total employees between the 
treatment and control group increases over time (Panel b), even though it has declined for 
both groups. The subsequent table shows that after five years R&D employment as a 
percentage of total employees among awardees increased by 17% (in comparison with the 
control group), i.e. that the programme has also had a positive effect on the proportion of 
R&D employment as compared to the employee base, albeit a milder one in comparison 
with other measures of R&D performance . The results are statistically significant (since the p-
value is lower than 0.05).  
Figure 22 Estimated impacts of the EI R&D direct financial supports on R&D performance on R&D 




Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
R&D employees / 
total employees  
beta 0.136 0.203 0.187 0.194 0.232 0.205 0.170 
s.e. 0.027 0.031 0.036 0.042 0.049 0.059 0.032 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
We consulted awardees via our online survey on the benefits and impacts that they had 
experienced through their interaction with the EI RD&I Programme. The results of the survey 
resonate well with the findings of the econometric analysis set out in the preceding section, 
indicating a series of intermediate outcomes (related to RD&I capacity) have also been 
achieved thanks to the programme. 
The reported benefits experienced are summarised in Figure 23, which shows the most 
commonly-reported benefit being the ‘Development of new or enhanced products, processes 
or services‘, ‘Higher capability to undertake RD&I activities’, ‘Higher capacity to undertake 
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RD&I activities’ and ‘Improved knowledge on the benefits of RD&I for our company’. Each of 
these have been at least partially experienced by almost 90% of survey respondents. On the 
other end of the scale, less than half (49%) saw ‘Development of new or enhanced IP strategy’ 
to some extent, with the full realisation experienced by under one fifth (18%). Benefits reported 
under the open ‘other’ option include ‘Business transformation’ and ‘strengthening of 
reputation and credibility’. 
We also asked companies to estimate the effect of the programme on their R&D activities, and 
the results show that the median respondent has increased their financial resources devoted 
to RD&I activities by 50.8% (44% average value). This is lower than the findings from the 
econometric analysis, perhaps indicating that awardee companies are underestimating the 
effect of the grants on their investments in RD&I. 
While the econometric analysis does not include micro companies (which do not feature in 
the ABSEI), further analysis of the survey data by company size reveals that micro companies 
(1 – 9 FTEs) do well in improving their RD&I knowledge but are less able to translate the 
knowledge gained into higher R&D capacity, higher R&D capability or the development of 
new products.   
During analysis of the survey responses, the study team also examined the extent to which the 
number of grants received would (positively) impact on the benefits experienced. This analysis 
revealed some mixed results. Recipients of two grants have consistently reported a higher 
‘achievement rate’ (Benefit has been experienced at some or at a large extent) than 
recipients of a single grant. The trend, however, does not continue for recipients of three grants, 
who exhibit a lower achievement rate than singe grant recipients in half of cases. The only 
exception to this pattern is observed for ‘Development of business innovations’ with an 
achievement rate of 59%, 59% and 64% for respondents with one, two and three received 
grants, respectively. Overall, the variations appear generally too small for a conclusive finding.  
Figure 23 Benefits experienced by awardee firms 
 
Source: Technopolis, based on survey data. Base = 181 – 186, base for ‘Other = 5 
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Box 1 Agile Innovation Fund 
A company used the Agile Innovation Fund to develop their current technology and integrate it with 
AI and machine learning. The company knew that the technology worked but wanted to develop it 
further and explore potential markets for it. They successfully applied for the Agile Innovation Fund to 
pursue these goals further. 
 
The grant provided the company with €70k, a significant amount of money for them. They view their 
programme involvement as having been successful. They used the money to help develop a solution 
suitable for use across multiple sites, helping provide access to much more senior individuals at client 
organisations. The Agile Innovation Fund-supported technology has also helped the company 
become a leader in a new market. This in turn has opened up new export markets, as well as offering 
higher value chain opportunities amongst existing customers. 
Source: firm interview 
Box 2 Exploring Innovation Grant 
One company consulted has benefited from several RD&I programmes. The company provides 
nutritional supplements, and has been looking to enter new export markets, as well as improving and 
developing existing ones. Researchers for instance identified new active ingredients that could 
enhance their products.  
 
EI’s Exploring Innovation Grant helped fund much of the firm’s recent R&D activity. The company 
recently secured a multi-million euro deal with a client in another continent, drawing in large part on 
research funded through the RD&I support. The company has also benefited from the Intellectual 
Property Strategy Offer, with company representatives highlighting how it has helped improve staff’s 
IP capabilities, which in turn has made it easier to engage with collaborators. 
 
Source: firm interview 
4.1.3 Impacts on economic performance 
Using a similar approach to that above, the figures below, show a more mixed view of 
economic performance. The economic performance of awardees is significantly better than 
that of matched non-awardees for each year over the five year period after the first approval 
of EI RD&I Programme support in terms of: 
•  Turnover 
•  Total value added 
•  Employment 
•  Export sales 
•  Export intensity/(Export/turnover) 
However, there is no evidence of a significant improvement of the performance of awardees 
in terms of productivity (turnover/employee), product innovation (new product sales) as well 
as product innovation intensity (new product sales/turnover).  
In the paragraphs below we explain the results for each measure. The relationship between 
R&D investment and productivity is explored in more depth at the end of this section. 
Figure 24 below shows that the mean value of turnover for the treatment and control group, in 
the years after the treatment (Panel a). It shows that the difference in (mean value of) turnover 
between those two groups increases over time (Panel b) and is always statistically significant. 
The subsequent table shows that, over five years, turnover among awardees increased on 
average by 19.5% (in comparison with the control group), i.e. that the programme has had a 
positive effect on companies sales. This result is also statistically significant (since the p-value is 
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lower than 0.05), which means that we have 95% confidence that the results are different from 
zero). The results are  shown using a logarithm scale (a treatment needed for the econometric 
analysis), as such their nominal values only provide a visual representation of the trends 
between the control and treatment group (but not the value of the impact). The value of the 
impact is shown in the tables below the figures. The same applies for the subsequent indicators. 






Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
Turnover  
beta 0.121 0.182 0.161 0.203 0.196 0.281 0.195 
s.e. 0.025 0.033 0.039 0.042 0.050 0.057 0.032 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
Figure 25 below shows that the (mean value of) employment for the treatment and control 
group (Panel a). It shows that the difference (in the mean value of) employment between 
those two groups  increases over time (Panel b) and is always statistically significant. The 
subsequent table shows that, over  five years, employment among awardees increased on 
average  by 18.9% (in comparison with the control group), i.e. that the programme has had 
a positive effect on employment. This result is also statistically significant (since the p-value is 
lower than 0.05).  
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Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
Employment  
beta 0.131 0.148 0.170 0.190 0.201 0.220 0.189 
s.e. 0.019 0.023 0.028 0.033 0.040 0.043 0.025 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
Figure 26 below shows the mean value added for the treatment and control group (Panel 
a). It shows that the difference (in the mean value of) value added between the treatment 
and control group increases over time (Panel b), although this difference is not always 
statistically significant. The subsequent table shows, however, that over  five years, total value 
added among awardees increased on average by 35.2% (in comparison with the control 
group), i.e. that the programme has had a positive effect on this measure of economic 
performance. This overall result (i.e. the average effect across five years) is statistically 
significant (since the p-value is lower than 0.05).  




Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
Total value 
added  
beta 0.189 0.499 0.239 0.287 0.217 0.424 0.352 
s.e. 0.128 0.143 0.146 0.165 0.168 0.167 0.111 
p-value 0.140 0.000 0.101 0.083 0.197 0.011 0.001 
 
Figure 27 below shows the (the mean value of) exports for the treatment and control group 
increases (Panel a). It shows that the difference (in the mean value of) exports between 
those two groups increases over time (Panel b), albeit not steadily (but always statistically 
significant). The subsequent table shows, however, that over  five years export sales among 
awardees increased on average by 69.3% (in comparison with the control group). This overall 
result (i.e. the average effect across five years) is statistically significant (since the p-value is 
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Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
Export sales  
beta 0.510 0.448 0.701 0.687 0.435 0.630 0.693 
s.e. 0.114 0.145 0.171 0.180 0.192 0.226 0.131 
p-value 0.000 0.002 0.000 0.000 0.024 0.005 0.000 
 
The results in terms of turnover and exports mean that exports intensity (i.e. exports as a 
percentage of turnover) has also increased due to the programme, and this is further 
corroborated by Figure 28 that shows that  the difference (in the mean value of exports 
intensity) between the treatment and control group increases over time (Panel b); albeit this 
difference is not always statistically significant (specifically in year 1, 4 and 5). The subsequent 
table shows, however, that over five years the export intensity  among awardees increased 
on average by 49.6% (in comparison with the control group). This overall result (i.e. the 
average effect across the five years) is statistically significant (since the p-value is lower than 
0.05).  






Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
Export / turnover  
beta 0.389 0.265 0.536 0.478 0.234 0.345 0.496 
s.e. 0.108 0.138 0.162 0.169 0.181 0.210 0.122 
p-value 0.000 0.055 0.001 0.005 0.196 0.100 0.000 
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Figure 29 below shows that the difference (in the mean value of) productivity (i.e. turnover 
per employee) between the treatment and control group has been mixed, with awardees 
showing higher levels of productivity in comparison with the control group in only 3 years 
(Panel a and b). The differences however are not statistically significant. In line with this, the 
subsequent table shows, that the average effect on productivity over five years is 0.4%. 
However, this is not statistically significant (since the p-value is higher than 0.05).  
Figure 29 Estimated impacts of EI RD&I direct financial supports on Turnover / employee (log) 
 
(a) (b) 
   
Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
Turnover / 
employee  
beta -0.010 0.030 -0.011 0.013 0.003 0.061 0.004 
s.e. 0.021 0.026 0.030 0.031 0.037 0.040 0.023 
p-value 0.624 0.253 0.710 0.678 0.925 0.133 0.859 
 
The relationship between public R&D investment and productivity39 has been researched 
extensively, particularly as governments have made efforts to stimulate growth through 
innovation funding. The results of this body of research have been mixed (Castellani, D., et 
al, 2016; Coccia, M., 2011; Czarnitzki, D. and O’Byrnes, N., 2007).40 An analysis of the wider 
European research landscape suggests that R&D supports may positively impact 
productivity in some cases (Petrin, T., 2018).41  
Studies focused on Ireland have indicated that R&D investment has been associated with 
long-term productivity gains, albeit over a longer period than the five years possible in our 
 
 
39 Productivity measures used in empirical analyses of the impact of public R&D investment include labour productivity 
and total factor productivity (TFP). While TFP more directly reflects technological progress linked to R&D investment 
and innovation, measuring TFP is challenging because it is not observed in reality.  Estimates of TFP at firm level can 
be obtained using different econometric methodologies. Such methodologies require information on capital stocks 
at the firm level which are not available in the case of Ireland. See van Beveren (2012) for a review of most recent 
econometric methods to estimate TFP: Total factor productivity Estimation: A Practical Review. Journal of Economic 
Surveys, 26(1), pp. 98 - 128. Available at: https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1467-6419.2010.00631.x  
40 Castellani, D., et al, 2016. The Productivity Impact of R&D Investment: A Comparison between the EU and the US. 
Available at:  http://ftp.iza.org/dp9937.pdf; Coccia, M., 2011. The interaction between public and private R&D 
expenditure and national productivity. Available at: 
https://www.tandfonline.com/doi/abs/10.1080/08109028.2011.601079; Czarnitzki, D. and O’Byrnes, N., 2007. The 
Impact of R&D on Productivity. Available at: https://core.ac.uk/download/pdf/6304277.pdf. 
41 Petrin, T., 2018. A literature review on the impact and effectiveness of government support for R&D and innovation. 
Available at: http://www.isigrowth.eu/wp-content/uploads/2018/02/working_paper_2018_05.pdf   
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current study (O’Malley, E., Hewitt-Dundas, N., Roper, S., 2008).42 Further, literature also shows 
that firm-level spending on R&D, which we have seen across many of the awardees of RD&I 
Programme support, is also an indicator of future productivity improvements (Di Ubaldo, M., 
and Siedschlag, I., 2017).43 Building upon this existing country specific research, it is possible 
that the RD&I Programme would see productivity gains over a longer timescale. 
Our consultation with awardees and EI Development Advisors suggests that there are often 
sectoral considerations to the link between R&D investment and productivity. This suggests 
that productivity effects may not be seen in firms that work sequentially on R&D or where 
business models require continual investment in staffing to support the introduction of new 
products or services (e.g. in software, services and industries with short product lifecycles, or 
where firms are entering new markets). 
Figure 30 below shows that  the difference (in the mean value of) the value of new product 
sales (a proxy for innovation) between the treatment and control group has increased over 
time, however, this difference is only statistically significant in the year when the investment 
took place and for years  3 and 4 (Panel a and b). Furthermore, the subsequent table shows, 
that over  five years the value of new product sales among awardees increased on average 
by 89.4% (in comparison with the control group), but again the overall result (i.e. the average 
effect across the five years) is not statistically significant (since the p-value is higher than 0.05).  




Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
New product 
sales  
beta 1.752 0.494 0.862 2.608 2.234 1.477 0.894 
s.e. 0.709 0.737 0.745 0.869 0.974 1.343 0.647 
p-value 0.013 0.502 0.247 0.003 0.022 0.271 0.167 
 
Finally, Figure 31 below shows that  the difference (in the mean value of) the value of new 
product sales as a percentage of turnover (a proxy for innovation intensity) between the 
treatment and control group has increased over time but, again, this difference is only 
statistically significant in the year when the investment took place and for years, 3 and 4. 
Furthermore, the subsequent table shows, that the average effect over five years on the 
 
 
42 O’Malley, E., Hewitt-Dundas, N., and Roper, S., 2008. High Growth and Innovation with Low R&D: Ireland, in: Edquist, 
C., and Hommen, L. (ed.), Small Country Innovation Systems. Edward Elgar Publishing. Available at: 
https://ideas.repec.org/h/elg/eechap/3981_5.html  
43 Di Ubaldo, M., and Siedschlag, I., 2017. The impact of investment in innovation on productivity: firm-level evidence 
from Ireland. Available at: https://www.esri.ie/publications/the-impact-of-investment-in-innovation-on-productivity-
firm-level-evidence-from  
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value of new product sales among awardees increased by 85% (in comparison with the 
control group. However, this effect  is not statistically significant (since the p-value is higher 
than 0.05).  





Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
New product sales 
/ turnover  
beta 1.721 0.447 0.873 2.642 2.212 1.513 0.851 
s.e. 0.713 0.735 0.744 0.861 0.959 1.341 0.644 
p-value 0.016 0.543 0.241 0.002 0.021 0.259 0.186 
 
4.2 Increasing the number of firms performing RD&I 
Evaluation requirement: Determine how effective the EI RD&I Programme has been at 
increasing the number of companies investing in RD&I and the intensity of these RD&I 
investments: determine the factors that limit the take-up of direct financial supports that 
can be accessed through the EI RD&I Programme (Objective 1c) 
 
The study team examined the linked RD&I Programme and ABSEI dataset and survey data to 
understand the extent to which the Programme is i) attracting non-RD&I performers, and ii) is 
helping those non-performers to become active in RD&I.  
The econometric analysis and the survey data both support the view that the Programme is 
attracting non-RD&I performers. Figure 32, below, shows the proportion of firms that were not 
previously RD&I active, that were awarded a grant in each year from 2007 to 2016. Across the 
period, anywhere between 8% and 14% of awardees were previously not RD&I performers. 
Similarly, 9% of awardees that responded to the survey (20 respondents) reported having not 
spent any amount on RD&I prior to their grant award. A further 5% (10 respondents) reported 
having previously spent only negligible amounts (less than €300) on RD&I previously. 
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Figure 32 Share of awardees with no previous R&D in total awardees by year    
 
Source: ESRI estimates based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise 
Ireland 
Further, the RD&I Programme appears to have a positive effect when enabling those non-RD&I 
active firms into RD&I performers following their grant award. Figure 33, below, sets out the 
share of awardees with no previous R&D activity before receipt of an award from the RD&I 
Programme (left) and then each year up to five years after receipt of a grant. This analysis 
highlights a year-on-year and average reduction of the proportion of previously non-RD&I 
active firms.  
This is further substantiated by survey data. While this is a small sample, some indication of initial 
RD&I activity is evident. When comparing the reported post-award levels of RD&I expenditure 
of those previously non-active firms, 70% (21 respondents) reported an increase in spending on 
R&D. While RD&I expenditure levels remained relatively modest among this group post-award, 
one firm reported expenditure of approximately €200,000. 
Figure 33 Share of awardees with no previous R&D in total awardees before and five years after the first 
approved awards 
 
Source: ESRI estimates based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise 
Ireland 
When asked in interviews, two of the four international comparator programme representatives 
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and attempting improved communication with the subset of firms, in terms of setting out the 
potential benefits of RD&I. One programme in Denmark exists to help firms hire individuals to 
help them to scope RD&I prospects in the future. This was regarded as an effective approach. 
4.3 Added value of the RD&I Programme 
In order to understand the extent to which firms believe the RD&I Programme support to be 
important to their RD&I activity and experienced benefits, awardees were asked via survey to 
reflect on i) what would have happened in the absence of their grant, and ii) the degree of 
contribution their specific grant had made to their experienced results. 
Figure 34 shows that the RD&I Programme is regarded as having allowed the awardees to 
pursue their plans. Only 7% of respondents declared that they would have continued with their 
efforts at the same scale and time frame, while 81% declared that they would have had to 
scale down or delay (or both) their project. Finally, 10% would not have undertaken the project 
at all.  
Figure 34 What would have happened in the absence of the grant 
 
Source: Technopolis, based on survey data. Base: 190 
When asked about the level of contribution of each grant to their overall results, survey 
responses demonstrate a variation among the different grants within the programme. 95% of 
recipients of the Agile Innovation Fund reported that the grant has contributed ‘to a medium 
extent’ and ‘to a large extent’ to their achieved results. However, this represents a small 
number of respondents. 91% of recipients of the RD&I Fund reported that the grant had 
contributed ‘to a medium extent’ and ‘to a large extent’ to their achieved results. These 
findings are currently tentative and require further analysis. Examining the raw data showed 
that the number of respondents who answered the question for some grants exceeded in the 
number of respondents that earlier reported themselves as recipients of that specific grant. The 
study team thus repeated the analysis drawing on only the answers from confirmed grant 






2% We would have continued with our efforts or
project at a later time
We would have continued with our efforts or
project at a reduced scale
We would have continued with our efforts or
project at a reduced scale and at a later time
We would not have undertaken the project
We would have continued with our efforts or
project at the same scale and in the same
timeframe
We would have continued our with our efforts or
project at an alternative location (outside Ireland)
 
Evaluation of the Enterprise Ireland Research, Development and Innovation Programme 51 
Figure 35 Extent to which each grant has contributed to results 
 
Source: Technopolis, based on survey data. Base for ‘The RD&I Fund’ = 148, for all others base = 4 – 19   
4.4 Interaction of direct and indirect supports for RD&I  
4.4.1 The role and performance of indirect RD&I supports 
Evaluation requirement: Compare the role and performance of the direct to firm financial 
supports of the EI RD&I Programme in terms of achieving increased BERD to the roles and 
performances of: The Knowledge Development Box; The R&D Tax Credit; European Space 
Agency Funding; and Small Business Innovation Research. (Objective 2a) 
 
Due to data limitations,44 it has been difficult to quantitatively examine the performance of the 
suite of indirect supports in terms of increasing business expenditure in R&D, and the 
performance of combined direct and indirect supports. A descriptive analysis of the 
participation in ESA funding is available in Appendix A.3.45  
In order to mitigate this, the study team consulted stakeholders and awardees via interview, as 
well as with representatives of comparator programmes in other countries. Through this 
approach, it was possible to reach a high-level view of the value of indirect supports in addition 
to direct supports through programmes such as the RD&I Programme.  
Emerging from these conversations was a view that indirect supports for RD&I such as the R&D 
Tax Credit, ESA funding and SBIR funding are important components in increasing R&D 
expenditure within the firm base. Firms that had accessed the R&D Tax Credit, for example, 
were positive about its utility, but stressed that it is a complementary support to their grants that 
performs a different function for their business. In particular, firms that had used both suggested 
in interview that the R&D Tax Credit is less restrictive than grants and allows them to maximise 
the return of their RD&I activity with relatively little effort, and often helped firms to further invest 
in their R&D functions.  
Similarly, consultation revealed that ESA funding and SBIR funding are, overall, well-regarded 
by firms that have the ability to operate in those priority areas. There are a small number of 
examples of firms that have accessed the RD&I Programme to explore other application areas 
 
 
44 Inclusive of access issues to R&D Tax Credit data 
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for the products developed through ESA contracts.46 During the analysis, the study team 
attempted to identify firms that had benefited from both ESA funding and the RD&I 
Programme, but the number of observations was too small for analysis. The limited number of 
observations for firms accessing ESA47 and SBIR funding, within the datasets used in this study, 
reinforces the view that these indirect supports have most relevance for a smaller number of 
firms operating in specific areas. It should be noted that SBIR is a rather new programme at the 
time of this study. 
National stakeholders supported the view that funding both direct and indirect supports was 
the optimal approach to reaching the goal of increasing R&D expenditure. 
4.4.2 Synergies between available RD&I support 
Evaluation requirement: Explore the synergies with the above RD&I supports to the EI RD&I 
Programme (Objective 2b) 
 
This section examines the degree of interaction and complementarity that exists between the 
supports available for RD&I in Ireland. To do so, we draw on i) survey data, which indicate a 
high degree of synergy, ii) interview data, within which interviewees suggest that the holistic 
approach is most impactful, as different supports address different needs in different ways and 
often work well for different sub-sets of firms, and iii) and examination of the objectives of each 
scheme within the RD&I Programme and suite of indirect supports, found in section 2.2.  
Taking the examination of individual objectives first, an evident complementarity is seen 
among the RD&I Programme schemes and the suite of indirect supports. This examination of 
individual scheme objectives highlights that there are a number of ways in which firms are 
encouraged or supported to invest in RD&I (e.g. RD&I Fund, R&D Tax Credit) that use different, 
complementary mechanisms. The Exploring Innovation Grant is an important addition to these 
mechanisms to help firms to understand the role that RD&I could play for them, and to 
encourage better planning. The relationship between the Knowledge Box and Intellectual 
Property Strategy Offer may be seen similarly in their individual approaches to encouraging 
firms to better manage and leverage intellectual assets. There are then a series of schemes 
across the direct and indirect supports that target more specific cases, from the Agile 
Innovation Fund (for firms in sectors such as ICT or with short product cycles) and the Business 
Innovation Offer (for non-technological innovations), to the more ‘specialised’ or thematically-
focused ESA and SBIR programmes. There are also a small number of firms -revealed in 
consultation – that had received ESA funding and subsequently accessed the RD&I 
Programme in order to explore further areas of application for the innovations developed.  
Turning to the survey of awardees of the RD&I Programme, respondents were asked about their 
use of alternative support programmes. The responses revealed that the ‘R&D Tax Credit’ is the 
only instrument that is used by a large share on a regular basis (59%, 104 respondents). All other 
schemes have been used by less than a third of respondents. Awareness of the schemes can 
also be seen to vary. In the case of the European Space Agency, less than a third (30%) of the 
respondents were aware of the programme – see Figure 36.  
 
 
46 It should be noted that the performance of ESA beneficiaries measured here is only a sub-section of the overall 
performance of ESA beneficiaries 
47 A separate exercise will evaluate the European Space Programmes and provide baseline figures to 2019, against 
which it is intended that progress can be measured on realising the ambition expressed in the National Space 
Strategy for Enterprise  
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When asking the same question of clients that have not received support through the RD&I 
Programme, the R&D Tax Credit was by far the most commonly reported indirect support 
accessed, followed by collaborative R&D supports such as the Innovation Voucher and 
Innovation Partnerships grant (not shown in the Figure). 
Figure 36 Level of engagement with alternative supports for RD&I 
 
Source: Technopolis, based on survey data. Base = 140 - 182, base for ‘Other Support’ = 8 
The above findings are also reflected in the results for the perceived compatibility between the 
support provided by Enterprise Ireland and alternative support schemes. When asked about 
the possible interaction of different support measures, 107 out of 138 awardees that responded 
to the survey considered the R&D Tax Credit as complementary to the Enterprise Ireland RD&I 
Programme. By comparison, only four out of the 23 respondents felt so for the European Space 
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Figure 37 Complementarity between RD&I programme and alternative support measures 
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5 Assessment of efficiency 
Evaluation requirement: Determine whether the Programme can be delivered more 
efficiently (Objective 1d) 
 
To address this evaluation requirement, the study team has examined three dimensions of 
efficiency as related to the delivery of a support programme: 
i) The processes and procedures related to the implementation of the programme, 
through the lens of awardee satisfaction, 
ii) The extent to which awardees experienced barriers to accessing support and 
maximising the benefits or impact of that support 
iii) The main routes through which firms learn about and access the support available 
through the programme 
Each of these aspects were explored through the survey of awardees, and the analysis is 
presented in turn, below.48 Taken together, these aspects present a positive picture of the RD&I 
Programme.  
5.1 Firm satisfaction with procedures 
The survey results show a largely positive picture regarding the procedures involved in 
accessing support, and the nature of the support received. The analysis of survey responses 
reveals a positive picture. Only 15% reported that they were either ‘Not satisfied’ (12%, 21 
respondents) or ‘Not satisfied at all’ (3%, 5 respondents) with the ‘Administrative requirements 
following the approval of the application’. For all other services, the share of respondents who 
were either ‘Satisfied’ or ‘Very satisfied’ was 69% or higher. In the case of ‘Support provided by 
the Enterprise Ireland Development Advisor’ the according approval rate was 83%.  
Figure 38 Satisfaction with procedures and received support 
 
Source: Technopolis, based on survey data. Base = 140 - 183 
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5.2 Barriers experienced 
In order to understand both general satisfaction and the presence of any issues in a) accessing 
support and b) maximising the benefits of that support, our survey of awardees asked a range 
of questions related to what barriers, if any, had been experienced during and following the 
application process.  
Figure 39 shows the different types of barriers perceived. Overall, the results show relatively 
consistent patterns among the different grants. ‘The work required to prepare and submit the 
application’, for instance, is the most frequently perceived barrier among all respondents. On 
the other hand, ‘Securing co-financing for the grant’ and ‘Securing internal resourcing to 
continue the work after the grant finished’ are not a common barrier among any of the grant 
recipients.  
Further analysis of the results reveals a connection between the size of the company and the 
perception of barriers before, during or after the application process. Comparing the results for 
the eight different types of possible barriers, large companies (250 or more FTEs) least often 
reported experiencing issues, whereas micro (1 – 9 FTEs) and small (10 – 49 FTEs) firms consistently 
reported the highest share.  
The segmentation in different regions does not reveal any distinct correlations with the 
perception or experience of barriers. Examining perceived barriers across industry segments 
reveals some points of difference. Respondents within the chemical and pharmaceuticals 
industry consistently reported the lowest level of barriers perceived (except for ‘Securing 
internal resourcing to continue the work after the grant finished’).  
Enterprise Ireland clients that had not accessed the RD&I Programme primarily reported their 
barriers to access related to a lack of alignment from the Programme with their own business 
needs or plans (e.g. 17% or 8 respondents are not R&D active and do not plan to be in the near 
future), difficulty obtaining match funding (again 17%, 8 respondents), the complexity of the 
application process (11%, 5 respondents), a lack of awareness of available support (a further 
17%, 8 respondents).  
Figure 39 Perceived barriers experienced in accessing mechanisms 
 
Source: Technopolis, based on survey data. Base = 4 – 21, base for ‘RD&I Fund’ = 163. NB: The chart shows that no 
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The appraisal process has been consciously improved over time in terms of turnaround time, 
and the introduction of the Agile Innovation Fund was noted in interviews as being a positive 
move for businesses in sectors such as ICT or those with short product lifecycles. In conversation 
with Development Advisors, there was a sense that the new streamlined approvals processes 
were not always used to the fullest extent. For example, the Management Approval 
Committee, which meets weekly and approves Agile Innovation Fund grants that are too large 
to be approved online (and where a firm has had no prior support) reportedly lacks 
technological expertise in its process. This has sometimes meant that proposals that are on an 
agile track have been taken through the R&D Committee, which meets less frequently, 
meaning that the agile process that should take three weeks might eventually take up to 12 
weeks. This appears to be a disincentive to make use of the committee processes that are 
designed to minimise turnaround times. Due to requirements of funding, the agile process also 
excludes firms that have previously received support. This can create problems for repeat 
innovators that operate in sectors where the Agile Innovation Fund would be most beneficial.  
The general view among awardees is that some administration is required and expected when 
accessing public funds, and that some learning curve is expected when accessing a scheme 
for the first time. This is well understood and is often a calculated decision for firms when 
accessing the Programme, and, once this learning has occurred, most found the process 
manageable. This appears to especially be the case among firms that access the Programme 
repeatedly. However, in interviews, some firms explained that they had experienced difficulties 
fulfilling monitoring procedures. Two examples of this include completing timesheets where 
firms have different established project management systems (leading to duplicated effort) 
and the requirement for external auditors to sign off claims (with cost implications for firms).  
Another barrier explained was the non-eligibility of overseas labour or services, especially in 
areas where firms experience a fairly limited pool of appropriate talent. Firms in some sectors 
stated that they face difficulty securing required expertise in Ireland, while others suggested 
that they had experienced difficulty while attempting to run market testing overseas. Two firms 
mentioned difficulties from experiencing draw down delays, which impacted the progress of 
their supported projects. There was limited discussion about the application process. Several 
firms reflected the complexity of the application process, and a number of Development 
Advisors suggested that they have had to provide additional guidance over and above what 
is available in written form, or to compensate for a perceived non-intuitive online process (e.g. 
a confusing or out-dated user interface, and the need for applicant firms to reply to an 
automated email with documentation).  
5.3 Access routes to support 
Our survey of awardees asked respondents to indicate via which route they had been 
introduced to the RD&I Programme. The results show that the ‘internal’ communication 
channels of Enterprise Ireland is most common, as the vast majority (71%, 147 respondents) first 
heard about the available grants by their Enterprise Ireland Development Advisor while 
another 19% found the information directly on the Enterprise Ireland website – see Figure 40. 
‘Other’ sources include outside consultants, word of mouth and past experience among 
others.  
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Figure 40 Source of Information 
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6 Comparative view of select RD&I supports  
Evaluation requirement: Assess the performance of the Programme relative to similar 
programmes available in other comparator countries (Objective 1e) 
6.1 Introduction to the international comparators 
The following chapter sets out a comparison of the RD&I Programme with a number of similar 
programmes delivered in other countries, focusing on the role and performance of support for 
RD&I. The list of comparator countries was selected based on several criteria. First, the schemes 
operate in countries that are either members of the Small Advanced Economies Initiative of 
which Ireland is also a member,49 or rank well in the latest Global Innovation Index (2019) 
published by Cornell University, INSEAD, and the World Intellectual Property Organization 
(WIPO).50 In this analysis, the study team has excluded policy systems are qualitatively different 
to Ireland, such as federal states (i.e. the US, Germany) or where instrumentation is significantly 
dissimilar to Ireland (e.g. Japan, the Republic of Korea, Singapore). In addition, programmes 
were selected that cover broad in-house RD&I activities (rather than collaborative RD&I 
programmes) that are instrumented in an open way (rather than in targeted thematic areas). 
There is some commonality between the selected programme countries and the countries 
focused on in the 2017 Indecon report, though the approach taken to the current evaluation 
focuses specifically at the programme level rather than a system perspective. 
Most schemes among these comparators are similar in terms of structure and eligibility. Most of 
the programmes are aimed towards, and actively target, small and medium-sized enterprises 
(SMEs), and most offer support via a grant mode similar to the RD&I Programme.51  
Table 11 Overview of international comparator programmes 
Country Organising body Programme 
Austria Austrian Research Promotion Agency 
(FFG) 
Frontrunner 
Denmark Innovationsfonden InnoBooster 
Finland Business Finland Research, development and piloting for SMEs & 
midcaps 
Israel Innovation Israel Authority R&D Fund 
Netherlands Netherlands Enterprise Agency (RVO) SME+ Innovation Fund (Innovatiefonds MKB+) 
New Zealand Callaghan Innovation R&D Project Grant 
Sweden Vinnova Innovation projects in small and medium-sized 
companies 
Switzerland Innosuisse Innovation projects (without innovation partner) 
 
 
49 See: https://smalladvancedeconomies.org/  
50 The Global Innovation Index (GII) is an annual ranking of economies by innovation performance. See: 
https://www.globalinnovationindex.org/home 
51 The Finnish programme is based on loans which have the potential to be converted into grants and is therefore 
also included 
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United 
Kingdom 
Innovate UK Smart Grants 
6.2 Budgets and eligibility 
While the nine comparator programmes are broadly similar in terms of their mode of funding, 
eligibility criteria and funding levels, some differences are evident in the grant size and 
intervention rate. These range from 33% (Denmark) to 70% (Finland, UK) of total project costs. 
Most schemes offer different intervention rates based on the size of the applicant firm. The 
maximum rate is summarised in the table below. 
Table 12 Comparator programme budgets and intervention rates 
Programme Latest annual budgets (EUR) Max. project costs (SMEs) 
Frontrunner (Austria) €20m (2019) 50% 
InnoBooster (Denmark) €40m (approx., 2019)52 33% 
Research, development and piloting 
for SMEs and midcaps (Finland) 
Not found 70% 
R&D Fund (Israel) €110m (approx., 2018)53  50% 
SME+ Innovation Fund (Innovatiefonds 
MKB+) (Netherlands) 
€70m (Innovation Credit, 2019)54 Not found 
R&D Project Grant (New Zealand) €15m (approx., 2017/18)55 40% 
Innovation projects in small and 
medium-sized companies (Sweden) 
Not found 50% 
Smart grants (United Kingdom) Not found 70% 
Source: Technopolis, based on reviews of agency websites 
6.3 Range of available support 
The Enterprise Ireland RD&I Programme is among the most comprehensive support available 
to firms for RD&I within this set of comparators. This is largely due to the features of the 
international comparator programmes, which in general focus more narrowly on technological 
innovations. The RD&I Programme is made up of more components and supports a broader 
range of activities, from specific IP support to support for business innovations. The addition of 
the Agile Innovation Fund for firms in sectors with short product cycles also stands out among 
the comparators, as does the explicit eligibility of commercialisation costs. While it is clear in 
the examples from Finland, the Netherlands, New Zealand, Switzerland and UK that additional, 
linked business/product development support is also made available, the support available 
through Enterprise Ireland appears to be more holistic in nature, due to the presence of 
 
 
52 See: https://www.teknologiudvikling.dk/innobooster 
53 See: https://innovationisrael.org.il/en/reportchapter/innovation-authority 
54 See: https://www.rvo.nl/subsidies-regelingen/innovatiekrediet 
55 See: https://www.callaghaninnovation.govt.nz/sites/all/files/callaghan-innovation-annual-report-2018.pdf 
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dedicated Development Advisors that work with firms to identify and signpost additional 
support attached to their funding. 
Table 13 Standalone or holistic support available via comparator programmes 
Programme Nature of support 
Frontrunner (Austria) Appears to be relatively standalone in nature 
InnoBooster (Denmark) Appears to be relatively standalone in nature  
Research, development and piloting for 
SMEs and midcaps (Finland) 
Clearly linked advisory services, access to networks, peer support, etc. 
SME+ Innovation Fund (Innovatiefonds 
MKB+) (Netherlands) 
Grants and repayable credits with linked expertise in areas such as 
support for digital communication, smart organisation, and finding 
business partners 
R&D Project Grant (New Zealand) Clearly linked access to experts and innovation skills development 
Innovation projects in small and 
medium-sized companies (Sweden) 
Appears to be relatively standalone in nature  
Innovation projects (without innovation 
partner) (Switzerland) 
Clearly linked access to coaching, training, mentoring, peer networks 
Smart grants (United Kingdom) Clearly linked access to networking, collaboration, attracting 
investors, market access support, etc. 
Source: Technopolis, based on reviews of agency websites 
6.4 Documented impacts and lessons learned 
The study team has reviewed the available evaluative material to reach a view of the 
achievements, benefits and impacts of the selected comparator schemes. Four of the nine 
selected comparator schemes have been evaluated in the last three years, with others 
addressed via – for example – annual reports. An evaluation is in progress for the Innovate UK 
Smart Grants Programme. In order to gain further insight, the study team sought to interview 
representatives of the programmes. In total, four interviews were conducted, with 
representatives of the programmes in Austria, Denmark, the Netherlands and Sweden. 
While it is not possible to compare the performance of these comparators with the RD&I 
Programme,56 the study team has summarised the key achievements and impacts, key success 
factors and lessons learned of the four programmes where documentation allowed and/or 
consultation was possible. The selection of key success factors and lessons learned appear to 
be broadly in line with the approach taken to evolving the RD&I Programme. 
Table 14 Impacts and lessons learned among international comparators 
Programme Achievements and 
impacts 
Key success factors Lessons learned 
Frontrunner (Austria) 57 Allowed projects to be 
technologically more 
demanding and/or 
generally more extensive 
than without support 
Programme signals 
belief in the firm to 
international actors – 
helping SMEs access 
international markets 
More focus needed on target 
groups of mainly SMEs and 
midcaps to maximise impact 
 
 
56 Due to, in part, methodological differences and elsewhere a lack of appropriate data  
57 Available at: https://repository.fteval.at/389/1/EB_ohne_Kommentare_TC_FFG_BMVIT_barrierefrei.pdf (in German) 
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Helped support 
established frontrunner 
companies to build new 
market segments 
The simplicity of the 
support was deemed 
to be a reason for 
signalling success  
Future iterations could be 
geared toward promoting 
diversification among strong 
companies in new segments 
Improvements needed to 
project monitoring in order to 
enable necessary changes 
InnoBooster (Denmark) 58 Encourages firms of 
varying stages of 
readiness to develop 
RD&I capability and 
activity 
Helps firms to crowd in 
funding from other 
sources 
There has been a positive 
effect on start-ups, which 
while not intentional now 
makes up a significant 
proportion of awards 
Broad range of 
available grant sizes 
and the lack of 
thematic restrictions 
Support is capped low 
(33% of costs) to 
ensures firms apply 
with a concrete and 
well-backed project  
Some funding criteria 
changed  
Flexibility is important – 
consideration is being given 
to allowing the support to 
extend to collaborative 
projects in future  
Effectively addresses the 
demand side, though mid-
sized companies are 
underrepresented 
SME+ Innovation Fund 
(Innovatiefonds MKB+) 
(Netherlands)  
The creation of an 
ecosystem of venture 
capital investments 
The attraction of projects 
related to ‘higher 
government goals’, 
encouraging private 
investment in public 
missions 
Making the market 
responsible for 
investment decisions 
(based on deep and 
relevant experience) 
Ensuring market readiness 
before launching a new 
scheme 
Ensuring a mixture of industry 
and government 
representatives in the process, 
to maximise the perspective 
of the market 
Innovation projects in 
small and medium-sized 
companies (Sweden) 
Financing a broad 
spectrum of SMEs 
A number of the 
companies funded 
through the scheme have 
become success stories 
(e.g. listed among the 
most successful SMEs in 
Sweden) 
Producing non-
thematic,  open calls 
allows a high variety 
of firms to apply and 
broadens the impact  
Flexibility to evolve 
with time and as the 
ecosystem changes 
(e.g. moving to a 
sustainability focus) 
Having a diverse 
programme team, 
with a broad pool of 
skills and backgrounds 
(especially industry 
experience) 
A change of focus from 
purely R&D potential to 
commercial potential as well 
was necessary 
Change to the structure of 
the programme: separating 
start-ups and SMEs to offer 
fairer conditions and criteria  
Allowing the programme to 
evolve in response to both 
‘push’ and ‘pull’ factors 
Source: Technopolis, based on available evaluations 
6.5 Lessons for Ireland from the group of comparator programmes 
As set out above, comparator programmes were selected based on two main criteria: i) the 
country of operation was either a member of the Small Advanced Economies Initiative of which 
Ireland is also a member, or ranks well in the 2019 Global Innovation Index, and has a similar 
policy system to Ireland, and ii) the programmes cover in-house RD&I activities that are 
instrumented in an open way (rather than in targeted thematic areas).  
 
 
58 Available at: https://ufm.dk/publikationer/2019/filer/evalueringsrapporten.pdf  
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Ireland’s support is already among the most comprehensive within this group in that it covers a 
broad range of RD&I (technological and non-technological), caters explicitly to several kinds 
of industries (including those with short cycles), and is open to both established and new 
performers. The main lessons for Ireland drawn from the examination of this group of 
comparator programmes can be summarised as follows: 
•  A continued focus on agile innovation and non-technological innovation (i.e. business 
innovations) should be maintained to continue the support for a broad range of firms 
•  Ireland appears to also be somewhat a front-runner in supporting a broad range of firms, 
including new and less-experienced performers, and so current approaches could be 
continued  
•  Where some programmes – such as in in the Netherlands and Sweden have pushed hard 
on examining and emphasising commercial aspects, it is clear that Ireland has already 
instituted examinations of commercial and technological aspects at the appraisal stage, 
which is a direction also taken by some programmes within this group 
•  The Netherlands has sought to build a network of private investors around their programme 
– this could be a useful augmentation to the RD&I Programme 
•  Some programmes include a challenge-based perspective. Where this could usefully be 
covered by SBIR in Ireland, it is possible that some orientation of grants under the RD&I 
Programme could encourage a broader range of firms to participate in this type of 
mechanism. However, it is not clear what the appetite among firms would be for this 
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7 Conclusions and recommendations 
Evaluation requirement: Develop findings, conclusions and recommendations from the 
evaluation of the RD&I Programme and the comparison of the role and performance of 
enterprise RD&I supports (Objective 3) 
7.1 Conclusions 
An assessment of appropriateness 
The EI RD&I Programme is well-aligned with both national policy and firms’ needs. The 
Programme has been consciously developed over its lifetime, in response to both client 
feedback, including the introduction of the Agile Innovation Fund and the Business Innovation 
Offer in 2016/17. These two new strands of the Programme address support requirements for 
shorter lifecycle projects and non-technical, business innovations. This – and the support 
available from Development Advisors – makes the RD&I Programme among the most 
comprehensive support schemes available when compared to similar schemes in other 
countries.  
An assessment of effectiveness 
While the Programme evidently has a positive impact on a number of innovation and 
economic performance indicators, there are some areas where the impact of the Programme 
is less distinct.  
When compared to similar, matched firms that had not received support through the 
Programme, awardees of grants show a significant boost to their R&D performance in the five 
years after receiving their grant(s).  In particular, these include: 
•  Net R&D expenditures (including as a proportion of  turnover, as a proportion of number of 
employees) 
•  R&D employment (and R&D employment as a proportion of number of employees) 
Over the five years since awarding of their grant(s), the economic performance of awardees 
is significantly better than that of matched non-awardees in four areas: i) turnover, ii) total value 
added, iii) employment, and iv) export sales. 
However, there is no evidence that productivity performance (as measured by Total value 
added per employee and Turnover per employee) is significantly better among awardees. 
Literature suggests that this may be related to the timeframe under examination. Productivity 
effects may also vary across sectors. For example, sectors such as ICT and services tend to be 
in constant cycles of innovation, meaning almost-perpetual reinvestment, which may mask 
measures of productivity. 
The Programme is also attracting non-RD&I performers, and appears to help a proportion of 
them to become RD&I-active post-award. 
Where firms experienced positive effects, they were affirmative about the contribution of the 
Programme to those effects. The majority of firms also suggested that the Programme had 
allowed them to undertake their RD&I projects at a larger scale and sooner than if the support 
had not been available. The RD&I Fund in particular was regarded positively for its contribution 
to experienced benefits. 
There is evidence of synergy and positive interaction between the direct financial support 
available through the RD&I Programme and the indirect support for RD&I available particularly 
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through the R&D Tax Credit. Firms and stakeholders believe that a holistic approach – i.e. the 
presence of both types of support – is the optimal way to achieve an uplift in RD&I expenditure. 
An assessment of efficiency 
Awardees are predominantly satisfied with the processes and procedures associated with 
accessing support. Where concerns were raised in consultation, these were largely seen as 
being a reasonable cost for accessing the support, though some consultees noted that the 
turnaround times of agile-track applications, where committees are not effectively used. The 
main concern raised in terms of procedures related to the recently-introduced Business 
Innovation Offer, whose criteria some firms felt were difficult to grasp. Firms’ Development 
Advisors were the most common routes to access support from the RD&I Programme. Among 
client firms that had not accessed the Programme, the main barrier to doing so was a lack of 
relevance or low awareness. 
7.2 Recommendations 
Drawing on the analysis above, the report concludes with nine recommendations. 
Appropriateness 
 Our examination of the support available for RD&I in light of both policy objectives and firm 
needs suggests that the holistic approach to RD&I support (a mix of both direct and indirect 
supports) is optimal and appropriate. It is clear that the individual supports address different 
objectives and are used differently by firms. Similarly, Ireland appears to be a frontrunner 
among comparators in the ways in which a broad range of firms are addressed via its RD&I 
support. Ireland should continue to invest in both direct and indirect support for RD&I, rather 
than focusing solely on directional grants or indirect supports 
Effectiveness 
 Our econometric analysis and consultation with firms has revealed the RD&I Programme to 
be effective when considering the economic and innovation performance of beneficiaries 
as compared to firms that have not accessed the programme. While the effect of the 
programme on firms’ productivity is less visible, this is likely related to the time period of data 
examined in this study. Therefore, the current constitution of the Programme should be 
maintained, with sensitivity to the productivity issue – some consideration may need to be 
given to how productivity is addressed in some sectors 
 While our analysis shows that the RD&I Programme performs well in attracting and 
supporting new performers, a recent OECD review suggested that there is untapped 
entrepreneurial potential within the firm base. The review suggests a further role for the Local 
Enterprise Offices across Ireland in order to better tap into this potential for innovation 
among firms. We would mirror this and suggest a review of the role or the Local Enterprise 
Offices to attract firms in the regions, or firms that have not yet applied for RD&I support 
Efficiency 
 It is clear that continual efforts are being made to improve turnaround times for the 
approval of grant applications, some issues were revealed in consultation regarding the 
use of the R&D Committee for agile-track applications. We recommend that these efforts 
are maintained, and that some  consideration should be given to procedures to ensure no 
barriers exist to accessing appropriate funding along optimal timescales (e.g. in scenarios 
where serial innovators apply for Agile Innovation Fund grants) 
 Furthermore, we would suggest that efforts are continued to simplify the application 
process to encourage greater up-take among less-experienced firms. It is clear that firms 
expect a learning curve in applying for (and managing) public grants, but consultation 
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revealed that some Development Advisors believe that application systems could be 
improved, including the online system 
 Consultation with firms revealed a high degree of connectedness and trust in Development 
Advisors, who were the most-commonly reported route to finding out about and applying 
for support through the RD&I Programme. In order to further broaden the base of firms 
accessing the Programme, more active communication about the Programme and its 
benefits could be instrumented via Development Advisors 
Future monitoring and evaluation 
 Like the expected learning curve in applying to public grants (see above), consulted firms 
also largely reported an expectation to participate in monitoring activities as part of 
accessing public money. Many found this to be manageable once learned, though some 
found difficulties in fulfilling the requirements to complete project timesheets in addition to 
their own systems (leading to duplication), while others found the requirement for an 
external audit of claims to be financially challenging. Some consideration could be given 
to simplifying these requirements in some cases  
 Linked to the second recommendation, above, we believe that there is merit in seeking to 
further understand the link between RD&I and productivity across sectors within the 
economy. This research project would ideally feed into the ways in which data are 
collected through applications and monitoring, as well as broader on-going data 
collection exercises. We would also recommend further monitoring with sensitivity at the 
sectoral level, in order to better assess impact across the programme in future  
 Finally, in order to gain a better view of the effects of the RD&I Programme on firm 
productivity, we recommend that this evaluation exercise is repeated in two or three years. 
This would enable the evaluation to examine data across a larger time period, ideally seven 
or nine years after grant award, which literature suggests is a more appropriate window to 
observe productivity effects for such activities. The repeated evaluation would also be in a 
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 Additional statistical data 
 Composition analysis: Direct financial supports  
Figure 41 Average EI RD&I direct financial supports per each grants, 2007-2018 
 
Source: ESRI elaboration based on the data provided by Enterprise Ireland.  
Note: Figures are in constant 2015 prices in 1,000,000 euros. 
 
Table 15 Number of grants, number of awardees of EI RD&I direct financial supports, and total 
amount of approved and paid funds by year  
Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Total 
# grants 223 224 215 165 148 167 179 168 129 107 111 169 2,005 
# awardees 134 143 176 124 128 148 142 132 105 92 91 147 1,562 
Value approved 48.9 54.8 47.6 36.2 27.6 39.5 39.5 47.9 28.0 30.0 31.9 32.7 464.7 
Paid 
(%) 
38.4 44.1 38.6 25.0 20.4 28.4 26.8 31.9 18.5 14.9 13.1 5.3 305.5 
79% 80% 81% 69% 74% 72% 68% 67% 66% 50% 41% 16% 66% 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. Notes: Different projects of the same grant 
type and approved on the same date are aggregated to one grant. Approved and paid grants are in constant 2015 
prices in million euros. 
Table 16 EI RD&I direct financial supports by equity or non-equity 
 Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Non-
equity 
# grants 211 215 201 155 138 153 175 167 129 103 97 154 
# awardees 127 135 163 115 118 135 140 131 105 88 78 134 
Approved 43.9 48.9 41.1 31.5 24.2 35.3 38.9 47.8 28.0 29.1 26.3 28.9 
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Paid 33.5 39.7 32.8 20.8 17.3 24.2 26.2 31.8 18.5 14.0 8.1 2.9 
Equity 
# grants 12 9 14 10 10 14 4 1  4 14 15 
# awardees 12 9 13 10 10 14 4 1  4 13 15 
Approved 4.9 5.9 6.5 4.7 3.4 4.2 0.6 0.2 0.0 0.9 5.6 3.8 
Paid 4.9 4.4 5.9 4.2 3.2 4.2 0.6 0.2 0.0 0.9 5.0 2.4 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. Note: Different projects of the same grants 
type and approved on the same date are aggregated to one grant. One awardee may get more than one grant 
that may belong to the same or different categories in a year. Approved and paid grants are in constant 2015 prices 
in 1,000,000 euros. 
Table 17 EI RD&I direct financial supports by package or standalone 
 Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Package  
# grants 36 26 31 27 23 31 33 34 13 13 14 16 
# awardees 24 17 27 21 22 27 27 25 11 9 12 12 
Approved 12.2 14.1 16.2 9.8 7.4 17.0 12.0 24.9 7.9 11.3 5.9 5.2 
Paid 10.8 10.9 14.0 8.2 5.3 10.2 5.7 14.9 2.4 2.9 0.8 0.0 
  
Standalone 
# grants 187 198 184 138 125 136 146 134 116 94 97 153 
# awardees 113 126 149 104 106 121 117 107 94 83 79 136 
Approved 36.7 40.7 31.4 26.5 20.2 22.5 27.6 23.0 20.1 18.7 26.1 27.5 
Paid 27.6 33.2 24.6 16.8 15.2 18.2 21.0 17.1 16.1 12.0 12.3 5.3 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. Note: Different projects of the same grants 
type and approved on the same date are aggregated to one grants. One awardee may get more than one grants 
that may belong to the same or different categories in a year. Approved and paid grants are in constant 2015 prices 
in 1,000,000 euros. 
Table 18 EI RD&I direct financial supports by offer bundle (main offer bundles) 























Company   
Expansions 
# grants 36 26 26 26 21 30 32 5     
# 
awardees 24 17 23 20 20 26 26 4 
    
Approved 12.2 14.1 14.3 9.0 6.8 16.9 11.8 2.4     
Paid 10.8 10.9 12.2 7.7 4.7 10.1 5.5 2.1     
R&D Fund 
# grants  119 170 136 116 129 146 134 102 79 91 84 
# 
awardees 
 70 136 102 97 114 117 107 82 69 75 71 
Approved  25.4 31.0 26.5 20.0 22.0 27.6 23.0 18.4 16.7 25.2 22.6 
Paid  20.3 24.4 16.7 15.0 17.7 21.0 17.1 14.8 10.6 11.8 4.1 
R & D  
Stimulation 
# grants  16 13 2 9 4       
# 
awardees 
 16 13 2 9 4       
Approved  0.5 0.3 0.0 0.2 0.1       
Paid  0.3 0.2 0.0 0.1 0.1       
Scaling  
including R&D  
# grants   5 1 2 1 1      
# 
awardees 
  4 1 2 1 1      
Approved   2.0 0.8 0.7 0.1 0.2      
Paid   1.8 0.5 0.6 0.1 0.2      
# grants        28 13 13 14 16 
 





       20 11 9 12 12 
Approved        21.3 7.9 11.3 5.9 5.2 




# grants         14 15 6 1 
# 
awardees 
        14 15 6 1 
Approved         1.7 2.0 0.8 0.1 
Paid         1.3 1.4 0.5 0.1 
Strategic R&D 
# grants 20 10 1          
# 
awardees 13 4 1 
         
Approved 14.9 8.4 0.1          
Paid 11.0 7.3 0.1          
RTI Fund 
# grants 163 53           
# 
awardees 96 37 
          
Approved 21.7 6.4           
Paid 16.6 5.3           
Source: ESRI elaboration based on the data provided by Enterprise Ireland.  
Notes: Different projects of the same grants type and approved on the same date are aggregated to one grants. One 
awardee may get more than one grants that may belong to the same or different categories in a year. Approved and 
paid grants are in constant 2015 prices in million euros. 
 




























Year 2007 2007 2012 2014 2018 2018 2018 2018 
# grants 3 1 3 1 39 16 4 9 
# 
awardees 3 1 3 1 39 16 4 8 
Approved 0.1 0.0 0.4 1.2 3.3 0.6 0.6 0.2 
Paid 0.0 0.0 0.4 0.0 0.9 0.1 0.0 0.0 
Source: ESRI elaboration based on the data provided by Enterprise Ireland.  
Notes: Different projects of the same grants type and approved on the same date are aggregated to one grants. One 
awardee may get more than one grants that may belong to the same or different categories in a year. Approved and 
paid grants are in constant 2015 prices in 1,000,000 euros. 
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Table 20 EI RD&I direct financial supports by grants type 
Grants type Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
R&D Facility 
# grants 81 75 31 37 19 15 31 33 21 13 14 15 
# awardees 81 73 31 37 19 15 31 32 21 13 14 15 
Approved 4.2 4.7 0.9 0.7 0.5 0.2 1.3 3.0 0.4 0.4 0.8 0.4 
Paid 2.0 2.7 0.6 0.3 0.2 0.0 0.5 2.4 0.1 0.0 0.0 0.0 
R&D Revenue 
# grants 123 123 152 113 110 133 141 131 107 90 82 113 
# awardees 122 118 150 112 109 131 140 130 105 88 78 112 
Approved 39.4 43.7 39.7 30.7 23.6 34.9 37.6 44.6 27.6 28.6 25.4 27.6 
Paid 31.3 36.7 31.9 20.4 16.9 24.1 25.6 29.3 18.3 14.0 8.1 2.8 
Preference Equity 
# grants 11 9 8 9 10 12 4 1 
 
2 10 11 
# awardees 11 9 8 9 10 12 4 1 
 
2 10 11 
Approved 4.7 5.9 3.3 4.5 3.4 3.4 0.6 0.2 
 
0.3 3.8 3.0 
Paid 4.7 4.4 2.7 4.0 3.2 3.4 0.6 0.2 
 
0.3 3.2 2.3 
Ordinary Equity 





   
2 4 4 





   






   






   




16 13 2 9 4 




16 13 2 9 4 




0.5 0.3 0.0 0.2 0.1 




0.3 0.2 0.0 0.1 0.1 




     




     




     




     






1 5 3 
  
1 
     
# awardees 
 
1 5 3 
  
1 
     
 
Evaluation of the Enterprise Ireland Research, Development and Innovation Programme 71 
Approved 
 
0.0 0.2 0.0 
  
0.1 
     
Paid 
 
0.0 0.1 0.0 
  
0.0 
     
[Grants type not known] 
# grants 7 
      
1 
   
9 
# awardees 7 
      
1 
   
8 
Approved 0.3 
      
0.0 
   
0.2 
Paid 0.2 
      
0.0 
   
0.0 
Source: ESRI elaboration based on the data provided by Enterprise Ireland.  
Notes: Different projects of the same grants type and approved on the same date are aggregated to one grants. One awardee may get more than one grants that may 
belong to the same or different categories in a year. Approved and paid grants are in constant 2015 prices in 1,000,000 euros. 
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The table below shows the number of awardees as well as approved and paid EI RD&I financial 
supports by sector. This analysis uses the sector classification provided by the DBEI.    
Table 21 Awardees of EI RD&I direct financial supports by sector  
Sector Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Food, Drink and 
Primary 
Production 
# grants 46 19 29 25 16 36 31 38 20 22 22 26 
# awardees 26 13 25 18 14 31 24 27 18 17 16 23 
Approved 13.8 6.7 8.6 4.3 1.8 12.2 11.9 16.3 6.5 11.3 5.5 5.2 
Paid 9.0 5.4 7.2 3.2 1.1 4.4 5.6 10.3 3.6 2.9 2.0 0.2 
Traditional 
Manufacturing 
# grants 69 73 74 37 55 44 58 49 36 22 38 43 
# awardees 45 49 57 31 49 38 41 40 28 19 33 35 
Approved 12.2 13.5 12.5 6.1 8.5 8.2 10.3 8.6 6.5 3.0 11.1 9.0 
Paid 10.2 10.0 9.2 5.0 6.7 6.8 8.6 6.7 5.0 1.4 3.1 0.5 
Chemicals and 
pharmaceuticals 
# grants 8 15 12 7 7 5 4 11 5 3 1 5 
# awardees 4 8 9 6 7 5 2 8 4 3 1 4 
Approved 0.4 2.1 2.5 1.4 1.8 1.6 0.2 3.7 0.7 0.3 0.2 1.0 




# grants 15 6 10 20 9 10 11 7 7 8 5 11 
# awardees 9 4 8 12 8 8 10 5 5 8 4 8 
Approved 2.9 1.7 4.0 3.2 2.3 2.5 3.1 0.8 1.5 2.5 3.1 2.7 
Paid 1.9 1.4 3.3 1.5 1.5 2.3 1.6 0.6 0.9 2.3 0.4 0.5 
Med Devices 
# grants  2 2 3 3 2 1 1  2  3 
# awardees  1 2 2 2 2 1 1  1  2 
Approved  0.2 0.5 0.5 0.6 0.1 0.1 0.2  0.8  0.2 
Paid  0.2 0.5 0.3 0.2 0.0 0.0 0.2  0.0  0.0 
Energy, Water, 
Waste 
# grants 4 5 4 3 5 5 6 8 1 3 2 4 
# awardees 2 3 3 2 4 4 4 4 1 2 2 3 
Approved 0.6 0.9 0.7 0.3 0.5 0.5 0.7 0.8 0.1 0.2 0.2 0.4 
Paid 0.6 0.7 0.6 0.2 0.1 0.5 0.5 0.4 0.1 0.1 0.1 0.0 
Construction  
# grants 2 1 5  2 1  1   1 2 
# awardees 1 1 4  1 1  1   1 2 
Approved 0.3 0.4 0.8  0.4 0.2  0.1   0.2 0.2 






# grants 74 63 66 45 30 48 48 33 45 37 35 47 
# awardees 44 40 55 34 25 44 44 28 36 34 28 45 
Approved 18.1 20.9 15.3 11.7 7.2 10.2 9.6 8.7 10.5 9.8 8.7 9.7 




# grants 5 37 12 25 18 12 19 19 13 10 7 28 
# awardees 3 22 12 19 15 11 15 17 11 8 6 25 
Approved 0.4 7.3 2.8 8.7 3.7 2.5 3.4 8.5 1.9 2.0 2.8 4.3 
Paid 0.1 5.8 2.0 6.1 2.4 2.0 2.2 5.4 1.6 0.5 1.6 1.2 
Semi-conductors 
# grants  3 1  3 4 1 1 2    
# awardees  2 1  3 4 1 1 2    
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Approved  1.2 0.0  0.8 1.4 0.2 0.2 0.3    
Paid  1.0 0.0  0.7 1.4 0.1 0.1 0.2    
Source: ESRI elaboration based on the RD&I data provided by Enterprise Ireland. Notes: Different projects of the same 
grant type and approved on the same date are aggregated to one grant. One awardee may get more than one 
grant that may belong to the same or different categories in a year. Approved and paid grants are in constant 2015 
prices in million euros. 
Table 22 Awardees of EI RD&I direct financial supports by sector (additional sub-sectors) 
Sub-sector Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Architectural 
consultants 
# grants  2  2    2     
# awardees  1  1    1     
Approved  0.3  0.3    0.3     




# grants 3 1 1 1 5 1 1 1  1  5 
# awardees 2 1 1 1 4 1 1 1  1  3 
Approved 0.1 0.0 0.3 0.1 0.6 0.1 0.2 0.1  0.1  0.9 
Paid 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1  0.0  0.0 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. Note: Different projects of the same grant 
type and approved on the same date are aggregated to one grant. One awardee may get more than one grant 
that may belong to the same or different categories in a year. Approved and paid grants are in constant 2015 prices 
in million euros. 
Table 16 below compares the distributions of the numbers of awardees and of EI clients by 
sector and by year. A few sizeable differences between the two distributions stand out. Relative 
to the sectoral profile of EI clients, a few sectors appear to be over-represented in the 
distribution of the number of awardees: the Food, Drink and Primary Production sector by 10.2 
percentage points in 2012; the Information and Communication and other Internationally 
Traded Services sector by 13.7 percentage points, 14.0 percentage points and 10.6 
percentage points in 2007, 2009, and 2010, respectively; the Traditional Manufacturing sector 
by 9.4 percentage points in 2017. The Business, Financial and Other Services sector  was under-
represented in the total number of awardees by 11.4 percentage points, 11.7 percentage 
points and 12.4 percentage points in 2009, 2012, and 2016 respectively. The Traditional 
Manufacturing sector was under-represented by 10.7 percentage points in 2010.           
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Table 23 The distributions of the numbers of awardees and of EI clients  by sector, 2007-2018  
Sector Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Food, Drink and Primary Production Awardees 18.0% 9.8% 16.4% 13.5% 11.1% 22.4% 18.2% 16.8% 16.1% 16.9% 16.0% 17.8% 
 EI clients 16.4% 14.7% 13.7% 13.0% 12.6% 12.2% 12.7% 13.2% 12.6% 12.3% 12.6% 12.6% 
  Difference 1.6 -4.9 2.7 0.5 -1.5 10.2 5.4 3.6 3.5 4.6 3.5 5.2 
Traditional Manufacturing Awardees 38.2% 33.3% 29.9% 22.5% 37.4% 25.9% 27.3% 32.7% 28.0% 23.4% 37.0% 23.7% 
 EI clients 39.8% 37.2% 34.6% 33.1% 32.0% 31.9% 30.5% 28.3% 29.2% 28.0% 27.6% 27.8% 
  Difference -1.6 -3.8 -4.8 -10.7 5.4 -6.0 -3.2 4.4 -1.2 -4.7 9.4 -4.1 
Chemicals and Pharmaceuticals Awardees 2.2% 6.9% 4.5% 4.5% 6.1% 4.3% 1.7% 7.1% 4.3% 3.9% 1.2% 3.4% 
 EI clients 3.0% 2.8% 2.7% 2.6% 2.9% 2.9% 2.7% 2.9% 2.9% 2.6% 2.6% 2.6% 
  Difference -0.7 4.1 1.8 1.9 3.2 1.4 -1.0 4.2 1.4 1.3 -1.3 0.7 
Computer, Electronic and Optical 
Products Awardees 3.4% 2.9% 3.7% 7.9% 6.1% 6.9% 6.6% 4.4% 4.3% 9.1% 4.9% 5.9% 
 EI clients 3.4% 3.2% 3.5% 3.6% 3.4% 3.2% 3.0% 2.9% 2.9% 2.7% 2.5% 2.6% 
  Difference 0.0 -0.3 0.2 4.3 2.6 3.7 3.6 1.5 1.4 6.4 2.4 3.4 
Medical Devices Awardees 0.0% 1.0% 0.7% 2.2% 2.0% 0.9% 0.8% 0.9% 0.0% 1.3% 0.0% 1.7% 
 EI clients 0.3% 0.4% 0.4% 0.5% 0.4% 0.5% 0.6% 0.7% 0.8% 0.8% 0.9% 0.9% 
  Difference -0.3 0.6 0.3 1.8 1.6 0.4 0.3 0.2 -0.8 0.5 -0.9 0.8 
Energy, Water, Waste Awardees 0.0% 1.0% 1.5% 2.2% 2.0% 0.9% 3.3% 3.5% 1.1% 1.3% 1.2% 1.7% 
 EI clients 1.3% 2.6% 3.2% 3.1% 3.3% 3.2% 2.9% 3.4% 3.6% 3.7% 3.6% 3.6% 
  Difference -1.3 -1.6 -1.7 -0.8 -1.3 -2.3 0.4 0.1 -2.5 -2.4 -2.4 -1.9 
Construction Awardees 0.0% 0.0% 1.5% 0.0% 1.0% 0.9% 0.0% 0.9% 0.0% 0.0% 1.2% 1.7% 
 EI clients 1.7% 1.9% 2.1% 2.0% 1.8% 1.9% 1.8% 1.7% 1.8% 2.1% 2.1% 2.1% 
  Difference -1.7 -1.9 -0.6 -2.0 -0.8 -1.1 -1.8 -0.8 -1.8 -2.1 -0.8 -0.4 
Information and Communication and 
other Internationally Traded Services Awardees 36.0% 25.5% 35.8% 33.7% 23.2% 28.4% 30.6% 21.2% 35.5% 37.7% 30.9% 30.5% 
 EI clients 22.2% 21.4% 21.8% 23.1% 24.6% 25.6% 26.3% 27.4% 27.2% 28.2% 29.4% 29.0% 
  Difference 13.7 4.1 14.0 10.6 -1.4 2.9 4.3 -6.2 8.3 9.4 1.4 1.5 
Business, Financial and Other Services Awardees 2.2% 17.6% 6.0% 13.5% 8.1% 6.0% 10.7% 11.5% 9.7% 6.5% 7.4% 13.6% 
 EI clients 11.3% 15.4% 17.3% 18.3% 18.1% 17.8% 18.8% 18.7% 18.3% 18.9% 18.2% 18.3% 
  Difference -9.0 2.3 -11.4 -4.9 -10.1 -11.7 -8.1 -7.2 -8.6 -12.4 -10.7 -4.7 
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Semi-conductors Awardees 0.0% 2.0% 0.0% 0.0% 3.0% 3.4% 0.8% 0.9% 1.1% 0.0% 0.0% 0.0% 
 EI clients 0.6% 0.6% 0.6% 0.7% 0.8% 0.9% 0.6% 0.7% 0.7% 0.6% 0.5% 0.6% 
  Difference -0.6 1.4 -0.6 -0.7 2.2 2.6 0.2 0.2 0.4 -0.6 -0.5 -0.6 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. 
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The table below  summarises information on the EI RD&I direct financial supports by region. 
This analysis uses the region classification provided by Enterprise Ireland.    
Table 24 Awardees of EI RD&I direct financial supports by region (EI classification)   
 Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Dublin 
# grants 61 77 75 73 50 56 57 43 49 33 40 61 
# awardees 37 48 60 53 43 52 51 38 39 30 32 58 
Approved 17.2 25.9 16.7 15.9 10.4 12.5 10.8 15.0 10.6 8.4 11.3 12.4 
Paid 14.5 21.2 15.3 10.1 8.2 11.8 9.1 9.7 6.6 6.2 6.3 3.4 
Mid-West 
# grants 35 23 23 17 9 14 22 18 14 8 12 17 
# awardees 22 15 18 12 8 14 16 14 11 7 11 15 
Approved 3.9 7.1 8.4 2.1 1.0 8.9 4.9 5.9 2.4 6.5 2.3 3.4 
Paid 3.4 4.8 7.0 1.8 0.8 3.3 3.2 5.2 1.8 2.2 0.4 0.1 
Midlands 
/Mid-East 
# grants 25 34 24 20 27 35 21 32 22 15 11 32 
# awardees 18 22 20 16 23 30 16 26 17 12 10 24 
Approved 5.7 5.0 5.1 6.9 3.7 4.6 4.7 12.1 6.2 5.7 2.0 5.9 
Paid 4.0 4.4 4.1 3.9 2.4 3.3 3.8 6.3 3.2 2.7 1.0 0.4 
North East 
/North West 
# grants 27 14 24 14 18 19 31 31 15 15 16 24 
# awardees 16 10 19 12 16 16 25 21 13 13 14 18 
Approved 2.9 2.5 4.7 1.8 3.5 3.8 8.3 6.1 2.5 3.0 6.3 5.8 
Paid 2.2 1.7 3.5 1.2 2.2 2.6 4.4 4.9 1.9 0.8 2.8 0.3 
South 
/South East 
# grants 57 60 47 31 32 34 35 30 20 28 23 24 
# awardees 30 37 40 23 27 28 25 22 17 23 16 22 
Approved 15.7 11.9 8.4 5.4 6.8 6.7 7.2 6.4 4.3 5.3 7.7 3.7 
Paid 11.1 10.1 6.3 4.5 5.3 4.9 4.5 4.3 3.3 2.3 1.6 0.9 
West 
# grants 18 16 22 10 11 9 13 13 9 8 8 10 
# awardees 11 11 19 8 10 8 9 10 8 7 7 9 
Approved 3.4 2.4 4.3 4.0 1.9 2.9 3.6 2.5 2.0 1.1 1.9 1.4 
Paid 3.1 1.8 2.4 3.5 1.3 2.4 1.8 1.6 1.7 0.6 0.6 0.1 
Overseas 
# grants     1   1   1 1 
# awardees     1   1   1 1 
Approved     0.3   0.1   0.5 0.1 
Paid     0.2   0.0   0.5 0.1 
Source: ESRI elaboration based on the RD&I data provided by Enterprise Ireland. Note: Different projects of the same 
grant type and approved on the same date are aggregated to one grant. One awardee may get more than one 
grant that may belong to the same or different categories in a year. Approved and paid grants are in constant 2015 
prices in 1,000,000 euros. 
Table  18 below compares the distributions of the numbers of awardees and of EI clients by 
region and by year. There are only a few sizeable differences between the two distributions. 
Relative to the profile of the EI clients, the share of the Border region in the number of awardees 
was lower by 5 percentage points in 2008 and higher by 9 and 7 percentage points in 2013 
and 2014, respectively.  The share of the Dublin region in the number of awardees was lower 
by 11 and 8 percentage points in 2014 and 2016, respectively.  The share of the Mid-West region 
in the number of awardees was lower by 7 percentage points in 2011.   
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Table 25 The distributions of the numbers of awardees and of EI clients  by region, 2007-2018  
Region Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Border 
Awardee
s 12.4% 6.9% 11.2% 7.9% 14.1% 13.8% 19.0% 17.7% 14.0% 10.4% 13.6% 10.2% 
 EI clients 12.6% 12.0% 11.7% 11.5% 11.4% 10.7% 10.5% 10.5% 10.8% 10.6% 10.5% 10.6% 
  
Differenc
e -0.2 -5.2 -0.5 -3.6 2.8 3.1 8.5 7.2 3.2 -0.3 3.1 -0.4 
Dublin 
Awardee
s 28.1% 34.3% 37.3% 44.9% 34.3% 31.0% 35.5% 28.3% 37.6% 32.5% 37.0% 39.8% 
 EI clients 33.6% 36.0% 37.3% 38.6% 38.8% 38.3% 38.4% 39.1% 39.4% 40.5% 40.3% 40.2% 
  
Differenc
e -5.5 -1.7 0.0 6.3 -4.5 -7.2 -2.9 -10.7 -1.8 -8.0 -3.3 -0.4 
Mid-East 
Awardee
s 9.0% 8.8% 6.0% 10.1% 9.1% 15.5% 7.4% 14.2% 10.8% 7.8% 4.9% 11.0% 
 EI clients 8.8% 8.4% 8.2% 8.1% 7.6% 8.3% 8.8% 8.7% 9.1% 8.8% 8.9% 8.8% 
  
Differenc
e 0.2 0.4 -2.3 2.1 1.5 7.2 -1.4 5.5 1.7 -1.0 -4.0 2.2 
Mid-West 
Awardee
s 10.1% 4.9% 9.7% 5.6% 2.0% 8.6% 9.1% 8.8% 6.5% 7.8% 11.1% 7.6% 
 EI clients 9.7% 9.0% 8.6% 8.8% 9.0% 8.7% 8.1% 7.7% 7.5% 7.8% 7.9% 7.8% 
  
Differenc
e 0.4 -4.1 1.1 -3.1 -7.0 -0.1 1.0 1.2 -1.0 0.0 3.2 -0.2 
Midlands 
Awardee
s 7.9% 7.8% 3.7% 4.5% 5.1% 3.4% 4.1% 3.5% 5.4% 5.2% 7.4% 5.9% 
 EI clients 5.3% 5.1% 4.7% 4.5% 4.5% 4.8% 4.8% 5.1% 5.2% 4.9% 5.0% 5.0% 
  
Differenc




s 9.0% 10.8% 6.7% 7.9% 8.1% 8.6% 7.4% 5.3% 4.3% 11.7% 8.6% 5.1% 
 EI clients 9.5% 9.2% 9.1% 8.6% 8.2% 8.7% 8.7% 8.4% 7.8% 7.7% 7.8% 7.8% 
  
Differenc




s 15.7% 16.7% 15.7% 12.4% 17.2% 13.8% 10.7% 14.2% 15.1% 16.9% 11.1% 13.6% 
 EI clients 13.3% 12.8% 12.6% 12.2% 12.9% 13.2% 13.2% 13.1% 12.9% 12.6% 12.7% 12.6% 
  
Differenc
e 2.4 3.9 3.1 0.2 4.3 0.6 -2.4 1.1 2.1 4.3 -1.5 0.9 
West 
Awardee
s 7.9% 9.8% 9.7% 6.7% 10.1% 5.2% 6.6% 8.0% 6.5% 7.8% 6.2% 6.8% 
 EI clients 7.2% 7.5% 7.7% 7.9% 7.7% 7.3% 7.5% 7.5% 7.3% 7.1% 7.0% 7.1% 
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Differenc
e 0.7 2.3 2.0 -1.1 2.4 -2.2 -0.9 0.4 -0.8 0.7 -0.8 -0.3 
 
Source: ESRI elaboration based on the data provided by Enterprise Ireland. 
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As shown in Table 26, the uptake of EI RD&I direct financial supports among Irish-owned EI client 
companies ranges from 6.8% in 2009 to 3.2% in 2016. The number of awardees has been the 
largest in 2009 (128) and the smallest in 2016 (78). In terms of the value of the approved awards, 
the largest amounts have been awarded in 2014 (42.2 million euros) and the smallest in 2015 
(26.0 million euros).        
Table 26 Uptake of EI RD&I direct financial supports by ownership 
 Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Irish 
# awardees 94 98 128 90 101 110 121 112 95 78 83 121 
# EI clients 
(%) 
1642 1805 1896 1887 1961 2034 2243 2204 2264 2419 2308 2261 
5.7% 5.4% 6.8% 4.8% 5.2% 5.4% 5.4% 5.1% 4.2% 3.2% 3.6% 5.4% 
Approved 31.6 33.5 36.9 23.1 23.8 35.0 32.2 42.2 26.0 26.6 29.1 29.4 
Paid 26.5 26.7 31.0 18.4 18.3 25.0 24.3 27.5 17.0 14.1 11.6 4.0 
Non-Irish 
# awardees  1 6 4 2 1 3 4 3 0 1 1 1 
# EI clients 
(%) 
17 17 17 16 16 16 12 12 12 12 12 12 
5.9% 35.3% 23.5% 12.5% 6.3% 18.8% 33.3% 25.0% 0.0% 8.3% 8.3% 8.3% 
Approved 0.1 4.0 4.7 1.3 0.4 0.9 4.4 2.6 0.0 0.5 0.5 0.2 
Paid 0.1 3.4 3.7 1.2 0.0 0.7 1.3 2.5 0.0 0.0 0.0 0.0 
Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same enterprise group. An awardee-group is classified as Irish if at least one awardee within the 
group is Irish-owned. Approved and paid grants are in constant 2015 prices in million euros. 
Table 27 shows that the largest number of awardees are small-sized companies. However, in 
relative terms, the uptake rates of EI RD&I financial supports are the greatest for large 
companies followed by medium-sized companies. This pattern reflects the distribution of firms 
by size with small size companies being the most numerous. The uptake rate among EI client 
companies ranges in the case of small companies from 5.7% in 2009 to 2.8% in 2016; for 
medium sized companies from 9.3% in 2009 to 4.2% in 2016; and for large companies from 
14.3% in 2009 to 5.3% in 2016.         
Table 27 Uptake of EI RD&I direct financial supports by size 
 Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Small 
# awardees  55 62 82 58 64 72 77 64 55 47 46 69 
# EI clients 
(%) 
1147 1293 1433 1408 1460 1502 1670 1591 1596 1707 1588 1479 
4.8% 4.8% 5.7% 4.1% 4.4% 4.8% 4.6% 4.0% 3.4% 2.8% 2.9% 4.7% 
Approved 12.5 15.6 18.2 11.7 12.8 14.5 15.1 12.4 11.4 10.1 12.7 13.4 
Paid 10.4 12.7 16.5 9.8 10.3 13.1 12.7 10.5 9.0 8.2 8.3 3.2 
Medium 
# awardees 26 30 35 27 27 30 34 34 32 24 28 35 
# EI clients 
(%) 
409 414 375 397 411 430 453 484 533 572 574 625 
6.4% 7.2% 9.3% 6.8% 6.6% 7.0% 7.5% 7.0% 6.0% 4.2% 4.9% 5.6% 
Approved 11.1 11.9 11.9 8.8 7.9 8.4 9.8 8.7 9.4 6.1 10.8 8.1 
Paid 9.0 9.6 8.7 6.5 6.1 6.5 7.2 5.3 5.7 3.6 2.8 0.4 
Large 
# awardees 14 12 15 7 11 11 14 17 8 8 10 18 
# EI clients 
(%) 
103 115 105 98 106 118 132 141 147 152 158 169 
13.6% 10.4% 14.3% 7.1% 10.4% 9.3% 10.6% 12.1% 5.4% 5.3% 6.3% 10.7% 
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Approved 8.1 10.0 11.5 3.9 3.5 13.0 11.7 23.7 5.2 11.0 6.2 8.0 
Paid 7.2 7.8 9.5 3.4 1.9 6.1 5.7 14.2 2.2 2.4 0.5 0.4 
Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same group.  A “Small Enterprise” is defined as an enterprise that has fewer than 50 employees 
and has an annual turnover of less than €10m; a “Large Enterprise” is defined as an enterprise that has more than 249 
employees or an annual turnover of more than €50m; The remainder are classified as “Medium-sized Enterprises”. 
Approved and paid grants are in constant 2015 prices in million euros. 
The uptake rates of EI RD&I direct financial supports are higher for companies with export 
activity. Among EI client companies, the uptake rates for exporters range from 8.1% in 2009 to 
3.7% in 2016. In comparison, the highest uptake rate for companies serving only the Irish market 
was in 2008 (2.5%) and the lowest in 2018 (0.5%). No awards were made to this category of 
companies in 2012 and 2016.     
Table 28 Uptake of EI RD&I direct financial supports by export participation  
 Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Exporter 
# 
awardees 91 95 124 88 99 113 119 112 94 79 82 121 
# EI 
clients (%) 
1340 1466 1536 1597 1687 1770 1921 1950 2008 2133 2053 2074 
6.8% 6.5% 8.1% 5.5% 5.9% 6.4% 6.2% 5.7% 4.7% 3.7% 4.0% 5.8% 
Approve
d 31.5 35.3 41.1 24.0 23.7 36.0 35.2 44.5 25.9 27.1 29.3 29.4 




awardees 4 9 8 4 3 0 6 3 1 0 2 1 
# EI 
clients (%) 
319 356 377 306 290 280 334 266 268 298 267 199 
1.3% 2.5% 2.1% 1.3% 1.0% 0.0% 1.8% 1.1% 0.4% 0.0% 0.7% 0.5% 
Approve
d 0.2 2.2 0.4 0.4 0.6 0.0 1.4 0.3 0.1 0.0 0.4 0.2 
Paid 0.0 1.8 0.3 0.3 0.5 0.0 1.2 0.2 0.1 0.0 0.3 0.0 
Source: ESRI elaboration based on the linked ABSEI and RD&I data sets  provided by the DBEI and Enterprise Ireland. 
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same enterprise group. An awardee-group is classified as an exporter if it has exporting activities. 
Approved and paid grants are in constant 2015 prices in million euros. 
Looking at the innovation profile of awardees,59 the uptake rates are higher for companies with 
product innovation, ranging from 8.8% in 2013 to 4.9% in 2016. The annual uptake rates for firms 
without product innovation range from 3.6% in 2018 to 1.5% in 2017.   
Table 29 Uptake of EI RD&I direct financial supports by product innovation 
 Year 2012 2013 2014 2015 2016 2017 2018 
Product innovators 
# awardees 86 99 88 75 56 68 85 
# EI clients  
(%) 
1159 1128 1150 1239 1135 1262 1251 
7.4% 8.8% 7.7% 6.1% 4.9% 5.4% 6.8% 
Approved 30.9 29.0 34.4 21.4 21.4 24.8 19.4 
Paid 21.8 21.8 23.1 13.3 10.2 8.7 2.5 
# awardees 27 26 27 20 23 16 37 
 
 
59 This analysis is based on data on sales of new products available from the ABSEI data set since 2012.  
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Without  product 
innovation 
# EI clients 
(%) 
891 1127 1066 1037 1296 1058 1022 
3.0% 2.3% 2.5% 1.9% 1.8% 1.5% 3.6% 
Approved 5.1 7.6 10.3 4.6 5.8 4.8 10.2 
Paid 3.9 3.7 7.0 3.7 3.9 2.9 1.5 
Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same enterprise -group. An awardee-group is classified as a new product innovator if it has sales 
of “new product” based on data available in the ABSEI data set (since 2012). Approved and paid grants are in 
constant 2015 prices in million euros. 
As shown in the table below, the uptake of EI RD&I direct financial supports among EI clients 
(aggregated at enterprise group level) ranges from 6.9% in 2009 to 3.2% in 2016. In terms of 
value, the largest amount was approved in 2014 (44.8 million euros) and the smallest in 2011 
(24.3 million euros). 83.9% of the approved awards in 2007 have been paid.     
Table 30 Uptake of EI RD&I direct financial supports by EI clients  
Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
# awardees 95 104 132 92 102 113 125 115 95 79 84 122 
# EI clients 
(%) 
1659 1822 1913 1903 1977 2050 2255 2216 2276 2431 2320 2273 
5.7% 5.7% 6.9% 4.8% 5.2% 5.5% 5.5% 5.2% 4.2% 3.2% 3.6% 5.4% 




26.6 30.0 34.7 19.6 18.3 25.7 25.6 30.0 17.0 14.1 11.6 4.0 
83.9% 80.1% 83.5% 80.5% 75.6% 71.4% 69.8% 67.1% 65.4% 52.0% 39.3% 13.5% 
Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Note: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same awardees-group. Approved and paid grants are in constant 2015 prices in million euros. 
Table 31 Intensity of EI RD&I direct financial supports by awardee-group size (approved grants over 
turnover) 
Year Small Medium Large 
 Mean Median  Mean Median  Mean Median  
2007 19.5% 7.4%  3.8% 2.4%  0.4% 0.3%  
2008 16.3% 7.7%  4.4% 2.9%  1.1% 0.6%  
2009 12.4% 8.2%  2.6% 1.8%  0.6% 0.5%  
2010 9.9% 6.8%  2.9% 2.1%  0.9% 0.1%  
2011 12.8% 7.2%  2.8% 1.6%  0.5% 0.4%  
2012 9.9% 6.2%  2.0% 1.9%  0.7% 0.3%  
2013 10.0% 7.5%  2.3% 1.8%  0.5% 0.3%  
2014 11.1% 6.1%  2.4% 1.2%  0.8% 0.6%  
2015 9.2% 6.5%  2.4% 1.4%  0.6% 0.6%  
2016 9.3% 7.2%  1.9% 1.0%  1.1% 0.9%  
2017 16.7% 6.4%  2.6% 1.8%  0.7% 0.5%  
2018 8.7% 5.4%  2.2% 1.7%  0.3% 0.2%  
Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland.  
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same awardees-group. A “Small Enterprise” is defined as an enterprise that has fewer than 50 
employees and has an annual turnover of less than €10m; a “Large Enterprise” is defined as an enterprise that has 
more than 249 employees or an annual turnover of more than €50m; the remaining enterprises are classified as 
“Medium Enterprises.” Approved grants and turnover are in constant 2015 price. 
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Table 32 Grants intensity of EI RD&I direct financial supports by export participation (approved 
grants over turnover) 
Year Exporter Non-exporter 
 Mean Median  Mean Median  
2007 12.5% 4.7%  9.7% 2.2%  
2008 11.5% 4.4%  6.7% 5.1%  
2009 8.7% 4.6%  4.4% 3.1%  
2010 7.2% 4.5%  5.5% 4.8%  
2011 8.8% 3.4%  11.2% 11.6%  
2012 6.9% 3.8%     
2013 6.3% 3.2%  16.0% 8.9%  
2014 6.6% 2.7%  21.2% 5.7%  
2015 6.3% 3.2%  0.4% 0.4%  
2016 6.2% 4.2%     
2017 10.1% 3.5%  7.9% 7.9%  
2018 5.6% 2.7%  3.7% 3.7%  
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same awardees-group. An awardee-group is classified as an exporter if it has exporting activities. 
Approved grants and turnover are in constant 2015 prices. 
Table 33 Grants intensity of EI RD&I direct financial supports by product innovation (approved 
grants over turnover) 
Year Product innovators Without product innovation 
 Mean Median  Mean Median  
2012 5.4% 3.5%  11.5% 4.8%  
2013 6.4% 3.1%  8.5% 3.9%  
2014 6.3% 2.2%  9.2% 6.4%  
2015 5.4% 2.2%  9.1% 4.6%  
2016 6.2% 4.2%  6.3% 4.3%  
2017 10.8% 3.5%  6.4% 3.9%  
2018 4.6% 2.6%  7.8% 3.1%  
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same awardees-group. An awardee-group is classified as a new product innovator if it has sales 
of “new product” based on ABSEI survey (since 2012). An awardee-group is classified as an exporter if it has exporting 
activities. Approved grants and turnover are in constant 2015 prices. 
 
Table 34 Grants intensity of EI RD&I direct financial supports by engagement in R&D 
(approved grants over turnover) 
Year With R&D expenditure Without R&D expenditure 
 Mean Median  Mean Median  
2007 12.3% 3.9%  14.7% 12.0%  
2008 11.4% 4.4%  4.2% 3.7%  
2009 8.5% 4.3%  7.4% 7.4%  
2010 7.3% 4.6%  2.5% 3.2%  
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2011 9.0% 3.6%  3.6% 3.9%  
2012 6.9% 3.6%  6.8% 5.5%  
2013 6.7% 3.3%  12.0% 3.7%  
2014 7.1% 2.8%  0.6% 0.6%  
2015 6.3% 3.2%  3.6% 1.4%  
2016 6.4% 4.3%  1.9% 1.9%  
2017 10.5% 3.6%  2.6% 2.2%  
2018 5.8% 2.8%  3.3% 1.8%  
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same awardees-group. An awardee-group is classified as “with R&D” if it has any R&D expenditure 
in that year. Approved and paid grants are in constant 2015 prices. 
Table 35 Grants intensity of EI RD&I direct financial supports by with or without in-house R&D 
expenditure (approved grants over turnover). 
Year With in-house R&D Without in-house R&D 
 Mean Median  Mean Median  
2007 12.3% 3.9%  14.7% 12.0%  
2008 11.4% 4.5%  4.2% 4.4%  
2009 8.5% 4.3%  7.2% 6.8%  
2010 7.3% 4.6%  2.5% 3.2%  
2011 9.0% 3.6%  3.6% 3.9%  
2012 6.9% 3.6%  6.8% 5.5%  
2013 6.7% 3.4%  9.0% 2.4%  
2014 7.2% 2.8%  0.5% 0.4%  
2015 6.3% 3.2%  3.7% 2.8%  
2016 6.4% 4.3%  1.9% 1.9%  
2017 10.6% 3.7%  2.3% 1.7%  
2018 5.9% 2.8%  3.2% 1.8%  
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are 
integrated if they belong to the same awardees-group. An awardee-group is classified as “with in-house R&D” if it 
has any in-house R&D expenditure in that year. Approved and paid grants are in constant price (2015 price). 
Table 36  Grants intensity of EI RD&I direct financial supports by awardee-group size 
(approved grants over employment). 
Year Small Medium Large 
 Mean Medium  Mean Medium  Mean Medium  
2007 13.5 8.9  5.9 5.0  1.6 1.0  
2008 17.6 10.4  6.9 4.8  2.2 1.6  
2009 14.7 11.2  3.7 3.2  2.0 1.4  
2010 10.7 8.9  5.0 5.1  1.1 0.9  
2011 13.1 9.9  3.6 3.4  1.7 0.9  
2012 11.9 9.5  3.6 2.5  2.2 1.0  
2013 11.9 9.0  4.2 3.2  2.4 0.9  
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2014 12.4 9.7  3.7 2.9  2.8 2.3  
2015 9.4 7.5  4.1 2.9  1.5 1.4  
2016 10.7 9.8  3.2 2.2  1.4 0.8  
2017 11.9 8.2  7.3 4.0  2.1 1.8  
2018 9.2 7.2  3.3 1.9  1.4 0.8  
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same awardees-group. A “Small Enterprise” is defined as an enterprise that has fewer than 50 
employees and has an annual turnover of less than €10m; a “Large Enterprise” is defined as an enterprise that has 
more than 249 employees or an annual turnover of more than €50m; a “Medium Enterprise” is the rest. Approved grants 
are in constant 2015 prices in 1,000 euros. 
Table 37 Grants intensity of EI RD&I direct financial supports by exporter or non-exporter 
(approved grants over employment) 
Year Exporter Non-exporter 
 Mean Median  Mean Median  
2007 9.5 6.9  13.5 2.0  
2008 12.6 7.3  14.4 7.1  
2009 10.7 6.6  4.6 3.3  
2010 8.3 6.0  8.6 6.1  
2011 9.3 4.9  12.1 8.2  
2012 8.8 5.6     
2013 8.7 6.2  10.3 5.4  
2014 8.3 5.0  10.5 10.8  
2015 7.0 5.4  1.1 1.1  
2016 7.5 5.1     
2017 9.3 5.7  6.1 6.1  
2018 6.4 3.5  4.7 4.7  
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Note: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same awardees-group. An awardee-group is classified as an exporter if it has exporting activities. 
Approved grants are in constant 2015 prices in 1,000 euros. 
Table 38 Grants intensity of EI RD&I direct financial supports by product innovation (approved 
grants over employment) 
Year New-product innovator Without product innovation 
 Mean Median  Mean Median  
2012 7.9 5.4  11.6 6.2  
2013 8.9 6.3  8.2 5.0  
2014 7.7 4.6  10.6 7.3  
2015 6.2 4.9  9.6 6.1  
2016 7.8 5.0  6.8 5.5  
2017 9.2 5.3  9.4 6.7  
2018 5.7 3.0  7.9 6.5  
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Note: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same awardees-group. An awardee-group is classified as a new product innovator if it has sales 
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of “new product” based on ABSEI survey (since 2012). An awardee-group is classified as an exporter if it has exporting 
activities. Approved grants are in constant 2015 prices in 1,000 euros. 
Table 39 Grants intensity of EI RD&I direct financial supports by engagement in R&D 
expenditure (approved grants over employment) 
Year With R&D expenditure Without R&D expenditure 
 Mean Median  Mean Median  
2007 9.3 6.8  15.8 6.4  
2008 13.0 7.3  6.5 6.5  
2009 10.4 6.4  7.8 7.8  
2010 8.4 6.1  5.5 4.0  
2011 9.5 5.4  3.1 3.9  
2012 8.8 5.6  7.9 5.7  
2013 8.7 6.2  10.5 5.3  
2014 8.5 5.1  0.7 0.7  
2015 7.1 5.4  3.7 4.1  
2016 7.6 5.5  1.4 1.4  
2017 9.5 6.1  4.2 3.2  
2018 6.6 4.1  4.4 3.4  
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Note: Different grants received by an awardee in the same year are aggregated. Individual awardees are integrated 
if they belong to the same awardees-group. An awardee-group is classified as “with R&D” if it has any R&D expenditure 
in that year. Approved grants are in constant 2015 prices in 1,000 euros. 
Table 40 Grants intensity of EI RD&I direct financial supports by with or without in-house R&D 
expenditure (approved grants over employment) 
Year With in-house R&D Without in-house R&D 
 Mean Median  Mean Median  
2007 9.3 6.8  15.8 6.4  
2008 13.0 7.3  7.2 6.8  
2009 10.4 6.4  8.5 9.6  
2010 8.4 6.1  5.5 4.0  
2011 9.5 5.4  3.1 3.9  
2012 8.8 5.6  7.9 5.7  
2013 8.8 6.2  8.1 3.1  
2014 8.6 5.3  1.0 0.8  
2015 7.1 5.5  4.0 4.4  
2016 7.6 5.5  1.4 1.4  
2017 9.5 6.1  5.9 4.3  
2018 6.7 4.3  4.1 3.2  
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Notes: Different grants received by an awardee in the same year are aggregated. Individual awardees are 
integrated if they belong to the same awardees-group. An awardee-group is classified as “with in-house R&D” if it 
has any in-house R&D expenditure in that year. Approved grants are in constant 2015 prices in 1,000 euros. 
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Table 41 Total amount of approved and cancelled funds by year 
Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Total 
Approved 48.9 54.8 47.6 36.2 27.6 39.5 39.5 47.9 28.0 30.0 31.9 32.7 464.7 
Cancelled 
(%) 
10.1 8.2 8.6 8.3 6.5 8.3 5.1 4.7 3.6 0.7 0.3 0.2 64.7 
21% 15% 18% 23% 24% 21% 13% 10% 13% 2% 1% 0% 14% 
Source: ESRI elaboration based on the data provided by Enterprise Ireland.  
Note: Grants cancellation normally happen two to three years after approval, therefore, cancellation information may 
not complete in recent year. Approved and paid grants are in constant 2015 prices in 1,000,000 euros. 
Table 42  Number of cancelled grants by cancellation category  
Year # grants Percentage of cancelled grants  
  >0% <10% [10-90%] >90% 
2007 223 
170 56 74 40 
76% 25% 33% 18% 
2008 224 
167 55 78 34 
75% 25% 35% 15% 
2009 215 
149 58 58 33 
69% 27% 27% 15% 
2010 165 
123 39 52 32 
75% 24% 32% 19% 
2011 148 
117 45 55 17 
79% 30% 37% 11% 
2012 167 
118 52 41 25 
71% 31% 25% 15% 
2013 179 
115 49 44 22 
64% 27% 25% 12% 
2014 168 
93 38 42 13 
55% 23% 25% 8% 
2015 129 
70 29 30 11 
54% 22% 23% 9% 
2016 107 
17 9 6 2 
16% 8% 6% 2% 
2017 111 
12 9 2 1 
11% 8% 2% 1% 
2018 169 
5 2 2 1 
3% 1% 1% 1% 
Overall 2005 
1156 441 484 231 
58% 22% 24% 12% 
Source: ESRI elaboration based on the data provided by Enterprise Ireland.  
Notes: Grants cancellation normally happen two to three years after approval, therefore, cancellation information 
may not complete in recent year. Percentage figures show the percent of cancellation over total number of approved 
grants in the same year. 
 
 
Evaluation of the Enterprise Ireland Research, Development and Innovation Programme 87 
Table 43 Number of awardees that have grants being cancelled by cancellation category 
Year # awardees Percentage of total grants being cancelled 
  >0% < 10% [10%, 90%] >90% 
2007 134 
113 49 54 10 
84% 37% 40% 7% 
2008 143 
115 53 50 12 
80% 37% 35% 8% 
2009 176 
125 52 56 17 
71% 30% 32% 10% 
2010 124 
96 37 43 16 
77% 30% 35% 13% 
2011 128 
104 44 49 11 
81% 34% 38% 9% 
2012 148 
107 51 38 18 
72% 34% 26% 12% 
2013 142 
97 49 38 10 
68% 35% 27% 7% 
2014 132 
80 40 34 6 
61% 30% 26% 5% 
2015 105 
60 30 24 6 
57% 29% 23% 6% 
2016 92 
17 10 5 2 
18% 11% 5% 2% 
2017 91 
12 9 2 1 
13% 10% 2% 1% 
2018 147 
5 2 2 1 
3% 1% 1% 1% 
Overall 1562 
931 426 395 110 
60% 27% 25% 7% 
Source: ESRI elaboration based on the data provided by Enterprise Ireland.  
Note: Grants cancellation normally happen two to three years after approval, therefore, cancellation information may 
not complete in recent year. Percentage figures show the percent of awardees that had grants cancellation over 
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 Econometric analysis: Direct financial supports  
Figure 42 shows the estimated propensity score for the awardees of EI RD&I direct financial 
supports and unmatched and matched control groups. The left panel shows that the 
distribution of the estimated propensity scores for the awardees and for the other firms differ 
significantly. The right panel shows that the distribution of the estimated propensity scores for 
the awardees and for their matched control group are very similar indicating that we have 
achieved a successful matching. The impact of the RD&I intervention can consequently be 
calculated as the performance differential between these two enterprise groups.  
Figure 42 Estimated propensity score for unmatched and matched data for the EI RD&I Programme 
Source: ESRI elaboration based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Table 44 Summary statistics of outcome performance variables, all firms  
 All firms   
Variables  Mean  SD  Min  Max 
Turnover (thousands euro, 2015 prices) 13885.9 48267.3 4.0 661062.0 
Total value added (thousands euro, 2015 prices) 4889.9 14013.8 0.0 225745.5 
Employment  53.7 126.0 1.0 1517.0 
Export sales (thousands euro, 2015 prices) 6842.9 30213.7 0.0 415066.0 
Turnover / employment (thousands euro/employee, 2015 prices) 195.2 240.0 1.3 2213.4 
Total value added / employment (thousands euro/employee, 2015 prices) 91.0 140.6 0.0 1522.0 
Export / turnover  0.4 0.4 0.0 1.0 
Net R&D (thousands euro, 2015 prices) 258.3 674.2 0.0 7028.6 
Net R&D / turnover  0.3 1.6 0.0 24.0 
Net R&D / employment (thousands euro/employee, 2015 prices) 11.0 22.6 0.0 198.5 
R&D employment  3.1 6.6 0.0 58.0 
R&D employment / employment 0.15 0.25 0.0 1.0 
New product sales* (thousands euro, 2015 prices) 779.9 2402.3 0.0 23704.2 
New product sales / turnover*  0.1 0.3 0.0 1.0 
Wages per employee (thousands euro/employee, 2015 prices) 47.5 27.1 0.0 241.9 
No. of observations    20,502  
Source: ESRI calculations based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland.  
Notes:  SD denotes the standard deviation statistics measuring the amount of variation of the performance outcomes 
across firms. * Data on new product sales is available since 2012. 11,228 observations are avaialble for the 
corresponding variables.  
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Table 45 Summary statistics for awardees and non-awardees 
 Non-awardees (a) Awardees (b) t-test 
Variables Mean SD Min Max Mean SD Min Max (b)>(a) 
Log turnover 7.58 1.9 1.4 13.4 8.50 1.6 1.4 13.4 1.00 
Log total value added  5.83 4.2 -6.9 12.3 7.13 3.3 -6.9 12.3 1.00 
Log employment  2.83 1.3 0.0 7.3 3.52 1.2 0.0 7.3 1.00 
Log export sales  3.64 5.6 -6.9 12.9 6.84 3.7 -6.9 12.9 1.00 
Log turnover / employment  4.75 1.1 0.3 7.7 4.98 0.8 0.3 7.6 1.00 
Log total value added / employment  3.01 3.8 -10.9 7.3 3.61 2.9 -10.9 7.3 1.00 
Log export / turnover  -3.93 5.2 -17.9 0.0 -1.66 3.1 -17.4 0.0 1.00 
Log net R&D  -0.76 5.8 -6.9 8.9 4.23 4.0 -6.9 8.9 1.00 
Log net R&D / turnover  -8.34 6.2 -19.1 3.2 -4.27 4.0 -19.1 3.2 1.00 
Log net R&D / employment  -3.59 5.9 -13.2 5.3 0.71 3.9 -13.2 5.3 1.00 
Log R&D employment  0.56 0.7 0.0 4.1 1.50 1.0 0.0 4.1 1.00 
Log R&D employment / employment -2.26 1.4 -6.4 0.7 -2.02 1.3 -6.4 0.7 1.00 
Log new product sales* -1.45 6.3 -6.9 10.1 2.55 6.4 -6.9 10.1 1.00 
Log new product sales / turnover*  -8.95 6.4 -19.0 0.1 -6.00 6.2 -19.0 0.1 1.00 
Log wages per employee 3.22 2.5 -11.1 5.5 3.78 0.9 -11.1 5.5 1.00 
Exporter (=1) 0.80 0.40 0 1 0.95 0.22 0 1 1.00 
Positive profit (=1) 0.60 0.49 0 1 0.64 0.48 0 1 1.00 
R&D activity (=1) 0.54 0.50 0 1 0.91 0.29 0 1 1.00 
Patent holder (=1) 0.07 0.26 0 1 0.26 0.44 0 1 1.00 
University link (=1) 0.08 0.28 0 1 0.23 0.42 0 1 1.00 
No. of observations 14,182 6,320 
Source: ESRI calculations based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Notes: SD denotes the standard deviation statistics measuring the amount of variation of the performance outcomes 
across firms. *Data on new product sales is available since 2012. For the corresponding variable, 7,765 observations are 
available for non-awardees and 3,463 observations for awardees. 
 
Table 46 shows summary statistics of the variables as used in the econometric analysis. It shows 
that a number of performance outcomes are unevenly distributed across firms, in particular 
total sales, export sales, sales of new products, total value added, and net R&D expenditures 
(the standard deviation statistics, are very high indicating a variation across a wide range of 
values). The distributions of the intensity of inputs and outputs (accounting for group size 
measured as turnover or employment) are less skewed (the standard deviation statistics for 
these performance outcomes are lower). Among all firms, 85% are exporters and 65% have 
reported R&D activity. In terms of innovation activities, 13% of all firms hold patents and 13% of 
all firms have links with universities.      
Table 46 Summary statistics of outcome performance,  all firms (2007-2016) 
 All firms   
Variables  Mean  SD  Min  Max 
Log turnover 7.86 1.84 1.39 13.40 
Log total value added  6.23 4.01 -6.91 12.33 
Log employment  3.04 1.29 0.00 7.32 
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Log export sales  4.63 5.27 -6.91 12.94 
Log turnover / employment  4.82 0.99 0.29 7.70 
Log total value added / employment  3.19 3.52 -10.88 7.33 
Log export / turnover  -3.23 4.78 -17.88 0.00 
Log net R&D  0.78 5.77 -6.91 8.86 
Log net R&D / turnover  -7.08 5.90 -19.06 3.18 
Log net R&D / employment  -2.26 5.73 -13.24 5.29 
Log R&D employment  0.85 0.93 0.00 4.08 
Log R&D employment / employment -2.19 1.37 -6.35 0.69 
Log new product sales* -0.22 6.58 -6.91 10.07 
Log new product sales / turnover*  -8.04 6.47 -18.96 0.12 
Log wages per employee 3.40 2.18 -11.10 5.49 
Exporter (=1) (share of companies that export) 0.85 0.36 0 1 
Positive profit (=1) (share of companies with positive profit) 0.61 0.49 0 1 
R&D activity (=1) (share of companies that are R&D active) 0.65 0.48 0 1 
Patent holder (=1) (share of companies that hold a patent) 0.13 0.34 0 1 
University link (=1) ) (share of companies that have links with universities) 0.13 0.33 0 1 
No. of observations    20,502  
Source: ESRI calculations based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Notes:  SD denotes the standard deviation statistics measuring the amount of variation of the performance outcomes 
across firms. * Data on new product sales is available since 2012. 11,228 observations are available for the 
corresponding variables. SD = Standard Deviation 
Table 47 Statistics of covariates for control and treated groups before matching for RD&I program 
Before matching Means Variances 
 Control Treated Control Treated 
Labour productivity (log) 3.041 3.485 12.378 8.147 
Employment (log) 2.888 3.405 1.568 1.550 
Wage (log) 3.217 3.765 6.103 0.773 
Exporter (=1) 0.819 0.957 0.148 0.041 
Positive profit (=1) 0.692 0.755 0.213 0.185 
R&D activity (=1) 0.571 0.920 0.245 0.073 
Patent holder (=1) 0.074 0.240 0.068 0.183 
University link (=1) 0.078 0.197 0.072 0.159 
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Note: labour productivity is measured by total value added / employment.   
Table 48 Balancing test of covariates before and after matching for RD&I program – difference in means 
and variance ratios 
Before/after matching Standardized differences Variance ratio 
 Raw Matched Raw Matched 
Labour productivity (log) 0.139 0.009 0.658 1.052 
Employment (log) 0.414 0.023 0.988 1.068 
Wage (log) 0.296 0.001 0.127 0.962 
Exporter (=1) 0.450 -0.008 0.277 1.035 
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Positive profit (=1) 0.141 0.004 0.869 0.996 
R&D activity (=1) 0.876 0.006 0.299 0.983 
Patent holder (=1) 0.469 0.000 2.674 1.000 
University link (=1) 0.350 0.000 2.197 1.000 
Source: ESRI elaboration based on the linked ABSEI data and data provided by Enterprise Ireland.  
Note: Labour productivity is measured by total value added / employment.   
Table 49 Statistics of covariates for control and treated groups before matching for ESA program 
Before matching Means Variances 
 Control Treated Control Treated 
Labour productivity (log) 3.254 1.550 10.386 24.930 
Employment (log) 3.068 2.939 1.592 2.297 
Wage (log) 3.369 3.732 4.706 1.698 
Exporter (=1) 0.861 0.940 0.120 0.057 
Positive profit (=1) 0.712 0.564 0.205 0.248 
R&D activity (=1) 0.671 0.902 0.221 0.089 
Patent holder (=1) 0.127 0.286 0.111 0.206 
University link (=1) 0.114 0.361 0.101 0.232 
Source: ESRI estimates based on the linked ABSEI data and ESA data provided by Enterprise Ireland.  
Note: Labour productivity is measured by total value added / employment.   
Table 50 Balancing test of covariates before and after matching for ESA program 
Before/after matching Standardized mean differences Variance ratio 
 Raw Matched Raw Matched 
Labour productivity (log) -0.406 -0.011 2.400 1.046 
Employment (log) -0.093 -0.035 1.443 1.005 
Wage (log) 0.203 0.009 0.361 0.975 
Exporter (=1) 0.265 0.000 0.476 1.000 
Positive profit (=1) -0.312 0.000 1.209 1.000 
R&D activity (=1) 0.587 0.000 0.403 1.000 
Patent holder (=1) 0.398 0.000 1.852 1.000 
University link (=1) 0.606 0.000 2.305 1.000 
Source: ESRI elaboration based on the linked ABSEI data and ESA data provided by Enterprise Ireland.  
Note: Labour productivity is measured by total value added / employment.   
Table 51 Statistics of covariates for control and treated groups before matching for combined funding 
from the EI RD&I and ESA Programmes  
Before matching Means Variances 
 Control Treated Control Treated 
Labour productivity (log) 3.067 3.314 12.239 9.060 
Employment (log) 2.887 3.316 1.573 2.189 
Wage (log) 3.189 3.759 6.520 0.237 
Exporter (=1) 0.814 1.000 0.152 0.000 
Positive profit (=1) 0.695 0.761 0.212 0.186 
R&D activity (=1) 0.565 0.978 0.246 0.022 
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Patent holder (=1) 0.072 0.348 0.067 0.232 
University link (=1) 0.074 0.457 0.069 0.254 
Source: ESRI elaboration based on the linked ABSEI, RD&I and ESA data provided by Enterprise Ireland.  Note: labour 
productivity is measured by total value added / employment.   
Table 52 Balancing test of covariates before and after matching for combined funding from the EI 
RD&I and ESA Programmes  
Before/after matching Standardized means  differences Variance ratio 
 Raw Matched Raw Matched 
Labour productivity (log) 0.076 0.017 0.740 0.981 
Employment (log) 0.313 0.012 1.392 1.148 
Wage (log) 0.310 -0.215 0.036 3.457 
Exporter (=1) 0.677  0.000  
Positive profit (=1) 0.147 0.000 0.878 1.000 
R&D activity (=1) 1.130 0.000 0.088 1.000 
Patent holder (=1) 0.715 0.000 3.481 1.000 
University link (=1) 0.951 0.000 3.679 1.000 
Source: ESRI elaboration based on the linked ABSEI, RD&I and ESA data sets provided by the DBEI and Enterprise Ireland.  
Note: Labour productivity is measured as total value added / employment. 
In the table below, the row “beta” shows the value of the impact, for a given number of years 
after approval of EI RD&I direct funding. The row ‘p-value’ indicates whether or not beta is 
statistically significant, with values above 0.010 indicating that the ‘beta’ (i.e. effect) is not 
statistically significant. 
Table 53 Estimated impacts of the EI RD&I direct financial supports on the performance of awardees  
Outcome variables Years after approval of EI RD&I direct funding  
  0 1 2 3 4 5 Average effect 
R&D performance outcomes      
Net R&D 
expenditures 
beta 0.997 1.425 1.517 1.757 1.975 2.295 1.569 
s.e. 0.172 0.194 0.214 0.250 0.268 0.288 0.168 




beta 0.877 1.250 1.362 1.555 1.777 2.013 1.378 
s.e. 0.172 0.194 0.214 0.245 0.265 0.285 0.167 




beta 0.864 1.277 1.348 1.567 1.776 2.077 1.380 
s.e. 0.171 0.193 0.212 0.246 0.264 0.286 0.166 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
R&D employees   
beta 0.267 0.351 0.358 0.388 0.436 0.427 0.360 
s.e. 0.025 0.031 0.036 0.043 0.050 0.056 0.031 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
R&D employees / 
total employees  
beta 0.136 0.203 0.187 0.194 0.232 0.205 0.170 
s.e. 0.027 0.031 0.036 0.042 0.049 0.059 0.032 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Economic and innovation performance outcomes      
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Turnover  
beta 0.121 0.182 0.161 0.203 0.196 0.281 0.195 
s.e. 0.025 0.033 0.039 0.042 0.050 0.057 0.032 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Total value added  
beta 0.189 0.499 0.239 0.287 0.217 0.424 0.352 
s.e. 0.128 0.143 0.146 0.165 0.168 0.167 0.111 
p-value 0.140 0.000 0.101 0.083 0.197 0.011 0.001 
Employment  
beta 0.131 0.148 0.170 0.190 0.201 0.220 0.189 
s.e. 0.019 0.023 0.028 0.033 0.040 0.043 0.025 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Export sales  
beta 0.510 0.448 0.701 0.687 0.435 0.630 0.693 
s.e. 0.114 0.145 0.171 0.180 0.192 0.226 0.131 
p-value 0.000 0.002 0.000 0.000 0.024 0.005 0.000 
Turnover / 
employee  
beta -0.010 0.030 -0.011 0.013 0.003 0.061 0.004 
s.e. 0.021 0.026 0.030 0.031 0.037 0.040 0.023 
p-value 0.624 0.253 0.710 0.678 0.925 0.133 0.859 
Total value added 
/ employee  
beta 0.062 0.346 0.075 0.100 0.027 0.219 0.165 
s.e. 0.124 0.140 0.143 0.157 0.155 0.154 0.105 
p-value 0.620 0.013 0.597 0.524 0.862 0.154 0.116 
Export / turnover  
beta 0.389 0.265 0.536 0.478 0.234 0.345 0.496 
s.e. 0.108 0.138 0.162 0.169 0.181 0.210 0.122 
p-value 0.000 0.055 0.001 0.005 0.196 0.100 0.000 
New product sales  
beta 1.752 0.494 0.862 2.608 2.234 1.477 0.894 
s.e. 0.709 0.737 0.745 0.869 0.974 1.343 0.647 
p-value 0.013 0.502 0.247 0.003 0.022 0.271 0.167 
New product sales 
/ turnover  
beta 1.721 0.447 0.873 2.642 2.212 1.513 0.851 
s.e. 0.713 0.735 0.744 0.861 0.959 1.341 0.644 
p-value 0.016 0.543 0.241 0.002 0.021 0.259 0.186 
Source: ESRI estimates based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. 
Note: Standard errors (s.e) are clustered at enterprise group level. 
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 Composition analysis: Indirect financial supports 
Table 54 Awardees of ESA funding by exporter status 
    2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Exporter 
ESA Awardees 0 3 2 2 4 5 7 6 9 2 10 
EI clients 1466 1536 1597 1687 1770 1921 1950 2008 2133 2053 2074 
%   0.20% 0.13% 0.12% 0.23% 0.26% 0.36% 0.30% 0.42% 0.10% 0.48% 
Total grants   0.54 0.29 1.53 1.46 1.64 3.35 1.80 4.34 2.22 11.81 
Non 
exporter 
ESA Awardees 4 3 6 3 1 2 2 2 2 3 3 
EI clients 356 377 306 290 280 334 266 268 298 267 199 
% 1.12% 0.80% 1.96% 1.03% 0.36% 0.60% 0.75% 0.75% 0.67% 1.12% 1.51% 
Total grants 2.48  1.79  1.54  0.82  0.71  1.00  0.64  2.01  1.22  0.70  1.07  
Source: DBEI elaboration based on the RD&I data provided by Enterprise Ireland 
Table 55 Awardees of ESA funding by product innovator status 
    2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Product 
innovator 
ESA Awardees         3 5 3 5 5 4   
EI Clients         1159 1128 1150 1239 1135 1262   
%         0.26% 0.44% 0.26% 0.40% 0.44% 0.32%   




ESA Awardees         2 2 5 3 8 3   
EI Clients         891 1127 1066 1037 1296 1058   
%         0.22% 0.18% 0.47% 0.29% 0.62% 0.28%   
Total grant         0.83 1.00 1.32 1.57 3.63 0.70   
Source: DBEI elaboration based on the RD&I data provided by Enterprise Ireland 
Table 56 Awardees of ESA funding by R&D status 
    2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
With R&D 
ESA awardees 0 3 3 5 4 5 7 6 9 4   
EI client 1137 1202 1233 1278 1347 1467 1505 1538 1609 1549   
%   0.25% 0.24% 0.39% 0.30% 0.34% 0.47% 0.39% 0.56% 0.26%   
Total grant   0.54 0.59 0.82 1.46 1.64 3.35 1.80 4.34 2.22   
Without 
R&D  
ESA awardees 2 2 3 2 1 2 1 2 2 3   
EI client 685 711 670 699 703 788 711 738 822 771   
% 0.29% 0.28% 0.45% 0.29% 0.14% 0.25% 0.14% 0.27% 0.24% 0.39%   
Total grant 1.89 1.56 0.51 1.53 0.71 1.00 0.21 2.01 1.22 0.70   
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Table 57 Awardees of ESA funding by R&D function 






Awardees 0 3 3 3 4 7 7 6 9 4   
EI clients 1105 1162 1184 1246 1303 1412 1448 1480 1545 1480   
%  0.26% 0.25% 0.24% 0.31% 0.50% 0.48% 0.41% 0.58% 0.27%   





Awardees 2 2 3 2 1 2 1 2 2 3   
EI clients 717 751 719 731 747 843 768 796 886 840   
% 0.28% 0.27% 0.42% 0.27% 0.13% 0.24% 0.13% 0.25% 0.23% 0.36%   
Total grant 1.89 1.56 0.51 1.53 1.05 1.00 0.21 2.01 1.22 0.70   
Source: DBEI elaboration based on the RD&I data provided by Enterprise Ireland   
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Table 58 Awardees of ESA funding by region 
    2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Border 
ESA Awardees 0 0 0 0 0 0 0 0 0 0 0 
EI Clients 227 233 227 233 227 245 242 254 268 252 248 
%                       
 
Total grants                       
Dublin 
ESA Awardees 3 5 7 4 4 6 4 7 8 8 10 
EI Clients 680 743 762 796 814 900 897 928 1019 969 944 
% 0.44% 0.67% 0.92% 0.50% 0.49% 0.67% 0.45% 0.75% 0.79% 0.83% 1.06% 
  Total grants 2.34 2.10 1.39 1.87 1.80 2.28 2.38 3.61 3.68 3.16 9.88 
Mid-East 
ESA Awardees 0 0 0 0 0 1 0 0 0 0 1 
EI Clients 159 164 159 156 177 206 199 214 221 214 206 
%           0.49%         0.49% 
  Total grants           0.35         0.50 
Mid-West 
ESA Awardees 0 0 0 0 0 0 1 2 1 0 1 
EI Clients 170 171 173 184 185 189 176 176 197 189 184 
%             0.57% 1.14% 0.51%   0.54% 
  Total grants             0.19 0.30 0.49   2.00 
Midland 
ESA Awardees 0 0 0 0 0 0 0 0 0 0 0 
EI Clients 96 94 88 93 103 113 117 123 124 119 118 
%                       
  Total grants                       
South East 
ESA Awardees 0 0 0 0 0 0 1 0 1 0 2 
EI Clients 174 181 170 168 184 204 192 184 193 187 184 
%             0.52%   0.52%   1.09% 
  Total grants             0.43   0.20   0.51 
South 
West 
ESA Awardees 1 1 1 2 2 1 4 1 3 1 3 
EI Clients 242 251 240 264 281 308 300 305 318 304 296 
% 0.41% 0.40% 0.42% 0.76% 0.71% 0.32% 1.33% 0.33% 0.94% 0.33% 1.01% 
  Total grants 0.15 0.22 0.44 0.80 0.52 0.20 1.11 0.04 1.72 0.19 0.89 
West 
ESA Awardees 1 0 0 0 0 0 0 0 0 0 1 
EI Clients 141 153 155 157 156 176 173 172 178 168 166 
% 0.71%                   0.60% 
  Total grants 0.15                   0.60 
Source: DBEI elaboration based on the RD&I data provided by Enterprise Ireland 
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Table 59 Awardees of ESA funding by sector 
  






ESA Awardees 0 0 0 0 0 0 0 0 0 0 0 
EI Clients 277 272 257 259 260 298 304 297 310 302 296 
%                       






ESA Awardees 4 4 4 3 4 4 4 4 6 5 5 
EI Clients 404 434 456 505 544 615 629 640 711 707 680 
Percentage 0.99% 0.92% 0.88% 0.59% 0.74% 0.65% 0.64% 0.63% 0.84% 0.71% 0.74% 






ESA Awardees 0 1 1 1 1 3 2 3 2 1 5 
EI Clients 61 70 71 70 68 71 67 69 68 61 60 
Percentage  1.43% 1.41% 1.43% 1.47% 4.23% 2.99% 4.35% 2.94% 1.64% 8.33% 
  Total grants   0.24 0.34 0.02 0.78 1.09 2.28 1.49 0.62 1.19 4.64 
Med 
devices 
ESA Awardees 0 0 0 0 0 0 0 0 0 0 0 
EI Clients 7 8 9 9 10 13 16 19 20 21 21 
%                       




ESA Awardees 0 0 0 0 0 0 0 0 0 0 0 
EI Clients 49 64 61 68 67 69 78 85 94 87 84 
%                       
  Total grants                       
Constructi
on 
ESA Awardees 0 0 0 0 0 0 0 0 0 0 0 
EI Clients 35 42 39 37 41 42 38 43 52 50 49 
%                       





ESA Awardees 0 0 0 1 0 0 1 0 1 0 1 
EI Clients 52 53 51 59 61 63 67 68 65 62 62 
Percentage       1.69%     1.49%   1.54%   1.61% 




ESA Awardees 1 1 1 0 0 0 1 0 1 1 2 
EI Clients 702 689 654 655 678 713 650 687 706 663 652 
Percentage 0.14% 0.15% 0.15%       0.15% 0 0.14% 0.15% 0.31% 





ESA Awardees 0 0 1 1 1 1 2 1 1 0 1 
EI Clients 290 345 362 372 378 441 430 431 475 436 429 
Percentage     0.28% 0.27% 0.26% 0.23% 0.47% 0.23% 0.21% 0 0.23% 




ESA Awardees 0 0 0 0 0 0 0 0 0 0 0 
EI Clients 11 12 13 16 19 15 16 16 16 13 13 
Percentage                       
Total grants                       
Source: DBEI elaboration based on the RD&I data provided by Enterprise Ireland   
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 Data tables for the survey of awardees  
Profile of respondents 
In total, 220 responded to the survey of awardees. The data describing the company 
characteristics are described in Table 60, Table 61, Table 62 and Table 63. The relative share of 
the sample group across these characteristics is broadly consistent with their respective 
proportion of the whole population described in chapter 2.3, though those firms within the 
‘Business and Financial Services’ sector account for 17% of the awardees within the data 
population, but have lower representation in the survey sample (5%). One tenth of survey 
respondents remain unclassified (‘Other’) despite re-defining a large share of them according 
to existing categories.  
Table 60 Data sample – Industry sectors (awardees) 
Industry Sector  Number Percentage 
Information, communication and computing 56 25.9% 
Traditional manufacturing 45 20.8% 
Food, drink and primary production 33 15.3% 
Others60 21 9.7% 
Computers, electronics and optical 18 8.3% 
Business and financial services 10 4.6% 
Chemicals and pharmaceuticals 10 4.6% 
Medical devices 10 4.6% 
Construction 8 3.7% 
Energy, waste, and water 5 2.3% 
Total 21
6 100% 
Source: Technopolis, based on survey data  
Table 61 Data sample – Number of full-time equivalent employees (awardees) 
Firm size (full-time equivalent) Number Percentage 
0-9 FTEs 19 8.8% 
10 – 49 FTEs 108 49.8% 
50 – 249 FTEs 69 31.8% 
250+ FTEs 21 9.7% 
Total 21
7 100% 
Source: Technopolis, based on survey data  
Table 62 Data sample – Region (awardees) 
Location (region) Number Percentage 
Dublin 76 34.9% 
South-East 29 13.3% 
Border 23 10.6% 
 
 
6032 respondents marked as ‘Others’ have been allocated to existing categories based on the description of their 
industry  
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Mid-West 23 10.6% 
South-West 23 10.6% 
West 17 7.8% 
Midlands 15 6.9% 
Mid-East 12 5.5% 
Total 21
8 100% 
Source: Technopolis, based on survey data  
Table 63 Data sample – Trade experience (awardees) 
Years of trading experience Number Percentage 
1 – 10 years 32 14.5% 
11 – 20 years 68 30.9% 
21 – 30 years 48 21.8% 
31 – 40 years 36 16.4% 
More than 40 years 36 16.4% 
Total 220 100% 
Source: Technopolis, based on survey data  
Grants received 
The number of received grants are summarised in Figure 43. The RD&I Fund is the most 
commonly-reported grant received, reported as accessed by almost 80% of respondents. The 
‘Agile Innovation Fund’, ‘Exploring Innovation Grant’ and the ‘Business Innovation Offer’ show 
similar frequency as one another while only a minority reported accessing the ‘Intellectual 
Property Strategy Offer’. Among the ‘Other’61 supports reported by respondents ‘Lean support’ 
grants were most common, having been received by approximately 15% of respondents. Other 
popular schemes classified under ‘Other’ include grants for employment, grants for market 
access, the Innovation Partnership grant and capital grants.  
The analysis shows that it is not uncommon for firms to engage in multiple support schemes with 
25% of the respondents having received at least 2 different grants. A small minority (11 
respondents, 5%) reported to have received up to three different grants. The analysis further 
revealed that the median grant duration lasted four years62. 
 
 
61 Various grants reported under  ‘Others’ have been re-classified under the pre-defined categories as part of the 
analysis 
62 Values that appeared incorrect or implausible have been removed from the data sample 
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Figure 43 Received EI grants 
 













Intellectual Property Strategy Offer
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 Data tables for the survey of Enterprise Ireland clients that have not accessed 
the programme  
Profile of respondents 
Table 64 Data sample – Industry sectors (clients that have not accessed the programme) 
Industry Sector Count of respondents % of respondents 
Business and financial services 4 8% 
Computers, electronics and optical (including semi-conductors) 2 4% 
Construction 5 10% 
Energy, waste, and water 1 2% 
Food, drink and primary production 5 10% 
Information, communication, and computing 12 24% 
Medical devices 3 6% 
Traditional manufacturing 17 35% 
Total 49 100% 
Source: Technopolis, based on survey data  
Table 65 Data sample – Number of full-time equivalent employees (clients that have not accessed the 
programme) 
Firm size (FTE) Count of respondents % of respondents 
0-9 FTEs 7 13% 
10-49 FTEs 26 49% 
250+ FTEs 1 2% 
50-249 FTEs 19 36% 
Total 53 100% 
Source: Technopolis, based on survey data  
Table 66 Data sample – Region (clients that have not accessed the programme) 
Base region Count of respondents % of respondents 
Border 7 13% 
Dublin 20 38% 
Mid-East 1 2% 
Midlands 2 4% 
South-East 8 15% 
South-West 9 17% 
West 6 11% 
Total 53 100% 
Source: Technopolis, based on survey data  
Table 67 Data sample – Trade experience (clients that have not accessed the programme) 
Number of years trading Count of respondents % of respondents 
1-10 6 11% 
11-20 12 22% 
21-30 9 17% 
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31-40 9 17% 
More than 40 years 18 33% 
Total 54 100% 
Source: Technopolis, based on survey data  
Grants applied for 
Figure 44 Grants applied for by client firms that have not accessed the programme 
 
Source: Technopolis, based on survey data. Base = 13 
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 Methodological information 
 Econometric analysis – data treatment 
Propensity score matching 
This technique allows us to compare the performance outcomes of awardees with the 
performance of a group of non-awardees with similar characteristics (control group).  The 
control group of firms would have the same chance to be awarded RD&I direct financial 
supports conditional on their characteristics. These characteristics are shown in Table 68. 
Table 68 also shows the estimates from an econometric model which identifies the importance 
of a range of enterprise characteristics which influence the chance to be awarded EI RD&I 
direct financial supports. The table shows that on average, the probability to be awarded RD&I 
direct financial supports is positively associated with a range of firm-specific characteristics 
including labour productivity, firm size, high skills, export participation, engagement in R&D 
activity, innovation activity, profitability, and links with universities. The year-specific effects 
indicate that relative to 2007 the probability to be awarded EI RD&I financial supports has 
declined significantly from 2010 until 2018, which is important to capture for the ‘matching’ 
process but does not have a wider implication for the programme and the evaluation.        
The estimates of the probabilities to be awarded EI RD&I direct financial supports are then used 
to match the group of awardees with a control group of non-awardees having similar 
characteristics with the awardees (and the same probability to be awarded EI RD&I direct 
financial supports).63 Using the propensity score estimates, 654 enterprise group awardees 
identified in the data set are matched using information from a control group of 12,094 
observations. The matching is carried out using the nearest neighbour method.       
Table 68 Determinants of the probability of approved EI RD&I awards 
 beta s.e. p-value Marginal effects 
Labour productivity (log) 0.034 0.019 0.07 0.0009 
Employment (log) 0.207 0.043 0.00 0.0053 
Wage per employee (log) 0.148 0.069 0.03 0.0038  
Exporter (=1) 1.049 0.207 0.00 0.0270 
Positive profit (=1) 0.252 0.123 0.04 0.0065 
R&D activity (=1) 1.853 0.158 0.00 0.0477 
Patent holder (=1) 0.832 0.159 0.00 0.0214 
University link (=1) 0.588 0.168 0.00 0.0151  
Constant -6.589 0.365 0.00  
Year fixed effects      
2008 0.055 0.155 0.72 0.0022 
2009 0.136 0.151 0.37 0.0057 
2010 -0.390 0.172 0.02 -0.0129 
2011 -0.391 0.175 0.03 -0.0129 
 
 
63 The matching has been done using the nearest neighbour with replacement method.       
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 beta s.e. p-value Marginal effects 
2012 -0.765 0.193 0.00 -0.0215 
2013 -0.346 0.168 0.04 -0.0117 
2014 -0.543 0.173 0.00 -0.0168 
2015 -0.921 0.190 0.00 -0.0243 
2016 -1.070 0.191 0.00 -0.0266 
No. of observations 12,748    
Pseudo R2 0.143    
Wald chi2 (17)  370.880    
Source: ESRI estimates based on the linked ABSEI and RD&I data sets provided by the DBEI and Enterprise Ireland. Note: 
Labour productivity is measured as total value added / employment. Covariates are averages over two years before 
the approval (treatment) year. The probabilities are estimated on the basis of the first approved EI RD&I direct financial 
support. Standard errors are clustered at enterprise-group level, using a probit model. S.E. = Standard Error ***Significant 
at 1% level, ** Significant at 5% level, *Significant at 10% level 
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 Interviews undertaken 
Interviews with firms 
Firm group Invited Completed 
Awardees 70 34 
EI clients that had not accessed 
the Programme 
18 6 
Total 88 40 
 
Interviews with Development Advisors 
Name Sector of focus 
James Croke  Services 
Helen McAuliffe  HPSU and ICT 
Michael Browne  Financial services 
Alan Dunne  Electronics 
Ray Walsh  ICT (software) 
Michelle O'Grady  ICT (cybersecurity) 
TJ Hughes  Medical devices & HPSU 
David O'Sullivan  Life Sciences and Pharma 
 
Interviews with representatives of international comparator programmes 
Country Programme Name 
Austria Frontrunner Martin Wilfling  
Denmark Innobooster Johan Lervang 
Netherlands SME+ Innovation Fund Natascha Szilágyi, Rein van Erp  
Sweden Innovation projects in small and 
medium-sized companies 
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 Data collection tools 
 Survey questionnaire for awardees of the RD&I programme 
Introduction 
Thank you for taking the time to reply to this survey. The Department of Business, Enterprise & 
Innovation (DBEI) has commissioned Technopolis Group to evaluate the direct financial support 
available for research and development (R&D) provided by Enterprise Ireland. This comprises 
a suite of supports, including: the Exploring Innovation Grant [LINK], the R&D Fund [LINK], the 
Agile Innovation Fund [LINK], the Business Innovation Projects grant [LINK], and the Intellectual 
Property Strategy Offer [LINK]. These grant schemes are collectively referred to as the RD&I 
Programme throughout this survey. 
You have received this survey as a client of Enterprise Ireland that has received support through 
the RD&I Programme. The objective of this survey is to gather feedback from recipients of the 
RD&I fund. The collection information will be used to evaluate the appropriateness and the 
effectiveness of the business support scheme as well as to identify needs for improvement. A 
letter of introduction, providing further information about the evaluation can be found at this 
[LINK]. 
All responses will be treated in strict confidence, and only reported at the highest possible level 
of aggregation.  
Confidentiality and data 
Your participation in this survey is voluntary you are able to withdraw at any time. Indeed, you 
are free to request the withdrawal and deletion of your submission and data at any point during 
the course of the study. Technopolis Group provides independent, evidence-based research 
to support policy makers across the world. Technopolis operates in compliance with GDPR and 
take all steps to ensure the protection and confidentiality of your personal information.  
For further information on your rights and how to contact Technopolis, please refer to their 
Privacy Notice: http://www.technopolis-group.com/privacy-policy. For any queries please 
contact Martin Wain at martin.wain@technopolis-group.com. 
 
About your company 
Q1: Can you please confirm: 
•  Your sector of operation  
[Drop down menu with sectors] 
•  The size of your firm (full time equivalents) 
[List of options: 0-9 FTEs, 10-49, 50-249, 250+] 
•  The region you are based in  
[Drop down menu with regions]     
•  Number of years trading 
[Number] 
•  Which grant(s) you received (please select all that apply)  
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[List of options with name of grants, other and don’t know options – multiple selections can be 
made]  
•  When was the first and last year you received a grant? Type year or type don’t know 
[List of options: First year; Last year] 
 
Your involvement with the RD&I programme 
Q2: How did you learn about the EI RD&I Programme? Please select one option. 
•  Directly via the Enterprise Ireland website 
•  Your Enterprise Ireland Development Advisor 
•  Local Enterprise Offices (LEO) 
•  Media advertisements 
•  Enterprise Ireland Events 
•  Other (please specify) 
 
Your motivations to access the RD&I programme 
Q3. On a scale of 1 to 5 (where one is ‘not at all important’ and 5 is ‘very important’) how 
important were the following motivations for applying for the RD&I programme?: 
[Matrix. Columns: 1-5, Do not know] 
•  Learn more about how RD&I could benefit your company 
•  Increase your company’s capacity and capability to undertake RD&I activities 
•  Undertake a new RD&I project in your company’s core business area 
•  Undertake a new RD&I project in a new business area (e.g. new application, new sector) 
•  Consolidate or increase your company’s current market position 
•  Expand to new markets outside Ireland 
•  Protect intellectual property emerging from your company’s RD&I activity 
•  Secure further private investments or financing (e.g. new investors, stronger commitment 
from existing investors) 
•  Secure further public investments or financing (e.g. research funds, grants, loans, equity 
investment, R&D tax credits, other public programmes) 
•  Increase profitability 
•  Reduce the financial risk associated with carrying out a new R&D project 
•  Other (please specify) 
 
Benefits emerging from your participation in RD&I programme  
Q4. To what extent have you experienced the following benefits from the support you received 
from the RD&I programme?:  
[Matrix. Columns: Yes, to a large extent; Yes, to some extent; No, but this is expected in the 
future; No, and this is not expected in the future, Not applicable] 
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•  Improved knowledge on the benefits of RD&I for our company 
•  Higher capacity to undertake RD&I activities 
•  Higher capability to undertake RD&I activities 
•  Development of new or enhanced products, processes or services 
•  Development of new or enhanced business innovations (e.g. organisational) 
•  Development of new or enhanced IP strategy  
•  Other (please specify) 
 
Q5. We want to understand how your level of R&D investment has changed since you received 
the support. What was the level of your annual R&D expenditure in the year before receiving 
the support and what is your current level of annual R&D expenditure? 
Please provide your best estimate in EUR or bands. 
[List of options: Before, Currently] 
 
Q6. To what extent have you experienced the following impacts on your business from the 
support you received? 
[Matrix. Columns: Yes, to a large extent; Yes, to some extent; No, but this is expected in the 
future; No, and this is not expected in the future, Not applicable] 
•  Increased or safeguarded turnover 
•  Created or safeguarded jobs  
•  Won new customers 
•  Won new business with existing customers 
•  Expanded to other sectors / product ranges 
•  Expanded to other markets outside Ireland 
•  Increased profitability 
•  Other (please specify) 
 
Q7. Have you experienced any other benefits from the RD&I programme (not captured in the 
prior questions)? Please describe: 
[Open text] 
Q8: Thinking about the ambition or project that motivated you to take part in the programme, 
what would have happened in the absence of support from the RD&I programme? 
•  We would have continued with our efforts or project at the same scale and in the same 
timeframe 
•  We would have continued with our efforts or project at a reduced scale 
•  We would have continued with our efforts or project at a later time 
•  We would have continued with our efforts or project at a reduced scale and at a later time 
•  We would have continued our with our efforts or project at an alternative location (outside 
Ireland) 
•  We would not have undertaken the project  
 
Evaluation of the Enterprise Ireland Research, Development and Innovation Programme 109 
 
Q9: Thinking about the benefits described in the prior questions, to what extent have each of 
the grant offers you received contributed to achieving those results?  . 
[Matrix. Columns:  Not applicable / Not at all / To a small extent / To a medium extent / To a 
large extent] 
•  Exploring Innovation Grant 
•  Research and Development (R&D) Fund 
•  Intellectual Property Strategy Offer (either IP Start of IP Plus) 
•  Agile Innovation Fund 
•  Business Innovation Projects 
Please describe your answer: [Open text] 
 
Your satisfaction with the RD&I programme 
Q10. Did you experience any of the following barriers during your application for or use of the 
support you received? Please tick all that apply, against each of the supports you received. 
Only tick the boxes for those schemes in which you were involved. 
[Matrix. Columns of tick boxes per grant scheme / support] 
•  The work required to prepare and submit the application 
•  The work required during the assessment process 
•  Securing co-financing for the grant 
•  Securing internal resourcing to implement the work 
•  Securing financing to continue the work after the grant finished 
•  Securing internal resourcing to continue the work after the grant finished 
•  Unable to hire people with the skills to undertake the project 
•  None 
•  Other (please specify) 
 
Q11. On a scale from 1 to 5 (where 1 is ‘not satisfied at all’, and 5 is ‘very satisfied’), how satisfied 
are you with the following aspects of the RD&I programme. Please respond to each of the 
supports you have received 
[Matrix. Drop-down boxes:  1-5, Do not know] 
•  Application process (e.g. clarity of the purpose of the grant, eligibility, level of detail 
required in the application process) 
•  The time from submission of the application to approval for the grant 
•  Administrative requirements following the approval of the application (e.g. reporting, 
monitoring) 
•  Size of the grant / level of the financial support 
•  The time period over which support is offered 
•  Support provided by the Enterprise Ireland Development Advisor 
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•  Support provided by the Enterprise Ireland Technologist 
 
Comparison with other RD&I support schemes 
Q12. Please indicate your level of engagement other R&D support measures available in 
Ireland:  
[Matrix. Columns:  Not aware / Aware but not accessed / Accessed once / Accessed 
repeatedly] 
•  R&D Tax Credit 
•  Knowledge Development Box 
•  Small Business Innovation Research 
•  European Space Agency 
•  Innovation Partnerships 
•  Innovation Vouchers 
•  European schemes (e.g. Enterprise Europe Network, Horizon 2020) 
•  Private sector support 
•  Others (Please specify) 
 
Q13. We are interested in understanding how various R&D support mechanisms interact and 
help businesses to achieve their goals. On a scale from 1 to 5 (where 1 is ‘not at all 
complementary’, and 5 is ‘completely complementary’), to what extent do you believe the 
RD&I Programme is complementary to the other listed RD&I support schemes?  
[Matrix. Columns:  1-5, Do not know, Not applicable/Not used] 
•  R&D Tax Credit 
•  Knowledge Development Box 
•  Small Business Innovation Research 
•  European Space Agency 
•  Innovation Partnerships 
•  Innovation Vouchers 
•  Horizon 2020 
 
Please explain your answer [open text] 
 
Future challenges 
Q14. What are the main challenges your business will face in the next 5-10 years? 
•  Recruitment issues (e.g. finding and retaining employees with appropriate skills) 
•  Technological advancements (e.g. integration, automation, etc.) 
•  Data management (e.g. information security, integrity, etc.) 
•  Supply chain issues (e.g. changing commodity prices, increasing competition, etc.) 
•  Maintaining profit margins 
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•  Increased market uncertainty (e.g. changing global conditions) 
•   Access to finance 
•  Changes in consumer demand 
•  Productivity (e.g. resource management) 
•  Other (please describe) 
 
Q15. On a scale of 1 to 5 (where one is ‘very appropriate’ and 5 is ‘not appropriate at all’), 
how appropriate is the RD&I programme (in its current configuration) in helping your 
organisation to address those future challenges? 
[Options: 1-5, Do not know] 
Please explain your answer [open text] 
 
Q16. What one thing would you recommend to Enterprise Ireland for improving the RD&I 




Q17. We would welcome the opportunity for a 15-20 minute telephone conversation discuss 
your answers and views in more detail. If you are willing to participate then please provide your 
details below. 
•  Name  
•  Email 
 
 Survey questionnaire for EI clients that have not accessed the RD&I programme  
Introduction 
Thank you for taking the time to reply to this survey. The Department of Business, Enterprise & 
Innovation (DBEI) has commissioned Technopolis Group to evaluate the direct financial support 
available for research and development (R&D) provided by Enterprise Ireland. This comprises 
a suite of supports, including: the Exploring Innovation Grant [LINK], the R&D Fund [LINK], the 
Agile Innovation Fund [LINK], the Business Innovation Projects grant [LINK], and the Intellectual 
Property Strategy Offer [LINK].  
You have received this survey as a client of Enterprise Ireland that has not yet received support 
through the RD&I Programme. As part of the evaluation of this fund, we are keen to understand 
what barriers might exist to firms undertaking this support. This will ensure that future iterations of 
the programme can be designed to best cater to the needs of Irish businesses. A letter of 
introduction, providing further information about the evaluation can be found at this [LINK]. 
All responses will be treated in strict confidence, and only reported at the highest possible level 
of aggregation.  
Confidentiality and data 
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Your participation in this survey is voluntary you are able to withdraw at any time. Indeed, you 
are free to request the withdrawal and deletion of your submission and data at any point during 
the course of the study. Technopolis Group provides independent, evidence-based research 
to support policy makers across the world. Technopolis operates in compliance with GDPR and 
take all steps to ensure the protection and confidentiality of your personal information.  
For further information on your rights and how to contact Technopolis, please refer to their 
Privacy Notice: http://www.technopolis-group.com/privacy-policy. For any queries please 
contact Martin Wain at martin.wain@technopolis-group.com. 
 
About your company 
Q1. Can you please confirm: 
•  Your sector of operation  
[Drop down menu with sectors] 
•  The size of your firm (full time equivalents) 
[List of options: 0-9 FTEs, 10-49, 50-249, 250+] 
•  The region you are based in  
[Drop down menu with regions]     
•  Number of years trading 
[Number] 
•  Please indicate if you have applied for the following grants under the EI RD&I programme  
[Drop down menu with name of grants, and option other]   
 
Reasons for not accessing the RD&I programme 
Q2. Which of the following statements best explain why you have not accessed the RD&I 
programme? Tick all that apply. 
•  We are not R&D active and do not plan to be in the near future 
•  We applied for Enterprise Ireland support but our application was not successful 
•  We were not aware of the available schemes 
•  We were not eligible for the programmes 
•  The application process was complex 
•  The process for drawing down other EI grants was complex 
•  We could not get matched funding for an RD&I grant 
•  Other schemes were more appropriate for our business 
•  Other, please describe 
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Future challenges 
Q4. What are the main challenges your business will face in the next 5-10 years? 
•  Recruitment issues (e.g. finding and retaining employees with appropriate skills) 
•  Technological advancements (e.g. integration, automation, etc.) 
•  Data management (e.g. information security, integrity, etc.) 
•  Supply chain issues (e.g. changing commodity prices, increasing competition, etc.) 
•  Maintaining profit margins 
•  Increased market uncertainty (e.g. changing global conditions) 
•   Access to finance 
•  Changes in consumer demand 
•  Productivity (e.g. resource management) 
•  Other (please describe) 
 
Q5. If you are planning future investment in R&D, on a scale of 1 to 5 (where one is ‘very 
appropriate’ and 5 is ‘not appropriate at all’), how appropriate do you believe the RD&I 
programme would be to address those future challenges?: 
[Options: 1-5, Do not know, Not Applicable] 
Please explain your answer [open text] 
 
Other schemes 
Q6. Have you received any other support from Enterprise Ireland? 
•  No, we have not received other support from Enterprise Ireland 
•  Yes, Capital support 
•  Yes, Employment support 
•  Yes, Market diversification support 
•  Other (Please specify) 
 
Q7. Have you used any alternative business support schemes for R&D? Tick all that apply 
•  R&D Tax Credit 
•  Knowledge Development Box 
•  Small Business Innovation Research 
•  European Space Agency 
•  Innovation Partnerships 
•  Innovation Vouchers 
•  European schemes (e.g. Enterprise Europe Network, Horizon 2020) 
•  Private sector support 
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•  Others (Please specify) 
 
Q8. We would welcome the opportunity for a 10-minute telephone conversation discuss your 
answers and views in more detail. If you are willing to participate then please provide your 
details below. 
•  Name  
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 Interview topic guide for RD&I programme awardees 
 Please tell us a little bit about your business  
 Could you briefly summarise your interactions with the Enterprise Ireland Development 
Advisor when applying to the RD&I programme? 
 Why did you / you and your DA decide to approach the RD&I programme? 
 What was the process of application? 
 To what extent were your business needs met through the RD&I programme? 
 Were any of your business needs un-met? 
 Is this due to missing provision or specific barriers 
 What do you regard as the most significant benefit or impact that the RD&I programme 
support has had on your business? 
 Do you expect any further benefits or impacts to be realised in the future? 
 Did you experience any barriers to maximising the benefits of the RD&I support? 
 Have you gone on to use any other RD&I-focused business support since using the RD&I 
programme? 
 Do you see any overlaps between the RD&I programme support you received and 
other support for RD&I in Ireland? 
 Do you have any other comments or remarks? 
 
 Interview topic guide for EI clients that have not accessed the RD&I programme 
8 Please tell us a little bit about your business  
9 Have you held any conversations with your Enterprise Ireland Development Advisor about 
receiving RD&I programme support? 
 Do you have any emergent business needs that might be served by the RD&I 
programme? 
10 Could you please summarise the reasons for not applying to the RD&I programme? 
 Were there any specific barriers that deterred you? 
11 Have you considered using any other RD&I-focused business support since using the RD&I 
programme? 
 If yes, what would make these suitable for your business? 
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 Interview topic guide for EI Development Advisors 
•  How many client firms do you have in your current portfolio? 
- Has this changed (increased/decreased) in the last 5-10 years? 
•  Which sector do you cover? 
•  What do you regard as the key achievements or impacts of the RD&I Programme (or its 
constituent parts)? 
•  Our econometric analysis shows that productivity effects have been limited among 
beneficiaries of the programme. Does this resonate with the evidence / feedback you get 
from client companies?  
- If yes, what is precluding them from achieving those benefits? 
- If not, do you have any examples on how participating in the programme has led to 
productivity effects? 
•  Our econometric analysis also shows that R&D expenditure has increased disproportionally 
more than R&D employment. Do you have a view of why that could be case?  
- Do you have a sense of how the grants accessed through the programme affect RD&I 
employment in beneficiary firms? 
•  Going forward, what changes would you make to the RD&I Programme to improve its 
effectiveness (e.g. orientation in terms of target groups/thematic vs open calls, etc.)? 
- Are there any special features or requirements of certain sectors that necessitate any 
changes in approach? 
•  In our prior consultations, we have heard some sense that the eligibility of the Business 
Innovation Offer has been confusing – does this resonate with you? 
•  Do you have any other comments you would like to make? 
 
 Interview topic guide for representatives of international comparator 
programmes 
•  What do you regard as the key achievements or impacts of [insert programme name]? 
- Have you noticed any productivity effects on beneficiaries of the programme? 
•  What would you say are the key success factors of [insert programme name]? 
•  Could you tell us about the key lessons learnt over the period of implementation? 
- Have any changes to the programme (e.g. orientation in terms of target 
groups/thematic vs open calls, etc.)? 
•  What is your approach to supporting new R&D performers (i.e. those firms that have not 
been R&D active before)? 
- How do you identify such firms? 
- How do you attract such firms? 
- How do you track the developments of these firms? 
•  Are there any differences in how R&D support is addressed nationally and regionally in 
[country]? 
•  [Only if the country offers an R&D tax credit or similar] Do you have any sense of how your 
beneficiary firms access/combine the support offered by [insert programme name] with 
[country’s] tax credit or similar incentives? 
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- Do you have a sense of which is more impactful for businesses? 
•  Do you have any other comments you would like to make? 
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 Template for international comparator data collection 
Descriptive information: 
•  Name of Initiative:  
•  Start date/End date:  
•  Funding agency:  
Contacts for further information: 
•  Name: 
•  Email: 
•  Bio: 
Description: 
•  Support available (type, duration) 
•  Maximum and minimum funding levels 
•  Basic details (format, budget, how long it has been running) 
Objectives: 
•  What does it aim to achieve? 
•  Rationale behind the programme, was it designed to help countries achieve certain 
targets? 
Eligibility criteria: 
•  Who can apply? 
•  What conditions exist for them to become beneficiaries?  
Achievements to date: 
•  What has the programme achieved? Over what time frame? 
•  How many have interacted with the programme? 
•  Were there any unintended benefits? 
Examples of success stories: 
•  Short case study vignettes of success stories seen through the programme (if available) 
Lessons learnt: 
•  Commentary on the key barriers and enablers to the programme 
How the case study programme compares to the EI RD&I programme: 
•  How does the programme’s performance compare to that of the EI RD&I?  
•  What lessons could be applied to the EI RD&I? 
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